Personensuche

Es wurde 1 Person gefunden.

Prof. Dr. med. Ken Herrmann

Funktionen

Direktor, Klinik für Nuklearmedizin

Aktuelle Veranstaltungen

WiSe 2025

Vergangene Veranstaltungen (max. 10)

SoSe 2025

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

Artikel in Zeitschriften

Lanzafame, Helena; Heilig, Christoph E.; Wardelmann, Eva; Desaulniers, Mélanie; Pabst, Kim Magaly; Mavroeidi, Ilektra Antonia; Pretzell, Ina; Fragoso Costa, Pedro; Nader, Michael; Leyser, Stephan; Schuler, Martin; Bauer, Sebastian; Siveke, Jens Thomas; Kamkar, Leila; Kreutzfeldt, Simon; Fröhling, Stefan; Mühl, Sebastian; Herrmann, Ken; Fendler, Wolfgang Peter; Hamacher, Rainer

90Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 9, S. 1378 – 1384

DOI
Hricak, Hedvig; Mayerhoefer, Marius E; Herrmann, Ken; Lewis, Jason S; Pomper, Martin G; Hess, Christopher P; Riklund, Katrine; Scott, Andrew M; Weissleder, Ralph

Advances and challenges in precision imaging

In: The Lancet Oncology, Jg. 26, 2025, Nr. 1, S. e34 – e45

DOI
Van Naarden, Jacob S.; Herrmann, Ken; Czernin, Johannes

Advancing Tomorrow’s Cancer Medicines

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 3, S. 337 – 339

DOI
Almeida, Ludmila Santiago; García Megías, Irene; Etchebehere, Elba Cristina Sá Camargo; Calapaquí Terán, Adriana K.; Herrmann, Ken; Giammarile, Francesco; Treglia, Giorgio; Delgado Bolton, Roberto C.

Assessment of the therapeutic efficacy of [¹⁷⁷Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer : A systematic review and meta-analysis

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 3, S. 936 – 954

DOI
Wei, Weijun; Grünwald, Viktor; Herrmann, Ken

CD70-targeted cancer theranostics : Progress and challenges

In: Med, Jg. 6, 2025, Nr. 8, 100671

DOI
Hahner, Stefanie; Hartrampf, Philipp; Beuschlein, Felix; Miederer, Matthias; Miehle, Konstanze; Schlötelburg, Wiebke; Fuß, Carmina Teresa; Pfluger, Thomas; Fottner, Christian; Tönjes, Anke; Herrmann, Ken; Amthauer, Holger; Reincke, Martin; Schreckenberger, Mathias; Sabri, Osama; Werner, Johanna; Reuter, Miriam; Kircher, Stefan; Arlt, Wiebke; Fassnacht, Martin; Konrad Buck, Andreas; Müller, Hans-Helge; Schirbel, Andreas

Combined [¹⁸F]Fluorodeoxyglucose PET and [¹²³I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias : the cross-sectional diagnostic test accuracy study FAMIAN

In: eBioMedicine, Jg. 116, 2025, 105735

DOI (Open Access)
Armstrong, Andrew J.; Sartor, Oliver; de Bono, Johann; Chi, Kim; Fizazi, Karim; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Saad, Fred; Beer, Tomasz M.; Wu, Jiwen; Mirante, Osvaldo; Morris, Michael J.

Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial”

In: European Urology, Jg. 87, 2025, Nr. 6, S. 738 – 739

DOI (Open Access)
Oster, Christoph; Matyar, Aylin; Schmidt, Teresa; Hummel, Thomas; Hattingen, Elke; Jokisch, Martha; Jokisch, Daniel; Grieger, Jana; Cappello, Giorgio; Kizina, Kathrin; Lazaridis, Lazaros; Ahmadipour, Yahya; Rauschenbach, Laurèl; Stuschke, Martin; Pöttgen, Christoph; Guberina, Nika; Tertel, Tobias; Giebel, Bernd; Dreizner, Gian Luca; Barbato, Francesco; Skoda, Eva-Maria; Scheffler, Björn; Müther, Michael; Herrmann, Ken; Kleinschnitz, Christoph; Sure, Ulrich; Deuschl, Cornelius; Glas, Martin; Kebir, Sied

Decoding glioblastoma survival : unraveling the prognostic potential of olfactory function in a prospective observational study

In: Neurological Research and Practice, Jg. 7, 2025, Nr. 1, 51

DOI (Open Access)
Keyl, Julius; Keyl, Philipp; Montavon, Grégoire; Hosch, René; Brehmer, Alexander; Mochmann, Liliana; Jurmeister, Philipp; Dernbach, Gabriel; Kim, Moon; Koitka, Sven; Bauer, Sebastian; Bechrakis, Nikolaos; Forsting, Michael; Führer-Sakel, Dagmar; Glas, Martin; Grünwald, Viktor; Hadaschik, Boris; Haubold, Johannes; Herrmann, Ken; Kasper, Stefan; Kimmig, Rainer; Lang, Stephan; Rassaf, Tienush; Roesch, Alexander; Schadendorf, Dirk; Siveke, Jens T.; Stuschke, Martin; Sure, Ulrich; Totzeck, Matthias; Welt, Anja; Wiesweg, Marcel; Baba, Hideo A.; Nensa, Felix; Egger, Jan; Müller, Klaus-Robert; Schuler, Martin; Klauschen, Frederick; Kleesiek, Jens

Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence

In: Nature Cancer, Jg. 6, 2025, Nr. 2, S. 307 – 322

DOI (Open Access)
Lindemann, Maike E.; Jentzen, Walter; Kersting, David; Fragoso Costa, Pedro; Küper, Alina; Umutlu, Lale; Herrmann, Ken; Quick, Harald H.

Detection and quantification of small and low-uptake lesions for differentiated thyroid carcinoma using non-time-of-flight iodine-124 PET/MRI

In: Medical Physics, Jg. 52, 2025, Nr. 2, S. 837 – 846

DOI (Open Access)
Storey, Claire M.; Altai, Mohamed; Lückerath, Katharina; Zedan, Wahed; Zhu, Henan; Breuer, Lara; Trajkovic-Arsic, Marija; Park, Julie; Hasson, Abbie; Siveke, Jens; Abou, Diane; Marks, Haley; Ulmert, Enna; Ridley, Alexander; Safi, Marcella; Lamminmäki, Urpo; Yuen, Constance; Geres, Susanne; Mao, Liqun; Cheng, Michael; Subudhi, Sumit K.; Siddiqui, Bilal A.; Federman, Noah; Czernin, Johannes; Herrmann, Ken; Bentolila, Laurent; Yang, Xia; Graeber, Thomas G.; Damoiseaux, Robert; Thorek, Daniel; Ulmert, David

Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance

In: Signal Transduction and Targeted Therapy, Jg. 10, 2025, Nr. 1, 319

DOI (Open Access)
Pouget, Jean-Pierre; Gabina, Pablo Minguez; Herrmann, Ken; Deandreis, Desirée; Konijnenberg, Mark; Taieb, David; van Leeuwen, Fijs W. B.; Kurth, Jens; Eberlein, Uta; Lassmann, Michael; Lückerath, Katharina; EANM Radiobiology Working Group

EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? : Part I: back to the basics of absorbed dose–response and threshold absorbed doses

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 3, S. 1210 – 1222

DOI (Open Access)
Moraitis, Alexandros; Kahl, Theresa; Kandziora, Jens; Jentzen, Walter; Kersting, David; Püllen, Lukas; Reis, Henning; Köllermann, Jens; Kesch, Claudia; Krafft, Ulrich; Hadaschik, Boris A.; Zaidi, Habib; Herrmann, Ken; Barbato, Francesco; Fendler, Wolfgang P.; Darr, Christopher; Fragoso Costa, Pedro

Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and their Prognostic Value in Radical Prostatectomy

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 3, S. 352 – 358

DOI
Braune, Anja; Hosch, René; Kersting, David; Müller, Juliane; Hofheinz, Frank; Herrmann, Ken; Nensa, Felix; Kotzerke, Jörg; Seifert, Robert

External phantom-based validation of a deep-learning network trained for upscaling of digital low count PET data

In: EJNMMI Physics, Jg. 12, 2025, Nr. 1, 38

DOI (Open Access)
García Megías, Irene; Almeida, Ludmila Santiago; Calapaquí Terán, Adriana K.; Pabst, Kim M.; Herrmann, Ken; Giammarile, Francesco; Delgado Bolton, Roberto C.

FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours : Are we nearer to surrounding the hallmarks of cancer?

In: Annals of Nuclear Medicine, Jg. 39, 2025, Nr. 5, S. 407 – 423

DOI (Open Access)
Gallardo Zamora, L.; von Rundstedt, F.C.; Wach, C.; Fendler, Wolfgang; Maric, I.; Herrmann, Ken; Siveke, Jens; Cheung, P.F.-Y.; Grünwald, Viktor

Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract

In: Urology Case Reports, Jg. 61, 2025, 103105

DOI (Open Access)
Fizazi, K.; Chi, K.N.; Shore, N.D.; Herrmann, Ken; de Bono, J.S.; Castellano, D.; Piulats, J.M.; Fléchon, A.; Wei, X.X.; Mahammedi, H.; Roubaud, G.; Fleming, M.; Haas, T.; Ghebremariam, S.; Kreisl, T.N.; Rajagopalan, S.; Sartor, O.; Morris, M.J.

Final overall survival and safety analyses of the phase III PSMAfore trial of [¹⁷⁷Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

In: Annals of Oncology, Jg. 36, 2025, Nr. 11, S. 1319 – 1330

DOI (Open Access)
Gal, Aharon; Herrmann, Ken; Czernin, Johannes

From Scientist to Analyst to Strategist : Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership inMultinational Pharma

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 2, S. 163 – 165

DOI
Veit-Haibach, Patrick; Herrmann, Ken; Zimmermann, Richard; Hustinx, Roland

Green Nuclear Medicine and Radiotheranostics

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 3, S. 340 – 343

DOI
Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Kersting, David; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel

Head-to-head comparison of ⁶⁸ Ga-FAPI-46 PET/CT, ¹⁸F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors

In: Annals of Nuclear Medicine, Jg. 39, 2025, Nr. 3, S. 255 – 265

DOI
Hosseini, Atefeh; Haj-Yehia, Elias; Korste, Sebastian; Kuzay, Yalcin; Trajkovic-Arsic, Marija; Settelmeier, Stephan; Cantore, Miriam; Ferenz, Katja; Siveke, Jens; Herrmann, Ken; Rassaf, Tienush; Hendgen-Cotta, Ulrike B.; Weber, Wolfgang A.; Varasteh, Zohreh

How Rapidly Does the FAPI PET Signal Reverse Following Therapy? : Assessing the FAPI PET Signal in Hypertensive Cardiac Injury and Fibrosis in Mice

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 11, S. 1757 – 1763

DOI (Open Access)
Borys, Katarzyna; Haubold, Johannes; Keyl, Julius; Bali, Maria A.; De Angelis, Riccardo; Boni, Kévin Brou; Coquelet, Nicolas; Kohnke, Judith; Baldini, Giulia; Kroll, Lennard; Schramm, Sara; Stang, Andreas; Malamutmann, Eugen; Kleesiek, Jens; Kim, Moon; Kasper, Stefan; Siveke, Jens T.; Wiesweg, Marcel; Merkel-Jens, Anja; Schaarschmidt, Benedikt M.; Gruenwald, Viktor; Bauer, Sebastian; Oezcelik, Arzu; Bölükbas, Servet; Herrmann, Ken; Kimmig, Rainer; Lang, Stephan; Treckmann, Jürgen; Stuschke, Martin; Hadaschik, Boris; Umutlu, Lale; Forsting, Michael; Schadendorf, Dirk; Friedrich, Christoph M.; Schuler, Martin; Hosch, René; Nensa, Felix

Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification

In: npj Digital Medicine, Jg. 8, 2025, Nr. 1, 611

DOI (Open Access)
Unterrainer, Lena M.; Hope, Thomas A.; Fendler, Wolfgang P.; Grogan, Tristan; Ndlovu, Honest; Armstrong, Wesley; Barbato, Francesco; Benz, Matthias R.; Rettig, Matthew B.; Kishan, Amar U.; Sathekge, Mike; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie

Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer : Retrospective Study from CHAARTED to PSMA PET ; An International Multicenter

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 1, S. 54 – 60

DOI
Gillessen, Silke; Turco, Fabio; Davis, Ian D.; Efstathiou, Jason A.; Fizazi, Karim; James, Nicholas D.; Shore, Neal; Small, Eric; Smith, Matthew; Sweeney, Christopher J.; Tombal, Bertrand; Zilli, Thomas; Agarwal, Neeraj; Antonarakis, Emmanuel S.; Aparicio, Ana; Armstrong, Andrew J.; Bastos, Diogo Assed; Attard, Gerhardt; Axcrona, Karol; Ayadi, Mouna; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Bourlon, Maria T.; Briganti, Alberto; Bulbul, Muhammad; Buttigliero, Consuelo; Caffo, Orazio; Castellano, Daniel; Castro, Elena; Cheng, Heather H.; Chi, Kim N.; Clarke, Caroline S.; Clarke, Noel; de Bono, Johann S.; De Santis, Maria; Duran, Ignacio; Efstathiou, Eleni; Ekeke, Onyeanunam N.; El Nahas, Tamer I.H.; Emmett, Louise; Fanti, Stefano; Fatiregun, Omolara A.; Feng, Felix Y.; Fong, Peter C.C.; Fonteyne, Valerie; Fossati, Nicola; George, Daniel J.; Gleave, Martin E.; Gravis, Gwenaelle; Halabi, Susan; Heinrich, Daniel; Herrmann, Ken; Hofman, Michael S.; Hope, Thomas A.; Horvath, Lisa G.; Hussain, Maha H.A.; Jereczek-Fossa, Barbara Alicja; Jones, Robert J.; Joshua, Anthony M.; Kanesvaran, Ravindren; Keizman, Daniel; Khauli, Raja B.; Kramer, Gero; Loeb, Stacy; Mahal, Brandon A.; Maluf, Fernando C.; Mateo, Joaquin; Matheson, David; Matikainen, Mika P.; McDermott, Ray; McKay, Rana R.; Mehra, Niven; Merseburger, Axel S.; Morgans, Alicia K.; Morris, Michael J.; Mrabti, Hind; Mukherji, Deborah; Murphy, Declan G.; Murthy, Vedang; Mutambirwa, Shingai B.A.; Nguyen, Paul L.; Oh, William K.; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Parker, Chris; Poon, Darren M.C.; Pritchard, Colin C.; Rabah, Danny M; Rathkopf, Dana; Reiter, Robert E.; Renard-Penna, Raphaele; Ryan, Charles J.; Saad, Fred; Sade, Juan Pablo; Sandhu, Shahneen; Sartor, Oliver A.; Schaeffer, Edward; Scher, Howard I.; Sharifi, Nima; Skoneczna, Iwona A.; Soule, Howard R.; Spratt, Daniel E.; Srinivas, Sandy; Sternberg, Cora N.; Suzuki, Hiroyoshi; Taplin, Mary-Ellen; Thellenberg-Karlsson, Camilla; Tilki, Derya; Türkeri, Levent N.; Uemura, Hiroji; Ürün, Yüksel; Vale, Claire L.; Vapiwala, Neha; Walz, Jochen; Yamoah, Kosj; Ye, Dingwei; Yu, Evan Y.; Zapatero, Almudena; Omlin, Aurelius; O’Sullivan, Joe M.

Management of Patients with Advanced Prostate Cancer : Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

In: European Urology, Jg. 87, 2025, Nr. 2, S. 157 – 216

DOI (Open Access)
Novruzov, Emil; Sheikh, Gabriel T.; Mamlins, Eduards; Holzgreve, Adrien; Mori, Yuriko; Ledderose, Stephan; Klauschen, Frederik; Watabe, Tadashi; Gorin, Michael A.; Pomper, Martin G.; Herrmann, Ken; Rowe, Steven P.; Werner, Rudolf A.; Giesel, Frederik L.

Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging : A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 8, S. 1245 – 1251

DOI (Open Access)
Mahmoud, Osama; Püllen, Lukas; Umutlu, Lale; Szarvas, Tibor; Fendler, Wolfgang; Ting, Saskia; Reis, Henning; Bayer, Henning; Herrmann, Ken; Hadaschik, Boris; Al-Nader, Mulham; Berliner, Christoph

Multitracer comparison of gold standard PSMA-PET/CT with 68Ga-FAPI and 18F-FDG in high-risk prostate cancer : a proof-of-concept study

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 13, S. 4860 – 4869

DOI
Kabunda, Joseph; Ndlovu, Honest; Singh, Karishma; Sibiya, Sandile; Mdanda, Sipho; Ramonaheng, Kamo; Al-Ibraheem, Akram; Herrmann, Ken; Mokoala, Kgomotso; Sathekge, Mike

Nectin-4, Bladder Cancer, and Nuclear Medicine : A Theranostic Frontier

In: Seminars in Nuclear Medicine, Jg. 55, 2025, Nr. 6, S. 912 – 927

DOI
Barata, Pedro C.; Zarrabi, Kevin K.; Bex, Axel; Grivas, Petros; Herrmann, Ken; Hofman, Michael S.; Li, Roger; Lopez-Beltran, Antonio; Padani, Anwar R.; Powles, Thomas; Taplin, Mary-Ellen; Loriot, Yohann

Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers

In: European Urology, Jg. 87, 2025, Nr. 4, S. 412 – 423

DOI
Sollini, Martina; Calais, Jeremie; Chiti, Arturo; Emmett, Louise; Fanti, Stefano; Fendler, Wolfgang; Herrmann, Ken; Hope, Thomas A.; Sartor, Oliver; Shuch, Brian; Tagawa, Scott; Hofman, Michael S.

Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers

In: European Urology, Jg. 87, 2025, Nr. 2, S. 125 – 139

DOI
Koller, Pia; Clement, Christoph; van Eijk, Albert; Seifert, Robert; Zhang, Jingjing; Prenosil, George; Sathekge, Mike M.; Herrmann, Ken; Baum, Richard; Weber, Wolfgang A.; Rominger, Axel; Shi, Kuangyu

Optimizing theranostics chatbots with context-augmented large language models

In: Theranostics, Jg. 15, 2025, Nr. 12, S. 5693 – 5704

DOI (Open Access)
Holzgreve, Adrien; Hellwig, Dirk; Barthel, Henryk; Beer, Ambros J.; Kobe, Carsten; Lapa, Constantin; Miederer, Matthias; Schwarzenböck, Sarah; Seifert, Robert; Todica, Andrei; Herrmann, Ken; Bengel, Frank M.; Schäfers, Michael; Moka, Detlef; Luster, Markus; Fendler, Wolfgang

PET imaging utilization and trends in Germany : a comprehensive survey

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 12, S. 4390 – 4398

DOI (Open Access)
Vargas, Hebert Alberto; Fanti, Stefano; Herrmann, Ken; Eiber, Mathias; Rowe, Steven P.; Rivera, Adrian; Pitsoulakis, Evangelia; Becker, Anton; Woo, Sungmin; Loeb, Stacy

PSMA PET/CT Reporting : Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation Frameworks

In: Radiology, Jg. 317, 2025, Nr. 1, S. e250702

DOI
Guberina, Maja; Metzenmacher, Martin; Pöttgen, Christoph; Wiesweg, Marcel; Guberina, Nika; Merkel-Jens, Anja; Lütke-Brintrup, Diana; Bölükbas, Servet; Eberhardt, Wilfried; Stamatis, Georgios; Doerr, Fabian; Plönes, Till; Hoffmann, Christian; Zaun, Gregor; Höing, Benedikt; Kürten, Cornelius; Mladenov, Emil; Iliakis, George; Kersting, David; Fendler, Wolfgang; Gauler, Thomas; Opitz, Marcel; Milosevic, Aleksandar; Forsting, Michael; Nensa, Felix; Umutlu, Lale; Funke, Faustina; Hautzel, Hubertus; Herrmann, Ken; Taube, Christian; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin

Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer

In: Thoracic Cancer, Jg. 16, 2025, Nr. 22, e70183

DOI (Open Access)
Pabst, Kim M.; Siegmund, Sophie C.; Holzgreve, Adrien; Schmid, Hans P.; Bartel, Timo; Herrmann, Ken; Küper, Alina T.; Aydogdu, Can; Kersting, David; Kesch, Claudia; Hadaschik, Boris A.; Unterrainer, Marcus; Stief, Christian G.; Cyran, Clemens C.; Werner, Rudolf A.; Fendler, Wolfgang P.; Casuscelli, Jozefina; Unterrainer, Lena M.

Potential value of [⁶⁸Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma : A bi-centric analysis

In: European Journal of Nuclear Medicine and Molecular Imaging, 2025, in press

DOI (Open Access)
Kasper, Stefan; Elez, E.; Neumann, U.; Lang, S.; Trampe, A.-K.; Salva, F.; Dopazo, C.; Virchow, I.; Hartmann, Sylvia; Herrmann, Ken; Tabernero, J.; Westendorf, Astrid; Schuler, Martin; Schramm, A.

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases : The PURPLE trial

In: ESMO Gastrointestinal Oncology, Jg. 9, 2025, 100226

DOI (Open Access)
Telli, Tugce; Lopes, Leonor; Karpinski, Madeleine; Pabst, Kim M.; Grünwald, Viktor; Shi, Kuangyu; Hadaschik, Boris; Kesch, Claudia; Umutlu, Lale; Herrmann, Ken; Seifert, Robert; Fendler, Wolfgang

Prognostic value of [¹⁸F]FDG- and PSMA-PET in patients evaluated for [¹⁷⁷Lu]Lu-PSMA therapy of mCRPC

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 9, S. 3199 – 3210

DOI (Open Access)
Kessler, Lukas; Settelmeier, Stephan; Pabst, Kim M.; Telli, Tugce; Varasteh, Zohreh; Costa, Pedro Fragoso; Jentzen, Walter; Barbato, Francesco; Hautzel, Hubertus; Himmen, Stephan; Rischpler, Christoph; Rassaf, Tienush; Herrmann, Ken; Kersting, David

Quantitative evaluation of ¹²³I-MIBG imaging in patients with myocarditis : Impairment of cardiac neuronal function revisited

In: Annals of Nuclear Medicine, 2025, in press

DOI (Open Access)
Civan, Caner; Guberina, Nika; Krafft, Ulrich; Fendler, Wolfgang; Stuschke, Martin; Herrmann, Ken

Radiopharmaceuticals in Prostate Cancer : General Considerations and Utility in Combination With EBRT

In: Seminars in Radiation Oncology, Jg. 35, 2025, Nr. 3, S. 463 – 473

DOI
Pizzuto, Daniele Antonio; Becker, Minerva; Veit-Haibach, Patrick; Messerli, Michael; Liberini, Virginia; Gennari, Antonio Giulio; Lam, Winnie Wing-Chuen; Maurer, Alexander; Sekine, Tetsuro; Picchio, Maria; Nogami, Munenobu; Annunziata, Salvatore; Herrmann, Ken; Huellner, Martin

Recent advances in PET/MR imaging for head and neck tumors : A systematic review of the last three years

In: La Radiologia Medica, Jg. 130, 2025, Nr. 11, S. 1827 – 1841

DOI (Open Access)
Hope, Thomas A.; Calais, Jeremie; Goenka, Ajit H.; Haberkorn, Uwe; Konijnenberg, Mark; McConathy, Jonathan; Oprea-Lager, Daniela E.; Trimnal, Laura; Zan, Elcin; Herrmann, Ken; Deroose, Christophe M.

SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 1, S. 26 – 33

DOI (Open Access)
Herrmann, Ken; Walz, Jochen; MacLennan, Steven; Briganti, Alberto; Cornford, Philip; Czernin, Johannes; Eiber, Matthias; Fanti, Stefano; Fendler, Wolfgang P.; Fizazi, Karim; Gafita, Andrei; Gillessen, Silke; Goffin, Karolien; Hadaschik, Boris; Hofman, Michael S.; Hope, Thomas A.; Maurer, Tobias; Morgans, Alicia K.; Morris, Michael J.; Murphy, Declan G.; Oprea-Lager, Daniela E.; Ost, Piet; ÓSullivan, Joe M.; Rouvière, Olivier; Sandhu, Shahneen; Sartor, Oliver; Sathekge, Mike Machaba; Tempany, Clare; Witjes, Wim; Emmett, Louise; Bjartell, Anders S.

SPARC : The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus ; A Delphi Analysis

In: European Urology, 2025, in press

DOI (Open Access)
Kersting, David; Borys, Katarzyna; Küper, Alina; Kim, Moon; Haubold, Johannes; Goerttler, Tsepo; Umutlu, Lale; Costa, Pedro Fragoso; Kleesiek, Jens; Rischpler, Christoph; Nensa, Felix; Herrmann, Ken; Fendler, Wolfgang; Weber, Manuel; Hosch, René; Seifert, Robert

Staging of prostate Cancer with ultra-fast PSMA-PET scans enhanced by AI

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 5, S. 1658 – 1670

DOI (Open Access)
Kesch, Claudia; Franiel, Tobias; Berliner, Christoph; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris

Stellenwert der PSMA-PET/CT („prostate-specific membrane antigen positron emission tomography/computed tomography“) im Rahmen des Stagings

In: Die Urologie, Jg. 64, 2025, Nr. 3, S. 220 – 228

DOI
Ciuciulkaite, Ieva; Herrmann, Ken; Lahner, Harald

Stellenwert der Peptid-Radio-Rezeptor-Therapie für das Management neuroendokriner Tumoren

In: Die Radiologie, Jg. 65, 2025, Nr. 5, S. 371 – 380

DOI
Lazaridis, Lazaros; Moenninghoff, Christoph; Bumes, Elisabeth; Spille, Dorothee Cäcilia; Müther, Michael; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Ahmadipour, Yahya; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Guberina, Nika; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin

Temporal Muscle Thickness as a Prognostic Marker in a Real-Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma : A Multicentric Imaging Analysis

In: Cancer Medicine, Jg. 14, 2025, Nr. 8, e70689

DOI (Open Access)
Albers, Peter; Franiel, Tobias; Kötter, Thomas; Kristiansen, Glen; Herrmann, Ken; Wiegel, Thomas

The Early Detection, Diagnostic Evaluation, and Local Treatment of Prostate Cancer : A Paradigm Shift

In: Deutsches Ärzteblatt International, Jg. 122, 2025, Nr. 15, S. 420 – 426

DOI (Open Access)
Pabst, Kim M.; Fendler, Wolfgang; Jochheim, Leonie S.; Herrmann, Ken

The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer : An Update

In: Seminars in Nuclear Medicine, Jg. 55, 2025, Nr. 5, S. 701 – 709

DOI (Open Access)
Primac, Irina; Tabury, Kevin; Tasdogan, Alpaslan; Baatout, Sarah; Herrmann, Ken

The molecular blueprint of targeted radionuclide therapy

In: Nature Reviews Clinical Oncology, Jg. 22, 2025, Nr. 11, S. 869 – 894

DOI
Stokkel, Marcel P M; Gotthardt, Martin; Herrmann, Ken; Gnanasegaran, Gopinath

Theranostics in Perspective : White Paper

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 7, S. 1007 – 1011

DOI
Čiučiulkaitė, Ieva; Zuccotti, Giulia A.; Jallo, Cherbel; Hautzel, Hubertus; Brandenburg, Tim; Costa, Pedro F.; Küper, Alina T.; Himmen, Stephan M.; Görges, Rainer; Bockisch, Andreas; Herrmann, Ken; Jentzen, Walter; Kersting, David; Fendler, Wolfgang

Thyroid Hormone Withdrawal Yields Higher ¹³¹I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer : Evidence from a Large ¹²⁴I PET/CT Dosimetry Cohort

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 11, S. 1722 – 1728

DOI
Moraitis, Alexandros; Prochnow, Andre; Poeppel, Thorsten Dirk; Schmitz, Jochen; Laschinsky, Christina; Herrmann, Ken; Bockisch, Andreas; Costa, Pedro Fragoso; Kersting, David; Jentzen, Walter; Fragoso Costa, Pedro

Tumor Dose–Response Relationship of [¹³¹I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [¹²⁴I]MIBG PET

In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 4, S. 641 – 647

DOI
Karpinski, Madeleine J.; Rahbar, Kambiz; Bögemann, Martin; Nikoukar, Laya Rahbar; Schäfers, Michael; Hoberück, Sebastian; Miederer, Matthias; Hölscher, Tobias; Rasul, Sazan; Miszczyk, Marcin; Lanfranchi, Francesco; Bauckneht, Matteo; Pfob, Christian H.; Kind, Felix; Goffin, Karolien; Hüsing, Anika; Kesch, Claudia; Herrmann, Ken; Stuschke, Martin; Gafita, Andrei; Hüsing, Johannes; Calais, Jeremie; Hofman, Michael S.; Hope, Thomas A.; Miksch, Jonathan; Soeterik, Timo F.W.; Di Giorgio, Andrea; Farolfi, Andrea; Bjartell, Anders; Trägårdh, Elin; Unterrainer, Lena M.; Holzgreve, Adrien; Sheikh, Gabriel T.; Rauscher, Isabel; Eiber, Matthias; Hadaschik, Boris A.; Fendler, Wolfgang P.; Rodriguez SantAnna Jauregui, Nadir; Hacker, Marcus; Shariat, Shahrokh F.; Fornarini, Giuseppe; Terrone, Carlo; Ahmadi Bidakhvidi, Niloefar; Evangelista, Laura; Santangelo, Alfonso; Vondrak, Andrej; van Melick, Harm H.E.; Rapa, Marco; Bianchi, Lorenzo; Rastbäck, Anniqa; Andersson, Åsa; Kunte, Sophie C.; Späth, Lukas; Hempel, Linus; Coban, Ömür

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2) : Results from an International Multicentre Registry Study

In: European Urology, Jg. 88, 2025, Nr. 5, S. 484 – 495

DOI (Open Access)
Lam, Marnix; Garin, Etienne; Haste, Paul; Denys, Alban; Geller, Brian; Kappadath, S. Cheenu; Turkmen, Cuneyt; Sze, Daniel Y.; Alsuhaibani, Hamad Saleh; Herrmann, Ken; Maccauro, Marco; Cantasdemir, Murat; Dreher, Matthew; Fowers, Kirk D.; Gates, Vanessa; Salem, Riad

Utility of pre-procedural [⁹⁹mTc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of ⁹⁰Y Glass microspheres in patients with Hepatocellular Carcinoma : Comparison of anatomic versus [⁹⁹mTc]TcMAA-based Segmentation

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 2, S. 744 – 755

DOI (Open Access)
Gafita, Andrei; Martin, Andrew J; Emmett, Louise; Eiber, Matthias; Iravani, Amir; Fendler, Wolfgang P.; Buteau, James; Sandhu, Shahneen; Azad, Arun A; Herrmann, Ken; Stockler, Martin R; Davis, Ian D; Hofman, Michael S

Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP) : A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial

In: European Urology Oncology, Jg. 8, 2025, Nr. 1, S. 21 – 28

DOI
Hoffmann, Christian; Hautzel, Hubertus; Wiesweg, Marcel; Kersting, David; Guberina, Nika; Pöttgen, Christoph; Metzenmacher, Martin; Schuler, Martin; Gauler, Thomas; Höing, Benedikt; Kürten, Cornelius; Doerr, Fabian; Bölükbas, Servet; Baldes, Natalie; Opitz, Marcel; Milosevic, Aleksandar; Nensa, Felix; Umutlu, Lale; Funke, Faustina; Fendler, Wolfgang; Herrmann, Ken; Stuschke, Martin; Guberina, Maja

[18F]FDG-PET/CT-based evaluation of tumor response kinetics during induction chemotherapy and concurrent radiochemotherapy in stage II - III small-cell lung cancer

In: European Journal of Nuclear Medicine and Molecular Imaging, 2025, in press

DOI (Open Access)
Rauschenbach, Laurèl; Gerach, Felix M.; Berliner, Christoph; Blau, Tobias; Kebir, Sied; Dobersalske, Celia; Deuschl, Cornelius; Sure, Ulrich; Herrmann, Ken; Dammann, Philipp

[⁶⁸Ga]-DOTA-conjugated somatostatin receptor-targeting peptide PET for the differentiation between meningioma and glioblastoma : A case report and review of the literature

In: Oncology Letters, Jg. 29, 2025, Nr. 4, 199

DOI (Open Access)
Pabst, Kim M; Weber, Manuel; Laschinsky, Christina; Sandach, Patrick; Bartel, Timo; Küper, Alina T; Kessler, Lukas; Trajkovic-Arsic, Marija; Eckstein, Markus; Gilman, Elena; Nader, Michael; Barbato, Francesco; Podleska, Lars; Hadaschik, Boris; Hamacher, Rainer; Kersting, David; von Ostau (N.), Nicola; von Tresckow, Bastian; Kaelberlah, Hans-Peter; Kesch, Claudia; Kuemmel, Sherko; Reinacher-Schick, Anke; Schuler, Martin; Siveke, Jens; Grünwald, Viktor; Herrmann, Ken; Fendler, Wolfgang P.

[⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trial

In: The Lancet Oncology, Jg. 26, 2025, Nr. 9, S. 1204 – 1214

DOI (Open Access)
Lanzafame, Helena; Mavroeidi, Ilektra A.; Pabst, Kim M.; Desaulniers, Mélanie; Ingenwerth, Marc; Hirmas, Nader; Kessler, Lukas; Nader, Michael; Bartel, Timo; Leyser, Stephan; Barbato, Francesco; Schuler, Martin; Bauer, Sebastian; Siveke, Jens T.; Herrmann, Ken; Hamacher, Rainer; Fendler, Wolfgang P.

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 880 – 887

DOI
Flippot, Ronan; Telli, Tugce; Velev, Maud; Fléchon, Aude; De Vries-Brilland, Manon; Turpin, Léa; Bergman, Andries; Turco, Fabio; Mahammedi, Hakim; Fendler, Wolfgang; Giraudet, Anne-Laure; Josset, Quentin; Montravers, Françoise; Vogel, Wouter; Gillessen, Silke; Berardi Vilei, Simona; Herrmann, Ken; Kryza, David; Paone, Gaetano; Hadaschik, Boris; Merlin, Charles; Dufour, Pierre-Alban; Bernard-Tessier, Alice; Naoun, Natacha; Patrikidou, Anna; Garcia, Camilo; Foulon, Stéphanie; Pagès, Arnaud; Fizazi, Karim

Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study

In: European Urology Oncology, Jg. 7, 2024, Nr. 5, S. 1132 – 1140

DOI
Kong, Grace; Noe, Geertje; Chiang, Cherie; Herrmann, Ken; Hope, Thomas A.; Michael, Michael

Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkers

In: Journal of Neuroendocrinology, Jg. 37, 2024, Nr. 7, Special Issue: Current status and cutting‐edge insights in Peptide Receptor Radionuclide Therapy, e13461

DOI (Open Access)
Armstrong, Andrew J.; Sartor, Oliver; de Bono, Johann; Chi, Kim; Fizazi, Karim; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Saad, Fred; Beer, Tomasz M.; Wu, Jiwen; Mirante, Osvaldo; Morris, Michael J.

Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [¹⁷⁷Lu]Lu-PSMA-617 in the Phase 3 VISION Trial

In: European Urology, Jg. 86, 2024, Nr. 6, S. 552 – 562

DOI (Open Access)
Moraitis, Alexandros; Jentzen, Walter; Reiter, Gloria; Schmitz, Jochen; Pöppel, Thorsten Dirk; Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang Peter; Fragoso Costa, Pedro; Bockisch, Andreas; Kersting, David

Biodistribution and radiation dosimetry of ¹²⁴I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric models

In: EJNMMI Physics, Jg. 11, 2024, Nr. 1, 3

DOI, Online Volltext (Open Access)
Weber, Manuel; Pettersson, Olof; Seifert, Robert; Schaarschmidt, Benedikt; Fendler, Wolfgang; Rischpler, Christoph; Lahner, Harald; Herrmann, Ken; Sundin, Anders

Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 3, S. 841 – 851

DOI (Open Access)
Karpinski, Madeleine J; Hüsing, Johannes; Claassen, Kevin; Möller, Lennart; Kajüter, Hiltraud; Oesterling, Florian; Grünwald, Viktor; Umutlu, Lale; Kleesiek, Jens; Telli, Tugce; Merkel-Jens, Anja; Hüsing, Anika; Kesch, Claudia; Herrmann, Ken; Eiber, Matthias; Hoberück, Sebastian; Meyer, Philipp T; Kind, Felix; Rahbar, Kambiz; Schäfers, Michael; Stang, Andreas; Hadaschik, Boris A.; Fendler, Wolfgang P.

Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer : A multicentre retrospective study

In: The Lancet Oncology, Jg. 25, 2024, Nr. 9, S. 1188 – 1201

DOI (Open Access)
Morris, Michael J.; de Bono, Johann; Nagarajah, James; Sartor, Oliver; Wei, Xiao X.; Nordquist, Luke T.; Koshkin, Vadim S.; Chi, Kim N.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Vickers, Adrian; Mirante, Osvaldo; Ghouse, Ray; Fizazi, Karim; Tagawa, Scott T.

Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer : Analysis of the phase 3 VISION trial

In: Cancer, Jg. 130, 2024, Nr. 20, S. 3426 – 3435

DOI (Open Access)
Schwander, Bjoern; Klesper, Katharina; Rossol, Siegbert; Herrmann, Ken; Zoellner, York Francis

Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective

In: ClinicoEconomics and Outcomes Research, Jg. 16, 2024, S. 483 – 492

DOI (Open Access)
Dobersalske, Celia; Rauschenbach, Laurèl; Hua, Yichao; Berliner, Christoph; Steinbach, Anita; Grüneboom, Anika; Kokkaliaris, Konstantinos D.; Heiland, Dieter H.; Berger, Pia; Langer, Sarah; Tan, Chin L.; Stenzel, Martin; Landolsi, Somaya; Weber, Flora; Darkwah Oppong, Marvin; Werner, Rudolf A.; Gull, Hanah; Schröder, Thomas; Linsenmann, Thomas; Buck, Andreas K.; Gunzer, Matthias; Stuschke, Martin; Keyvani, Kathy; Forsting, Michael; Glas, Martin; Kipnis, Jonathan; Steindler, Dennis A.; Reinhardt, Hans Christian; Green, Edward W.; Platten, Michael; Tasdogan, Alpaslan; Herrmann, Ken; Rambow, Florian; Cima, Igor; Sure, Ulrich; Scheffler, Björn

Cranioencephalic functional lymphoid units in glioblastoma

In: Nature Medicine, Jg. 30, 2024, Nr. 10, S. 2947 – 2956

DOI (Open Access)
Kupusovic, Jana; Kessler, Lukas; Kazek, Sandra; Chodyla, Michal Kamil; Umutlu, Lale; Zarrad, Fadi; Nader, Michael; Fendler, Wolfgang; Varasteh, Zohreh; Herrmann, Ken; Dobrev, Dobromir; Wakili, Reza; Rassaf, Tienush; Siebermair, Johannes; Rischpler, Christoph

Delayed ⁶⁸Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction

In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 50, 2024, 101340

DOI (Open Access)
Berrens, Anne-Claire; Scheltema, Matthijs; Maurer, Tobias; Herrmann, Ken; Hamdy, Freddie C.; Knipper, Sophie; Dell’Oglio, Paolo; Mazzone, Elio; de Barros, Hilda A.; Sorger, Jonathan M.; van Oosterom, Matthias N.; Stricker, Philip D.; van Leeuwen, Pim J.; Rietbergen, Daphne D. D.; Valdes Olmos, Renato A.; Vidal-Sicart, Sergi; Carroll, Peter R.; Buckle, Tessa; van der Poel, Henk G.; van Leeuwen, Fijs W. B.

Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery : Outcomes from an international multidisciplinary panel

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 10, S. 2893 – 2902

DOI
Sartor, Oliver; Fizazi, Karim; Herrmann, Ken; Morris, Michael J.

Design Considerations in the PSMAfore Trial

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 2, S. 226 – 227

DOI (Open Access)
Pabst, Kim M.; Mei, Riccardo; Lückerath, Katharina; Hadaschik, Boris; Kesch, Claudia; Rawitzer, Josefine; Kessler, Lukas; Bodensieck, Luisa S.; Hamacher, Rainer; Pomykala, Kelsey L.; Fanti, Stefano; Herrmann, Ken; Fendler, Wolfgang

Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [⁶⁸Ga]Ga-/[¹⁸F]F-PSMA-11/-1007, [⁶⁸Ga]Ga-FAPI-46 and 2-[¹⁸F]FDG PET/CT : a pilot study

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2024, Nr. 1, S. 342 – 353

DOI (Open Access)
Heinzelmann, Anna; Tewes, Mitra; Müller, Sandy; Sure, Ulrich; Herrmann, Ken; Schadendorf, Dirk; Warnecke, Eva; Rausch, Raya; Skoda, Eva-Maria; Salvador Comino, Maria Rosa

Determining the cut-off value for the Minimal Documentation System (MIDOS2) screening tool to initiate specialized palliative care based on patient’s subjective need for palliative support and symptom burden in inpatients with advanced cancer

In: Journal of Cancer Research and Clinical Oncology, Jg. 150, 2024, Nr. 7, 360

DOI, Online Volltext (Open Access)
Al-Ibraheem, Akram; Abdlkadir, Ahmed; Herrmann, Ken; Bomanji, Jamshed; Jadvar, Hossein; Shi, Hongcheng; Mansour, Asem; Paez, Diana; Chiti, Arturo; Scott, Andrew M.

Diagnostic Accuracy of [¹⁸F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma : A Systematic Review and Metaanalysis

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 10, S. 1533 – 1539

DOI
Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang

Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 3, S. 372 – 378

DOI (Open Access)
Vardarli, Irfan; Tan, Susanne; Görges, Rainer; Krämer, Bernhard K.; Herrmann, Ken; Brochhausen, Christoph

Diagnostic accuracy of Afirma gene expression classifier, Afirma gene sequencing classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV) thyroid nodules : A meta-analysis

In: Endocrine Connections, Jg. 13, 2024, Nr. 7, e240170

DOI (Open Access)
Farolfi, Andrea; Armstrong, Wesley R.; Djaileb, Loic; Gafita, Andrei; Hotta, Masatoshi; Allen-Auerbach, Martin; Unterrainer, Lena M.; Fendler, Wolfgang; Rettig, Matthew; Eiber, Matthias; Hofman, Michael S.; Hadaschik, Boris; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie; Benz, Matthias R.

Differences and Common Ground in ¹⁷⁷Lu-PSMA Radioligand Therapy Practice Patterns : International Survey of 95 Theranostic Centers

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 3, S. 438 – 445

DOI (Open Access)
Watanabe, Masao; Leyser, Stephan; Theysohn, Jens; Schaarschmidt, Benedikt; Ludwig, Johannes; Fendler, Wolfgang; Moraitis, Alexandros; Lahner, Harald; Mathew, Annie; Herrmann, Ken; Weber, Manuel

Dose-Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with ⁹⁰Y Glass Microspheres

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1175 – 1180

DOI
Stokke, Caroline; Gnesin, Silvano; Tran-Gia, Johannes; Cicone, Francesco; Holm, Søren; Cremonesi, Marta; Blakkisrud, Johan; Wendler, Thomas; Gillings, Nic; Herrmann, Ken; Mottaghy, Felix M.; Gear, Jonathan

EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 7, S. 1909 – 1922

DOI (Open Access)
Schuler, Martin; Hense, Jörg; Darwiche, Kaid; Michels, Sebastian; Hautzel, Hubertus; Kobe, Carsten; Lueong, Smiths; Metzenmacher, Martin; Herold, Thomas; Zaun, Gregor; Laue, Katharina; Drzezga, Alexander; Theegarten, Dirk; Nensa, Felix; Wolf, Jürgen; Herrmann, Ken; Wiesweg, Marcel

Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 851 – 855

DOI
Brehmer, Alexander; Sauer, Christopher Martin; Salazar Rodríguez, Jayson; Herrmann, Kelsey; Kim, Moon; Keyl, Julius; Bahnsen, Fin Hendrik; Frank, Benedikt; Köhrmann, Martin; Rassaf, Tienush; Mahabadi, Amir Abbas; Hadaschik, Boris; Darr, Christopher; Herrmann, Ken; Tan, Susanne; Buer, Jan; Brenner, Thorsten; Reinhardt, Hans Christian; Nensa, Felix; Gertz, Michael; Egger, Jan; Kleesiek, Jens

Establishing Medical Intelligence - Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management : Retrospective Cohort and Clinical Implementation Study

In: Journal of Medical Internet Research (JMIR), Jg. 26, 2024, e55148

DOI, Online Volltext (Open Access)
Oprea-Lager, Daniela-Elena; MacLennan, Steven; Bjartell, Anders; Briganti, Alberto; Burger, Irene A.; de Jong, Igle; De Santis, Maria; Eberlein, Uta; Emmett, Louise; Fizazi, Karim; Gillessen, Silke; Herrmann, Ken; Heskamp, Sandra; Iagaru, Andrei; Jereczek-Fossa, Barbara Alicja; Kunikowska, Jolanta; Lam, Marnix; Nanni, Cristina; O'Sullivan, Joe M.; Panebianco, Valeria; Sala, Evis; Sathekge, Mike; Sosnowski, Roman; Tilki, Derya; Tombal, Bertrand; Treglia, Giorgio; Tunariu, Nina; Walz, Jochen; Yakar, Derya; Dierckx, Rudi; Sartor, Oliver; Fanti, Stefano

European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer

In: European Urology, Jg. 85, 2024, Nr. 1, S. 49 – 60

DOI (Open Access)
Settelmeier, Stephan; Kessler, Lukas; Varasteh, Zohreh; Mahabadi, Amir Abbas; Michel, Lars; Papathanasiou, Maria; Laschinsky, Christina; Rischpler, Christoph; Fendler, Wolfgang; Schlosser, Thomas; Umutlu, Lale; Herrmann, Ken; Rassaf, Tienush; Kersting, David

FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice : A Pictorial Imaging Vignette

In: JACC Cardiovascular Imaging, Jg. 17, 2024, Nr. 7, S. 811 – 823

DOI (Open Access)
Hamacher, Rainer; Pabst, Kim M.; Cheung, Phyllis F.; Heilig, Christoph E.; Hüllein, Jennifer; Liffers, Sven-Thorsten; Borchert, Sabrina; Fragoso Costa, Pedro; Schaarschmidt, Benedikt; Kessler, Lukas; Miera, Monika A.; Droste, Margret; Akbulut, Merve; Falkenhorst, Johanna; Zarrad, Fadi; Kostbade, Karina; Mavroeidi, Ilektra A.; Glimm, Hanno; Umutlu, Lale; Schuler, Martin; Hübschmann, Daniel; Bauer, Sebastian; Fröhling, Stefan; Herrmann, Ken; Siveke, Jens T.; Schildhaus, Hans-Ulrich; Fendler, Wolfgang P.

Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 2, S. 252 – 257

DOI (Open Access)
Kessler, Lukas; Schwaning, Felix; Metzenmacher, Martin; Pabst, Kim; Siveke, Jens; Trajkovic-Arsic, Marija; Schaarschmidt, Benedikt; Wiesweg, Marcel; Aigner, Clemens; Plönes, Till; Darwiche, Kaid; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Theegarten, Dirk; Hamacher, Rainer; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Fendler, Wolfgang P.; Hautzel, Hubertus

Fibroblast Activation Protein-Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma : A Prospective, Single-Center, Observational Trial

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1188 – 1193

DOI
Moraitis, Alexandros; Küper, Alina; Tran-Gia, Johannes; Eberlein, Uta; Chen, Yizhou; Seifert, Robert; Shi, Kuangyu; Kim, Moon; Herrmann, Ken; Fragoso Costa, Pedro; Kersting, David

Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand Therapy

In: Seminars in Nuclear Medicine, Jg. 54, 2024, Nr. 4, S. 460 – 469

DOI (Open Access)
Webendoerfer, Maximilian; Konik, Margarethe; Zettler, Markus; Wienker, Johannes; Rawitzer, Josefine; Esser, Stefan; Kehrmann, Jan; Herrmann, Ken; Reinhardt, Hans Christian; Witzke, Oliver; Dolff, Sebastian

Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with Human Immunodeficiency Virus (HIV) with disseminated nontuberculous mycobacteriosis

In: Infection - A Journal of Infectious Disease, Jg. 52, 2024, Nr. 4, S. 1627 – 1631

DOI (Open Access)
Telli, Tugce; Hosseini, Atefeh; Settelmeier, Stephan; Kersting, David; Kessler, Lukas; Weber, Wolfgang A.; Rassaf, Tienush; Herrmann, Ken; Varasteh, Zohreh

Imaging of Cardiac Fibrosis : How Far Have We Moved From Extracellular to Cellular?

In: Seminars in Nuclear Medicine, 2024, in press

DOI (Open Access)
Jannusch, Kai; Umutlu, Lale; Kirchner, Julian; Bruckmann, Nils-Martin; Morawitz, Janna; Herrmann, Ken; Fendler, Wolfgang Peter; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Ruckhäberle, Eugen; Stuschke, Martin; Schmid, Werner; Giesel, Frederik; Häberle, Lena; Esposito, Irene; Budach, Wilfried; Grüneisen, Johannes; Matuschek, Christiane; Kowall, Bernd; Stang, Andreas; Antoch, Gerald; Buchbender, Christian

Impact of ¹⁸F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer : Results from a Prospective Double-Center Trial

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 12, S. 1855 – 1861

DOI
Albert, Nathalie L.; Preusser, Matthias; Traub-Weidinger, Tatjana; Tolboom, Nelleke; Law, Ian; Palmer, Joshua D.; Guedj, Eric; Furtner, Julia; Fraioli, Francesco; Huang, Raymond Y.; Johnson, Derek R.; Deroose, Christophe M.; Herrmann, Ken; Vogelbaum, Michael; Chang, Susan; Tonn, Joerg-Christian; Weller, Michael; Wen, Patrick Y.; van den Bent, Martin J.; Verger, Antoine; Ivanidze, Jana; Galldiks, Norbert

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands : Version 1.0

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 12, S. 3662 – 3679

DOI (Open Access)
Grünwald, Viktor; Hadaschik, Boris; Klümper, Niklas; Herrmann, Ken

Kick-Starting Molecular Theranostics in Renal Cell Carcinoma

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 5, S. 744 – 745

DOI (Open Access)
Guberina, Maja; Pöttgen, Christoph; Guberina, Nika; Hoffmann, Christian; Wiesweg, Marcel; Richlitzki, Cedric; Metzenmacher, Martin; Aigner, Clemens; Bölükbas, Servet; Gauler, Thomas; Eberhardt, Wilfried; Forsting, Michael; Herrmann, Ken; Theegarten, Dirk; Darwiche, Kaid; Jendrossek, Verena; Stuschke, Martin; Schuler, Martin

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III Disease

In: Cancers, Jg. 16, 2024, Nr. 6, 1174

DOI (Open Access)
Voltin, Conrad-Amadeus; Paccagnella, Andrea; Winkelmann, Michael; Heger, Jan-Michel; Casadei, Beatrice; Beckmann, Laura; Herrmann, Ken; Dekorsy, Franziska J.; Kutsch, Nadine; Borchmann, Peter; Fanti, Stefano; Kunz, Wolfgang G.; Subklewe, Marion; Kobe, Carsten; Zinzani, Pier Luigi; Stelljes, Matthias; Roth, Katrin S.; Drzezga, Alexander; Noppeney, Richard; Rahbar, Kambiz; Reinhardt, H. Christian; von Tresckow, Bastian; Seifert, Robert; Albring, Jörn C.; Blumenberg, Viktoria; Farolfi, Andrea; Flossdorf, Sarah; Gödel, Philipp; Hanoun, Christine

Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 5, S. 1361 – 1370

DOI (Open Access)
Herrmann, Ken; Gafita, Andrei; de Bono, Johann S.; Sartor, Oliver; Chi, Kim N.; Krause, Bernd J.; Rahbar, Kambiz; Tagawa, Scott T.; Czernin, Johannes; El-Haddad, Ghassan; Wong, Connie C.; Zhang, Zhaojie; Wilke, Celine; Mirante, Osvaldo; Morris, Michael J.; Fizazi, Karim

Multivariable models of outcomes with [¹⁷⁷Lu]Lu-PSMA-617 : analysis of the phase 3 VISION trial

In: eClinicalMedicine, Jg. 77, 2024, 102862

DOI (Open Access)
Püllen, Lukas; Costa, Pedro F.; Darr, Christopher; Heß, Jochen A.; Kesch, Claudia; Rehme, Christian R.; Wahl, Milan; Yirga, Leubet; Reis, Henning; Szarvas, Tibor; van Leeuwen, Fijs W. B.; Herrmann, Ken; Hadaschik, Boris; Tschirdewahn, Stephan; Krafft, Ulrich

Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experience

In: Journal of Surgical Oncology, Jg. 129, 2024, Nr. 7, S. 1325 – 1331

DOI (Open Access)
Belldegrun, Arie S.; Herrmann, Ken; Czernin, Johannes

Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship : A Conversation with Ken Herrmann and Johannes Czernin

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 12, S. 1821 – 1823

DOI
Hammersen, Noah; Jentzen, Walter; Stawitzki, Florian; Herrmann, Ken; Kersting, David; Fragoso Costa, Pedro; Moraitis, Alexandros

PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planning

In: Physics in Medicine and Biology, Jg. 69, 2024, Nr. 16, 165007

DOI (Open Access)
Santiago Almeida, Ludmila; Etchebehere, Elba Cristina Sá de Camargo; García Megías, Irene; Calapaquí Terán, Adriana K.; Hadaschik, Boris; Colletti, Patrick M.; Herrmann, Ken; Giammarile, Francesco; Delgado Bolton, Roberto C.

PSMA Radioligand Therapy in Prostate Cancer Where Are We and Where Are We Heading?

In: Clinical Nuclear Medicine, Jg. 49, 2024, Nr. 1, S. 45 – 55

DOI
Küper, Alina T.; Kersting, David; Telli, Tugce; Herrmann, Ken; Rominger, Axel; Afshar-Oromieh, Ali; Lopes, Leonor; Karkampouna, Sofia; Shi, Kuangyu; Kim, Moon; Hadaschik, Boris; Darr, Christopher; Umutlu, Lale; Fendler, Wolfgang; Seifert, Robert

PSMA-PET follow-up to assess response in patients not receiving PSMA therapy : Is there value beyond localization of disease?

In: Theranostics, Jg. 14, 2024, Nr. 9, S. 3623 – 3633

DOI, Online Volltext (Open Access)
Jannusch, Kai; Dietzel, Frederic; Bruckmann, Nils Martin; Morawitz, Janna; Boschheidgen, Matthias; Minko, Peter; Bittner, Ann-Kathrin; Mohrmann, Svjetlana; Quick, Harald H.; Herrmann, Ken; Umutlu, Lale; Antoch, Gerald; Rubbert, Christian; Kirchner, Julian; Caspers, Julian

Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [¹⁸F]FDG-PET/MRI

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 5, S. 1451 – 1461

DOI (Open Access)
Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel

Prognostic Implications of ⁶⁸Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 7, S. 1027 – 1034

DOI
Weber, Manuel; Fendler, Wolfgang P.; Ravi Kumar, Aravind S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Kretschmer, Alexander; Hekimsoy, Turkay; Brookman-May, Sabine D.; Mundle, Suneel D.; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Herrmann, Ken; Hofman, Michael S.; Eiber, Matthias; Hadaschik, Boris A.

Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer : An International Multicenter Retrospective Study

In: European Urology, Jg. 85, 2024, Nr. 6, S. 511 – 516

DOI (Open Access)
Kuo, Phillip H.; Morris, Michael J.; Hesterman, Jacob; Kendi, A Tuba; Rahbar, Kambiz; Wei, Xiao X.; Fang, Bruno; Adra, Nabil; Garje, Rohan; Michalski, Jeff M.; Chi, Kim; de Bono, Johann; Fizazi, Karim; Krause, Bernd; Sartor, Oliver; Tagawa, Scott T.; Ghebremariam, Samson; Brackman, Marcia; Wong, Connie C.; Catafau, Ana M.; Benson, Taylor; Armstrong, Andrew J.; Herrmann, Ken

Quantitative ⁶⁸Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following ¹⁷⁷Lu-PSMA-617 (VISION Trial)

In: Radiology, Jg. 312, 2024, Nr. 2, e233460

DOI
Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang; Hadaschik, Boris; Rowe, Steven P.; Herrmann, Ken; Solnes, Lilja B.; Calais, Jeremie; Rettig, Matthew B.; Weber, Manuel; Farolfi, Andrea; Benz, Matthias R.; Eiber, Matthias

RECIP 1.0 Predicts Progression-Free Survival After [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 917 – 922

DOI
Umutlu, Lale; Nensa, Felix; Demircioglu, Aydin; Antoch, Gerald; Herrmann, Ken; Forsting, Michael; Grüneisen, Johannes

Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer

In: Nuklearmedizin = Nuclear Medicine, Jg. 63, 2024, Nr. 1, S. 34 – 42

DOI
Al-Ibraheem, Akram; Zimmermann, Richard; Abdlkadir, Ahmed S.; Herrmann, Ken

Radiotheranostics Global Market and Future Developments

In: Seminars in Nuclear Medicine, Jg. 54, 2024, Nr. 4, S. 622 – 633

DOI
Abdel-Wahab, May; Giammarile, Francesco; Carrara, Mauro; Paez, Diana; Hricak, Hedvig; Ayati, Nayyereh; Li, Jing Jing; Mueller, Malina; Aggarwal, Ajay; Al-Ibraheem, Akram; Alkhatib, Sondos; Atun, Rifat; Bello, Abubakar; Berger, Daniel; Delgado Bolton, Roberto C; Buatti, John M; Burt, Graeme; Bjelac, Olivera Ciraj; Cordero-Mendez, Lisbeth; Dosanjh, Manjit; Eichler, Thomas; Fidarova, Elena; Gondhowiardjo, Soehartati; Gospodarowicz, Mary; Grover, Surbhi; Hande, Varsha; Harsdorf-Enderndorf, Ekaterina; Herrmann, Ken; Hofman, Michael S; Holmberg, Ola; Jaffray, David; Knoll, Peter; Kunikowska, Jolanta; Lewis, Jason S; Lievens, Yolande; Mikhail-Lette, Miriam; Ostwald, Dennis; Palta, Jatinder R; Peristeris, Platon; Rosa, Arthur A; Salem, Soha Ahmed; dos Santos, Marcos A; Sathekge, Mike M; Shrivastava, Shyam Kishore; Titovich, Egor; Urbain, Jean-Luc; Vanderpuye, Verna; Wahl, Richard L; Yu, Jennifer S; Zaghloul, Mohamed Saad; Zhu, Hongcheng; Scott, Andrew M

Radiotherapy and theranostics : a Lancet Oncology Commission

In: The Lancet Oncology, Jg. 25, 2024, Nr. 11, S. e545 – e580

DOI
Nikitas, John; Lam, Ethan; Booker, Kiara Adame; Fendler, Wolfgang; Eiber, Matthias; Hadaschik, Boris; Herrmann, Ken; Hirmas, Nader; Lanzafame, Helena; Stuschke, Martin; Czernin, Johannes; Steinberg, Michael L.; Nickols, Nicholas G.; Kishan, Amar U.; Calais, Jeremie

Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 7, S. 1076 – 1079

DOI
Jannusch, Kai; Bruckmann, Nils Martin; Morawitz, Janna; Boschheidgen, Matthias; Quick, Harald H.; Herrmann, Ken; Fendler, Wolfgang; Umutlu, Lale; Stuschke, Martin; Hadaschik, Boris; Antoch, Gerald; Schimmöller, Lars; Kirchner, Julian

Recurrent prostate cancer : combined role for MRI and PSMA-PET in ⁶⁸Ga-PSMA-11 PET/MRI

In: European Radiology, Jg. 34, 2024, Nr. 7, S. 4789 – 4800

DOI (Open Access)
Herrmann, Ken; Rahbar, Kambiz; Eiber, Matthias; Sparks, Richard; Baca, Nicholas; Krause, Bernd J.; Lassmann, Michael; Jentzen, Walter; Tang, Jun; Chicco, Daniela; Klein, Patrick; Blumenstein, Lars; Basque, Jean-René; Kurth, Jens

Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 1, S. 71 – 78

DOI (Open Access)
Vardarli, Irfan; Tan, Susanne; Brandenburg, Tim; Weidemann, Frank; Görges, Rainer; Herrmann, Ken; Führer, Dagmar

Risk and Incidence of Endocrine Immune-Related Adverse Effects under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors : A Meta-Analysis of Randomized Controlled Trials

In: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 109, 2024, Nr. 4, S. 1132 – 1144

DOI
Chi, Kim N.; Armstrong, Andrew J.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; de Bono, Johann S.; Adra, Nabil; Garje, Rohan; Michalski, Jeff M.; Kempel, Mette M.; Fizazi, Karim; Morris, Michael J.; Sartor, Oliver; Brackman, Marcia; DeSilvio, Michelle; Wilke, Celine; Holder, Geoffrey; Tagawa, Scott T.

Safety Analyses of the Phase 3 VISION Trial of [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer

In: European Urology, Jg. 85, 2024, Nr. 4, S. 382 – 391

DOI (Open Access)
Seifert, Robert; Telli, Tugce; Lapa, Constantin; Desaulniers, Mélanie; Hekimsoy, Turkay; Weber, Wolfgang A.; Pfob, Christian; Hadaschik, Boris; Bögemann, Martin; Schäfers, Michael; Herrmann, Ken; Rahbar, Kambiz; Eiber, Matthias; Fendler, Wolfgang

Safety and Efficacy of Extended Therapy with [¹⁷⁷Lu]Lu-PSMA : A German Multicenter Study

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 909 – 916

DOI
Moraitis, Alexandros; Jentzen, Walter; Fragoso Costa, Pedro; Kersting, David; Himmen, Stephan; Coelho, Marta; Meckel, Marian; van Echteld, Cees J A; Fendler, Wolfgang; Herrmann, Ken; Sraieb, Miriam

Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 931 – 937

DOI
Jakstaite, Aiste Monika; Vogel, Julia Kirsten; Lüdike, Peter; Janosi, Rolf Alexander; Carpinteiro, Alexander; Rischpler, Christoph; Herrmann, Ken; Rassaf, Tienush; Papathanasiou, Maria

Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red Flags

In: Journal of Clinical Medicine (JCM), Jg. 13, 2024, Nr. 3, 671

DOI (Open Access)
Ciuciulkaite, Ieva; Herrmann, Ken; Lahner, Harald

Stellenwert der Peptid-Radio-Rezeptor-Therapie für das Management neuroendokriner Tumoren

In: Die Onkologie, Jg. 30, 2024, Nr. 11, S. 1065 – 1074

DOI
Hyseni, Arberit; Viehof, Jan; Hockmann, Jan; Metzenmacher, Martin; Eberhardt, Wilfried; Herrmann, Ken; Hautzel, Hubertus; Aigner, Clemens; Plönes, Till

The Incidence of Distant Metastases in Patients with Pleural Mesothelioma Screened for a Multimodal Approach : How Much Staging Do We Really Need?

In: Cancers, Jg. 16, 2024, Nr. 10, 1917

DOI, Online Volltext (Open Access)
Oster, Christoph; Kessler, Lukas; Blau, Tobias; Keyvani, Kathy; Pabst, Kim M.; Fendler, Wolfgang; Fragoso Costa, Pedro; Lazaridis, Lazaros; Schmidt, Teresa; Feldheim, Jonas; Pierscianek, Daniela; Schildhaus, Hans-Ulrich; Sure, Ulrich; Ahmadipour, Yahya; Kleinschnitz, Christoph; Guberina, Nika; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin

The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival Data

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1217 – 1223

DOI
Tolboom, Nelleke; Verger, Antoine; Albert, Nathalie L.; Fraioli, Francesco; Guedj, Eric; Traub-Weidinger, Tatjana; Morbelli, Silvia; Herrmann, Ken; Zucchetta, Pietro; Plasschaert, Sabine L A; Yakushev, Igor; Weller, Michael; Glas, Martin; Preusser, Matthias; Cecchin, Diego; Barthel, Henryk; Van Weehaeghe, Donatienne

Theranostics in Neurooncology : Heading Toward New Horizons

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 2, S. 167 – 173

DOI (Open Access)
Mavroeidi, Ilektra Antonia; Romanowicz, Anna; Haake, Tristan; Wienker, Johannes; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Opitz, Marcel; Nader, Michael; Hamacher, Rainer; Siveke, Jens; Winantea, Jane; Fendler, Wolfgang P.; Wiesweg, Marcel; Eberhardt, Wilfried; Herrmann, Ken; Theegarten, Dirk; Schuler, Martin; Hautzel, Hubertus; Kersting, David

Theranostics with somatostatin receptor antagonists in SCLC : Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival

In: Theranostics, Jg. 14, 2024, Nr. 14, S. 5400 – 5412

DOI, Online Volltext (Open Access)
Singh, Simron; Halperin, Daniel; Myrehaug, Sten; Herrmann, Ken; Pavel, Marianne; Kunz, Pamela L; Chasen, Beth; Tafuto, Salvatore; Lastoria, Secondo; Capdevila, Jaume; García-Burillo, Amparo; Oh, Do-Youn; Yoo, Changhoon; Halfdanarson, Thorvardur R; Falk, Stephen; Folitar, Ilya; Zhang, Yufen; Aimone, Paola; de Herder, Wouter W; Ferone, Diego

[¹⁷⁷Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2) : an open-label, randomised, phase 3 study

In: Lancet, Jg. 403, 2024, Nr. 10446, S. 2807 – 2817

DOI
Pabst, Kim M.; Kessler, Lukas; Ferdinandus, Justin; Hamacher, Rainer; Bartel, Timo; Siveke, Jens T.; Nader, Michael; Brandenburg, Tim; Desaulniers, Mélanie; Herrmann, Ken; Fendler, Wolfgang P.

[⁶⁸Ga]Ga-FAPI versus 2-[¹⁸F]FDG PET/CT in patients with autoimmune thyroiditis : A case control study

In: EJNMMI Research, Jg. 14, 2024, Nr. 1, 66

DOI, Online Volltext (Open Access)
Morris, Michael J; Castellano, Daniel; Herrmann, Ken; de Bono, Johann S; Shore, Neal D; Chi, Kim N; Crosby, Michael; Piulats, Josep M; Fléchon, Aude; Wei, Xiao X; Mahammedi, Hakim; Roubaud, Guilhem; Študentová, Hana; Nagarajah, James; Mellado, Begoña; Montesa-Pino, Álvaro; Kpamegan, Euloge; Ghebremariam, Samson; Kreisl, Teri N; Wilke, Celine; Lehnhoff, Katja; Sartor, Oliver; Fizazi, Karim

¹⁷⁷Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore) : A phase 3, randomised, controlled trial

In: Lancet, Jg. 404, 2024, Nr. 10459, S. 1227 – 1239

DOI
Al-Ibraheem, Akram; Abdlkadir, Ahmed; Al-Adhami, Dhuha; Herrmann, Ken

¹⁷⁷Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy : Initial Clinical Experience in Renal Carcinoid

In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 9, 1494

DOI
Costa, Pedro Fragoso; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Tschirdewahn, Stephan; Moraitis, Alexandros; Radtke, Jan Philipp; Ting, Saskia; Nader, Michael; Wosniack, Jasmin; Kersting, David; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Hadaschik, Boris; Darr, Christopher

18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 4, S. 598 – 604

DOI (Open Access)
Mei, Riccardo; Kessler, Lukas; Pabst, Kim M.; Weber, Manuel; Schmidkonz, Christian; Rischpler, Christoph; Zacho, Helle Damgaard; Hope, Thomas; Schwarzenböck, Sarah M.; Allen-Auerbach, Martin; Emmett, Louise; Ferdinandus, Justin; Unterrainer, Marcus; Schaarschmidt, Benedikt M.; Umutlu, Lale; Farolfi, Andrea; Castellucci, Paolo; Nanni, Cristina; Telo, Silvi; Fanti, Stefano; Herrmann, Ken; Fendler, Wolfgang

68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment : An International Multicenter Prospective Study

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1043 – 1048

DOI (Open Access)
Kessler, Lukas; Hirmas, Nader; Pabst, Kim M.; Hamacher, Rainer; Ferdinandus, Justin; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Nader, Michael; Umutlu, Lale; Uhl, Waldemar; Reinacher-Schick, Anke; Lugnier, Celine; Witte, David; Niedergethmann, Marco; Herrmann, Ken; Fendler, Wolfgang P.; Siveke, Jens T.

68Ga-Labeled Fibroblast Activation Protein Inhibitor (⁶⁸Ga-FAPI) PET for Pancreatic Adenocarcinoma : Data from the ⁶⁸Ga-FAPI PET Observational Trial

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 12, S. 1910 – 1917

DOI (Open Access)
Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective Study

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 10, S. 1540 – 1549

DOI (Open Access)
Serani, Francesca; Fendler, Wolfgang; Castellucci, Paolo; Berliner, Christoph; Barbato, Francesco; Herrmann, Ken; Farolfi, Andrea; Fanti, Stefano

A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients

In: Cancers, Jg. 15, 2023, Nr. 8, 2208

DOI (Open Access)
Hockmann, Jan; Hautzel, Hubertus; Darwiche, Kaid; Eberhardt, Wilfried; Stuschke, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till

Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer

In: Asian Cardiovascular and Thoracic Annals, Jg. 31, 2023, Nr. 6, S. 506 – 511

DOI (Open Access)
Simeone, Diane M.; Herrmann, Ken; Czernin, Johannes

Advancing Clinical Trial Innovation in Pancreatic Cancer : A Conversation Between Diane Simeone, Ken Herrmann, and Johannes Czernin

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 2, S. 185 – 187

DOI (Open Access)
Handke, Analena; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Yang; Hakansson, Alexander; Davicioni, Elai; Hughes, Jason; Song, Hong; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy

In: Journal for ImmunoTherapy of Cancer, Jg. 11, 2023, Nr. 10, e007354

DOI (Open Access)
Delgado Bolton, Roberto C.; Calapaquí Terán, Adriana K.; Herrmann, Ken; Fanti, Stefano; Giammarile, Francesco

Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors with the Clinical Application of FAPI Imaging?

In: Clinical Nuclear Medicine, Jg. 48, 2023, Nr. 4, S. 318 – 319

DOI
Jeschke, Matthias; Ludwig, Johannes M.; Leyh, Catherine; Pabst, Kim M.; Weber, Manuel; Theysohn, Jens; Lange, Christian; Herrmann, Ken; Schmidt, Hartmut; Jochheim, Leonie S.

Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma : Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab

In: Cancers, Jg. 15, 2023, Nr. 17, 4274

DOI (Open Access)
Mathew, Annie; Fendler, Wolfgang; Theysohn, Jens; Herrmann, Ken; Führer, Dagmar; Lahner, Harald

Bone Metastases in Patients with Pancreatic NETs : Prevalence and Prognosis

In: Hormone and Metabolic Research, Jg. 28, 2023, Nr. 4

DOI
Morawitz, Janna; Sigl, Benjamin; Rubbert, Christian; Bruckmann, Nils-Martin; Dietzel, Frederic; Häberle, Lena J.; Ting, Saskia; Mohrmann, Svjetlana; Ruckhäberle, Eugen; Bittner, Ann-Kathrin; Hoffmann, Oliver; Baltzer, Pascal; Kapetas, Panagiotis; Helbich, Thomas; Clauser, Paola; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Schaarschmidt, Benedikt M.; Stang, Andreas; Umutlu, Lale; Antoch, Gerald; Caspers, Julian; Kirchner, Julian

Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on ¹⁸F-FDG PET/MRI and Machine Learning

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 2, S. 304 – 311

DOI (Open Access)
Feuerecker, Benedikt; Kratochwil, Clemens; Ahmadzadehfar, Hojjat; Morgenstern, Alfred; Eiber, Matthias; Herrmann, Ken; Pomykala, Kelsey L.

Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 685 – 692

DOI (Open Access)
Morawitz, Janna; Bruckmann, Nils-Martin; Jannusch, Kai; Dietzel, Frederic; Milosevic, Aleksandar; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Ruckhäberle, Eugen; Häberle, Lena; Fendler, Wolfgang; Herrmann, Ken; Giesel, Frederik Lars; Antoch, Gerald; Umutlu, Lale; Kowall, Bernd; Stang, Andreas; Kirchner, Julian

Conventional Imaging, MRI and ¹⁸F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer

In: Cancers, Jg. 15, 2023, Nr. 14, 3646

DOI (Open Access)
Thimm, Andreas; Carpinteiro, Alexander; Oubari, Sara; Papathanasiou, Maria; Kessler, Lukas; Rischpler, Christoph; Malik, Rayaz Ahmed; Herrmann, Ken; Reinhardt, Hans Christian; Rassaf, Tienush; Kleinschnitz, Christoph; Hagenacker, Tim; Stettner, Mark

Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis

In: Journal of Neurology, Jg. 270, 2023, Nr. 7, S. 3483 – 3491

DOI (Open Access)
Gear, Jonathan; Stokke, Caroline; Terwinghe, Christelle; Gnesin, Silvano; Sandström, Mattias; Tran‑Gia, Johannes; Cremonesi, Marta; Cicone, Francesco; Verburg, Fredrik; Hustinx, Roland; Giovanella, Luca; Herrmann, Ken; Gabiña, Pablo Minguez

Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 10, S. 3157 – 3158

DOI (Open Access)
Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland; Lassmann, Michael; Wadsak, Wolfgang; Kunikowska, Jolanta

Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 2, S. 630 – 630

DOI (Open Access)
Totzeck, Matthias; Aide, Nicolas; Bauersachs, Johann; Bucerius, Jan; Georgoulias, Panagiotis; Herrmann, Ken; Hyafil, Fabien; Kunikowska, Jolanta; Lubberink, Mark; Nappi, Carmela; Rassaf, Tienush; Saraste, Antti; Sciagra, Roberto; Slart, Riemer H.J.A.; Verberne, Hein; Rischpler, Christoph

Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity : prospects and proposal of use by the European Association of Nuclear Medicine (EANM) (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 3, (792-812), 10.1007/s00259-022-05991-7)

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 3, S. 970

DOI (Open Access)
Pacelli, Anna; Zarrad, Fadi; Warnier, Corentin; Gendron, Thibault; Otabashi, Muhammad; Vriamont, Charles; Jackson, Alex; Fendler, Wolfgang; Herrmann, Ken; Nader, Michael

Correction: Fully Automated, High-Dose Radiosynthesis of [18F]PARPi

In: Pharmaceuticals, Jg. 16, 2023, Nr. 7, 1024

DOI (Open Access)
Jannusch, Kai; Bittner, Ann-Kathrin; Bruckmann, Nils Martin; Morawitz, Janna; Stieglitz, Cleo; Dietzel, Frederic; Quick, Harald H.; Baba, Hideo Andreas; Herrmann, Ken; Umutlu, Lale; Antoch, Gerald; Kirchner, Julian; Kasimir-Bauer, Sabine; Hoffmann, Oliver

Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer

In: Cancers, Jg. 15, 2023, Nr. 6, 1651

DOI (Open Access)
Afshar-Oromieh, Ali; Eiber, Matthias; Fendler, Wolfgang; Schmidt, Matthias; Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Umutlu, Lale; Hadaschik, Boris; Hakenberg, Oliver W.; Fornara, Paolo; Kurth, Jens; Neels, O.; Wester, Hans-Jürgen; Schwaiger, Markus; Kopka, Klaus; Haberkorn, Uwe; Herrmann, Ken; Krause, Bernd J.

DGN-Handlungsempfehlung (S1-Leitlinie) : PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms - Stand: 01/2022 - AWMF-Registernummer: 031-055

In: Nuklearmedizin = Nuclear Medicine, Jg. 62, 2023, Nr. 1, S. 5 – 19

DOI
Slama, Alexis; Schaarschmidt, Benedikt M.; Okumus, Özlem; Herrmann, Ken; Aigner, Clemens; Collaud, Stephane; Hautzel, Hubertus

DOTATOC PET/CT imaging of a typical carcinoid tumor in a human ex-vivo perfused lung lobe

In: Quantitative Imaging in Medicine and Surgery, Jg. 13, 2023, Nr. 7, S. 4716 – 4722

DOI, Online Volltext (Open Access)
Settelmeier, Stephan; Varasteh, Zohreh; Staniszewska, Magdalena; Beerlage, Anna-Lena; Zarrad, Fadi; Fendler, Wolfgang; Rischpler, Christoph; Notni, Johannes; Totzeck, Matthias; Herrmann, Ken; Rassaf, Tienush; Hendgen-Cotta, Ulrike B.

Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo

In: Pharmaceuticals, Jg. 16, 2023, Nr. 6, 824

DOI, Online Volltext (Open Access)
Pasquier, David; Bidaut, Luc; Oprea-Lager, Daniela Elena; deSouza, Nandita M; Krug, David; Collette, Laurence; Kunz, Wolfgang; Belkacemi, Yazid; Bau, Maria Grazia; Caramella, Caroline; De Geus-Oei, Lioe-Fee; De Caluwé, Alex; Deroose, Christophe; Gheysens, Olivier; Herrmann, Ken; Kindts, Isabelle; Kontos, Michalis; Kümmel, Sherko; Linderholm, Barbro; Lopci, Egesta; Meattini, Icro; Smeets, Ann; Kaidar-Person, Orit; Poortmans, Philip; Tsoutsou, Pelagia; Hajjaji, Nawale; Russell, Nicola; Senkus, Elżbieta; Talbot, Jean-Noël; Umutlu, Lale; Vandecaveye, Vincent; Verhoeff, Joost J C; van Oordt, Willemien Menke-van der Houven; Zacho, Helle D; Cardoso, Fatima; Fournier, Laure; Van Duijnhoven, Frederieke; Lecouvet, Frédéric E

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer : a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

In: The Lancet Oncology, Jg. 24, 2023, Nr. 8, S. e331 – e343

DOI, Online Volltext (Open Access)
Gudenkauf, Lisa M.; Chavez, Melody N.; Maconi, Melinda Leigh; Geiss, Carley; Seyedroudbari, Ameen; Thin, Pan; Hoogland, Aasha I.; Nguyen, Kathleen; Murthy, Vishnu; Armstrong, Wesley R.; Komrokji, Khaled; Oswald, Laura B.; Jim, Heather S.L.; El-Haddad, Ghassan; Fendler, Wolfgang P.; Herrmann, Ken; Cella, David; Czernin, Johannes; Hofman, Michael S.; Dicker, Adam P.; Calais, Jeremie; Tagawa, Scott T.; Gonzalez, Brian D.

Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 6, S. 869 – 872

DOI (Open Access)
Lam, Marnix; Garin, Etienne; Palard-Novello, Xavier; Mahvash, Armeen; Kappadath, Cheenu; Haste, Paul; Tann, Mark; Herrmann, Ken; Barbato, Francesco; Geller, Brian; Schaefer, Niklaus; Denys, Alban; Dreher, Matthew; Fowers, Kirk D.; Gates, Vanessa; Salem, Riad

Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry : Round robin study on radioembolization treatment planning in hepatocellular carcinoma

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2023, Nr. 1, S. 245 – 257

DOI (Open Access)
Gear, Jonathan; Stokke, Caroline; Terwinghe, Christelle; Gnesin, Silvano; Sandström, Mattias; Tran-Gia, Johannes; Cremonesi, Marta; Cicone, Francesco; Verburg, Fredrik; Hustinx, Roland; Giovanella, Luca; Herrmann, Ken; Gabiña, Pablo Minguez

EANM enabling guide : How to improve the accessibility of clinical dosimetry

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 7, S. 1861 – 1868

DOI (Open Access)
Dickson, John C.; Armstrong, Ian S.; Gabiña, Pablo Minguez; Denis-Bacelar, Ana M.; Krizsan, Aron K.; Gear, Jonathan M.; Van den Wyngaert, Tim; de Geus-Oei, Lioe-Fee; Herrmann, Ken

EANM practice guideline for quantitative SPECT-CT

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 4, S. 980 – 995

DOI (Open Access)
Maric, Ines; Weber, Manuel; Prochnow, Andre; Schmitz, Jochen; Unger, Nicole; Schaarschmidt, Benedikt M.; Poeppel, Thorsten D.; Rischpler, Christoph; Bockisch, Andreas; Herrmann, Ken; Jentzen, Walter; Fendler, Wolfgang

Efficacy and Safety of¹²⁴I-MIBG Dosimetry-Guided High-Activity¹³¹I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 6, S. 885 – 891

DOI (Open Access)
Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann, Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta

European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations : molecular imaging and therapy in haematological tumours

In: The Lancet Haematology, Jg. 10, 2023, Nr. 5, S. e367 – e381

DOI (Open Access)
Milosevic, Aleksandar; Styczen, Hanna; Grueneisen, Johannes; Li, Yan; Weber, Manuel; Fendler, Wolfgang; Kirchner, Julian; Damman, Philipp; Wrede, Karsten; Lazaridis, Lazaros; Glas, Martin; Guberina, Maja; Eckstein, Anja; Blau, Tobias; Herrmann, Ken; Umutlu, Lale; Forsting, Michael; Deuschl, Cornelius; Schaarschmidt, Benedikt

Evaluation of [⁶⁸Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 8, S. 1185 – 1190

DOI (Open Access)
Kim, Moon; Seifert, Robert; Fragemann, Jana; Kersting, David; Murray, Jacob; Jonske, Frederic; Pomykala, Kelsey L.; Egger, Jan; Fendler, Wolfgang; Herrmann, Ken; Kleesiek, Jens

Evaluation of thresholding methods for the quantification of [⁶⁸Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 7, S. 2196 – 2209

DOI (Open Access)
Schmidt, Teresa; Agkatsev, Sarina; Feldheim, Jonas; Oster, Christoph; Blau, Tobias; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin; Lazaridis, Lazaros

Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma

In: Neuro-Oncology Advances, Jg. 5, 2023, Nr. 1, vdad090

DOI, Online Volltext (Open Access)
Hamacher, Rainer; Lanzafame, Helena; Mavroeidi, Ilektra A.; Pabst, Kim M.; Kessler, Lukas; Cheung, Phyllis F.; Bauer, Sebastian; Herrmann, Ken; Schildhaus, Hans-Ulrich; Siveke, Jens T.; Fendler, Wolfgang P.

Fibroblast Activation Protein Inhibitor Theranostics : The Case for Use in Sarcoma

In: PET Clinics, Jg. 18, 2023, Nr. 3, S. 361 – 367

DOI
Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 711 – 716

DOI (Open Access)
Karbhari, Aashna; Mosessian, Sherly; Trivedi, Kamaxi H.; Valla, Frank; Jacobson, Mark; Truty, Mark J.; Patnam, Nandakumar G.; Simeone, Diane M.; Zan, Elcin; Brennan, Tracy; Chen, Hongli; Kuo, Phillip H.; Herrmann, Ken; Goenka, Ajit H.

Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma : A phase 2, multicenter, single arm, open label non-randomized study protocol

In: PLoS ONE, Jg. 18, 2023, Nr. 11, e0294564

DOI (Open Access)
Fizazi, Karim; Herrmann, Ken; Krause, Bernd J; Rahbar, Kambiz; Chi, Kim N; Morris, Michael J; Sartor, Oliver; Tagawa, Scott T; Kendi, Ayse T; Vogelzang, Nicholas; Calais, Jeremie; Nagarajah, James; Wei, Xiao X; Koshkin, Vadim S; Beauregard, Jean-Mathieu; Chang, Brian; Ghouse, Ray; DeSilvio, Michelle; Messmann, Richard A; de Bono, Johann

Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trial

In: The Lancet Oncology, Jg. 24, 2023, Nr. 6, S. 597 – 610

DOI
Domouchtsidou, Aglaia; Beckmann, Ferdinand; Marenbach, Beate; Mueller, Stefan P.; Best, Jan; Herrmann, Ken; Horn, Peter; Barsegian, Vahé; Lindemann, Monika

In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival

In: Cancers, Jg. 15, 2023, Nr. 16, 4055

DOI (Open Access)
Sellmann, Timur; Staak, Felicitas; Maurer, Clemens; Rott, Gernot; Witzke, Oliver; Fendler, Wolfgang; Schildhaus, Hans-Ulrich; Podleska, Lars; Herrmann, Ken; Rischpler, Christoph

Incidental Detection of a Tenosynovial Giant Cell Tumor of the Thigh on [⁶⁸Ga]Ga-FAPI PET/CT : Presentation of an Unusual Case

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1162 – 1163

DOI (Open Access)
Veit-Haibach, Patrick; Ahlström, Håkan; Boellaard, Ronald; Delgado Bolton, Roberto C.; Hesse, Swen; Hope, Thomas; Huellner, Martin W.; Iagaru, Andrei; Johnson, Geoffrey B.; Kjaer, Andreas; Law, Ian; Metser, Ur; Quick, Harald H.; Sattler, Bernhard; Umutlu, Lale; Zaharchuk, Greg; Herrmann, Ken

International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 12, S. 3513 – 3537

DOI (Open Access)
Darr, Christopher; Costa, Pedro Fragoso; Kahl, Theresa; Moraitis, Alexandros; Engel, Jenna; Al-Nader, Mulham; Reis, Henning; Köllermann, Jens; Kesch, Claudia; Krafft, Ulrich; Maurer, Tobias; Köhler, Daniel; Klutmann, Susanne; Falkenbach, Fabian; Kleesiek, Jens; Fendler, Wolfgang P.; Hadaschik, Boris; Herrmann, Ken

Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens

In: European Urology Open Science, Jg. 54, 2023, S. 28 – 32

DOI (Open Access)
Seifert, Robert; Telli, Tugce; Hadaschik, Boris; Fendler, Wolfgang; Kuo, Phillip H.; Herrmann, Ken

Is ¹⁸F-FDG PET Needed to Assess ¹⁷⁷Lu-PSMA Therapy Eligibility? : A VISION-like, Single-Center Analysis

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 731 – 737

DOI (Open Access)
Kratochwil, Clemens; Fendler, Wolfgang P.; Eiber, Matthias; Hofman, Michael S.; Emmett, Louise; Calais, Jeremie; Osborne, Joseph R.; Iravani, Amir; Koo, Phillip; Lindenberg, Liza; Baum, Richard P.; Bozkurt, Murat Fani; Delgado Bolton, Roberto C.; Ezziddin, Samer; Forrer, Flavio; Hicks, Rodney J.; Hope, Thomas A.; Kabasakal, Levent; Konijnenberg, Mark; Kopka, Klaus; Lassmann, Michael; Mottaghy, Felix M.; Oyen, Wim J. G.; Rahbar, Kambiz; Schoder, Heiko; Virgolini, Irene; Bodei, Lisa; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken

Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT)

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 9, S. 2830 – 2845

DOI (Open Access)
Kersting, David; Jentzen, Walter; Jeromin, Daniel; Mavroeidi, Ilektra-Antonia; Conti, Maurizio; Büther, Florian; Herrmann, Ken; Rischpler, Christoph; Hamacher, Rainer; Fendler, Wolfgang Peter; Seifert, Robert; Fragoso Costa, Pedro

Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 2, S. 329 – 336

DOI (Open Access)
Guberina, Nika; Padeberg, Florian; Pöttgen, Christoph; Guberina, Maja; Lazaridis, Lazaros; Jabbarli, Ramazan; Deuschl, Cornelius; Herrmann, Ken; Blau, Tobias; Wrede, Karsten; Keyvani, Kathy; Scheffler, Björn; Hense, Jörg; Layer, Julian P.; Glas, Martin; Sure, Ulrich; Stuschke, Martin

Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis

In: Cancers, Jg. 15, 2023, Nr. 11, 2982

DOI (Open Access)
Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; Caffo, Orazio; Castellano, Daniel; Castro, Elena; Cheng, Heather H.; Chi, Kim N.; Chowdhury, Simon; Clarke, Caroline S.; Clarke, Noel; Daugaard, Gedske; De Santis, Maria; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; Ngozi Ekeke, Onyeanunam; Evans, Christopher P.; Fanti, Stefano; Feng, Felix Y.; Fonteyne, Valerie; Fossati, Nicola; Frydenberg, Mark; George, Daniel; Gleave, Martin; Gravis, Gwenaelle; Halabi, Susan; Heinrich, Daniel; Herrmann, Ken; Higano, Celestia; Hofman, Michael S.; Horvath, Lisa G.; Hussain, Maha; Jereczek-Fossa, Barbara Alicja; Jones, Robert; Kanesvaran, Ravindran; Kellokumpu-Lehtinen, Pirkko-Liisa; Khauli, Raja B.; Klotz, Laurence; Kramer, Gero; Leibowitz, Raya; Logothetis, Christopher J.; Mahal, Brandon A.; Maluf, Fernando; Mateo, Joaquin; Matheson, David; Mehra, Niven; Merseburger, Axel; Morgans, Alicia K.; Morris, Michael J.; Mrabti, Hind; Mukherji, Deborah; Murphy, Declan G.; Murthy, Vedang; Nguyen, Paul L.; Oh, William K.; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Pezaro, Carmel; Poon, Darren M.C.; Pritchard, Colin C.; Rabah, Danny M.; Rathkopf, Dana; Reiter, Robert E.; Rubin, Mark. A.; Ryan, Charles J.; Saad, Fred; Pablo Sade, Juan; Sartor, Oliver A.; Scher, Howard I.; Sharifi, Nima; Skoneczna, Iwona; Soule, Howard; Spratt, Daniel E.; Srinivas, Sandy; Sternberg, Cora N.; Steuber, Thomas; Suzuki, Hiroyoshi; Sydes, Matthew R.; Taplin, Mary-Ellen; Tilki, Derya; Türkeri, Levent; Turco, Fabio; Uemura, Hiroji; Uemura, Hirotsugu; Ürün, Yüksel; Vale, Claire L.; van Oort, Inge; Vapiwala, Neha; Walz, Jochen; Yamoah, Kosj; Ye, Dingwei; Yu, Evan Y.; Zapatero, Almudena; Zilli, Thomas; Omlin, Aurelius

Management of Patients with Advanced Prostate Cancer : Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

In: European Urology, Jg. 83, 2023, Nr. 3, S. 267 – 293

DOI (Open Access)
Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Matthew; Sweeney, Christopher J.; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; Caffo, Orazio; Castellano, Daniel; Castro, Elena; Cheng, Heather H.; Chi, Kim N.; Chowdhury, Simon; Clarke, Caroline S.; Clarke, Noel; Daugaard, Gedske; De Santis, Maria; Duran, Ignacio; Eeles, Ross; Efstathiou, Eleni; Efstathiou, Jason; Ekeke, Onyeanunam Ngozi; Evans, Christopher P.; Fanti, Stefano; Feng, Felix Y.; Fonteyne, Valerie; Fossati, Nicola; Frydenberg, Mark; George, Dan; Gleave, Martin; Gravis, Gwenaelle; Halabi, Susan; Heinrich, Daniel; Herrmann, Ken; Higano, Celestia; Hofman, Michael S.; Horvath, Lisa G.; Hussain, Maha; Jereczek-Fossa, Barbara A.; Jones, Rob; Kanesvaran, Ravindran; Kellokumpu-Lehtinen, Pirkko-Liisa; Khauli, Raja B.; Klotz, Laurence; Kramer, Gero; Leibowitz, Raja; Logothetis, Christopher; Mahal, Brandon; Maluf, Fernando; Mateo, Joaquin; Matheson, David; Mehra, Niven; Merseburger, Axel; Morgans, Alicia K.; Morris, Michael J.; Mrabti, Hind; Mukherji, Deborah; Murphy, Declan G.; Murthy, Vedang; Nguyen, Paul L.; Oh, William K.; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Pezaro, Carmel J.; Poon, Darren M.C.; Pritchard, Colin C.; Rabah, Danny M.; Rathkopf, Dana; Reiter, Robert E.; Rubin, Mark A.; Ryan, Charles J.; Saad, Fred; Sade, Juan Pablo; Sartor, Oliver; Scher, Howard I.; Sharifi, Nima; Skoneczna, Iwona; Soule, Howard; Spratt, Daniel E.; Srinivas, Sandy; Sternberg, Cora N.; Steuber, Thomas; Suzuki, Hiroyoshi; Sydes, Matthew R.; Taplin, Mary-Ellen; Tilki, Derya; Türkeri, Levent; Turco, Fabio; Uemura, Hiroji; Uemura, Hirotsugu; Ürün, Yüksel; Vale, Claire L.; van Oort, Inge; Vapiwala, Neha; Walz, Jochen; Yamoah, Kosj; Ye, Dingwei; Yu, Evan Y.; Zapatero, Almudena; Zilli, Thomas; Omlin, Aurelius; O’Sullivan, Joe M.

Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer : Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

In: European Journal of Cancer (EJC), Jg. 185, 2023, S. 178 – 215

DOI (Open Access)
Posdzich, Philip; Darr, Christopher; Hilser, Thomas; Wahl, Milan; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor

Metastatic Prostate Cancer : A Review of Current Treatment Options and Promising New Approaches

In: Cancers, Jg. 15, 2023, Nr. 2, 461

DOI, Online Volltext (Open Access)
Kersting, David; Mavroeidi, Ilektra-Antonia; Settelmeier, Stephan; Seifert, Robert; Schuler, Martin; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph

Molecular Imaging Biomarkers in Cardiooncology : A View on Established Technologies and Future Perspectives

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. Suppl. 2, S. 29S – 38S

DOI (Open Access)
Pomykala, Kelsey L.; Fendler, Wolfgang P.; Vermesh, Ophir; Umutlu, Lale; Herrmann, Ken; Seifert, Robert

Molecular Imaging of Lymphoma : Future Directions and Perspectives

In: Seminars in Nuclear Medicine, Jg. 53, 2023, Nr. 3, S. 449 – 456

DOI
Laschinsky, Christina; Theurer, Sarah; Herold, Thomas; Rawitzer, Josefine; Weber, Frank; Herrmann, Ken; Brandenburg, Tim; Führer-Sakel, Dagmar; Fendler, Wolfgang P.; Weber, Manuel

Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 12, S. 1865 – 1868

DOI (Open Access)
Isgandarov, A.; Darr, Christopher; Posdzich, P.; Herrmann, Ken; Hadaschik, Boris A.; Grünwald, Viktor

Neue Therapieansätze und Studienübersicht beim metastasierten hormonsensitiven Prostatakarzinom

In: Die Urologie, Jg. 62, 2023, Nr. 4, S. 369 – 375

DOI
Pomykala, K.L.; Hadaschik, Boris; Sartor, O.; Gillessen, S.; Sweeney, C.J.; Maughan, T.; Hofman, M.S.; Herrmann, Ken

Next generation radiotheranostics promoting precision medicine

In: Annals of Oncology, Jg. 34, 2023, Nr. 6, S. 507 – 519

DOI
Demmert, Tristan T.; Maric, Ines; Pomykala, Kelsey L.; Lueckerath, Katharina; Siveke, Jens; Schaarschmidt, Benedikt M.; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.

Novel ⁶⁸Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine-Related Pitfalls

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 3, S. 368 – 371

DOI (Open Access)
Demmert, Tristan T.; Pomykala, Kelsey L.; Lanzafame, Helena; Pabst, Kim M.; Lueckerath, Katharina; Siveke, Jens; Umutlu, Lale; Hautzel, Hubertus; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.

Oncologic Staging with ⁶⁸Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than ¹⁸F-FDG PET/CT

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 12, S. 1906 – 1909

DOI (Open Access)
Hager, Thomas; Borchert, Sabrina; Wessolly, Michael; Mathilakathu, Alexander; Mairinger, Elena; Kollmeier, Jens; Mairinger, Thomas; Hegedus, Balazs; Greimelmaier, Kristina; Wohlschläger, Jeremias; Herrmann, Ken; Mairinger, Fabian Dominik

One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy

In: International Journal of Molecular Sciences (IJMS), Jg. 24, 2023, Nr. 7, S. 6356

DOI (Open Access)
Voltin, Conrad-Amadeus; Gödel, Philipp; Beckmann, Laura; Heger, Jan-Michel; Kobe, Carsten; Kutsch, Nadine; Borchmann, Peter; Dietlein, Markus; Herrmann, Ken; Stelljes, Matthias; Rahbar, Kambiz; Lenz, Georg; Reinhardt, H. Christian; Teichert, Marcel; Noppeney, Richard; Albring, Jörn C.; Seifert, Robert; von Tresckow, Bastian; Flossdorf, Sarah; Hanoun, Christine

Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy

In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 7, 2023, Nr. 1, S. E817

DOI (Open Access)
Fendler, Wolfgang; Eiber, Matthias; Beheshti, Mohsen; Bomanji, Jamshed; Calais, Jeremie; Ceci, Francesco; Cho, Steve Y.; Fanti, Stefano; Giesel, Frederik L.; Goffin, Karolien; Haberkorn, Uwe; Jacene, Heather; Koo, Phillip J.; Kopka, Klaus; Krause, Bernd J.; Lindenberg, Liza; Marcus, Charles; Mottaghy, Felix M.; Oprea-Lager, Daniela E.; Osborne, Joseph R.; Piert, Morand; Rowe, Steven P.; Schöder, Heiko; Wan, Simon; Wester, Hans-Jürgen; Hope, Thomas A.; Herrmann, Ken

PSMA PET/CT : Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 5, S. 1466 – 1486

DOI (Open Access)
Civan, Caner; Kasper, Stefan; Berliner, Christoph; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, Michael; Schaarschmidt, Benedikt Michael; Lang, Stephan; Kersting, David; Nader, Michael; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel

PSMA-Directed Imaging and Therapy of Salivary Gland Tumors : A Single-Center Retrospective Study

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 3, S. 372 – 378

DOI (Open Access)
Palmedo, Holger; Ahmadzadehfar, Hojjat; Eschmann, Susanne; Niesen, Andreas; Schönberger, Johann; Barsegian, Vahé; Liepe, Knut; Mottaghy, Felix M.; Guan, Rongjin; Pinkert, Joerg; Sandström, Per; Herrmann, Ken

Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ²²³Ra : PARABO, a Prospective, Noninterventional Study

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 9, S. 1392 – 1398

DOI (Open Access)
Schuler, Martin; Bölükbas, Servet; Darwiche, Kaid; Theegarten, Dirk; Herrmann, Ken; Stuschke, Martin

Personalized Treatment for Patients With Lung Cancer

In: Deutsches Ärzteblatt International, Jg. 120, 2023, Nr. 17, S. 300 – 310

DOI (Open Access)
Lazaridis, Lazaros; Schmidt, Teresa; Oster, Christoph; Blau, Tobias; Pierscianek, Daniela; Siveke, Jens T.; Bauer, Sebastian; Schildhaus, Hans-Ulrich; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin

Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent glioma

In: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 7, S. 3513 – 3526

DOI (Open Access)
Pabst, Kim Magaly; Seifert, Robert; Hirmas, Nader; Bröcker-Preuß, Martina; Weber, Manuel; Fendler, Wolfgang Peter; Bartel, Timo; Theurer, Sarah; Herrmann, Ken; Görges, Rainer

Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer

In: Endocrine Connections, Jg. 12, 2023, Nr. 2, e220312

DOI, Online Volltext (Open Access)
Okumus, Özlem; Mardanzai, Khaled; Plönes, Till; Theegarten, Dirk; Darwiche, Kaid; Schuler, Martin; Nensa, Felix; Hautzel, Hubertus; Herrmann, Ken; Stuschke, Martin; Hegedus, Balazs; Aigner, Clemens

Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer

In: Lung Cancer, Jg. 176, 2023, S. 82 – 88

DOI
Djaïleb, Loïc; Armstrong, Wesley R.; Thompson, Daniel; Gafita, Andrei; Farolfi, Andrea; Rajagopal, Abhejit; Grogan, Tristan R.; Nguyen, Kathleen; Benz, Matthias R.; Hotta, Masatoshi; Barbato, Francesco; Ceci, Francesco; Schwarzenböck, Sarah M.; Unterrainer, Marcus; Zacho, Helle D.; Juarez, Roxanna; Cooperberg, Matthew; Carroll, Peter; Washington, Samuel; Reiter, Robert E.; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang P.; Czernin, Johannes; Hope, Thomas A.; Calais, Jeremie

Presurgical ⁶⁸Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment : A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial

In: European Urology, Jg. 84, 2023, Nr. 6, S. 588 – 596

DOI
Giovanella, Luca; Garo, Maria Luisa; Cuzzocrea, Marco; Paone, Gaetano; Herrmann, Ken

Prognostic role of early prostate specific antigen changes after [¹⁷⁷Lu]Lu-PSMA radioligand therapy of metastasized prostate cancer : A meta-analysis

In: European Journal of Clinical Investigation, Jg. 53, 2023, Nr. 9, e14014

DOI (Open Access)
Esen, Barış; Herrmann, Ken; Bavbek, Sevil; Kordan, Yakup; Tilki, Derya; Esen, Tarık

Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer

In: European Urology Focus, Jg. 9, 2023, Nr. 4, S. 596 – 605

DOI
Kersting, David; Moraitis, Alexandros; Sraieb, Miriam; Zarrad, Fadi; Umutlu, Lale; Rischpler, Christoph; Fendler, Wolfgang; Herrmann, Ken; Weber, Manuel; Conti, Maurizio; Fragoso Costa, Pedro; Jentzen, Walter

Quantification performance of silicon photomultiplier-based PET for small ¹⁸F-, ⁶⁸Ga- and ¹²⁴I-avid lesions in the context of radionuclide therapy planning

In: Physica Medica: European Journal of Medical Physics, Jg. 114, 2023, 103149

DOI (Open Access)
Storey, Claire M.; Altai, Mohamed; Bicak, Mesude; Veach, Darren R.; Lückerath, Katharina; Adrian, Gabriel; McDevitt, Michael R.; Kalidindi, Teja; Park, Julie E.; Herrmann, Ken; Abou, Diane; Zedan, Wahed; Peekhaus, Norbert; Klein, Robert J.; Damoiseaux, Robert; Larson, Steven M.; Lilja, Hans; Thorek, Daniel; Ulmert, David

Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response

In: Molecular Cancer Research, Jg. 21, 2023, Nr. 4, S. 307 – 315

DOI, Online Volltext (Open Access)
Kessler, Lukas; Fragoso Costa, Pedro; Kersting, David; Jentzen, Walter; Weber, Manuel; Lüdike, Peter; Carpinteiro, Alexander; Oubari, Sara; Hagenacker, Tim; Thimm, Andreas; Rassaf, Tienush; Herrmann, Ken; Papathanasiou, Maria; Rischpler, Christoph

Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosis

In: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 1, S. 101 – 111

DOI (Open Access)
Meetschen, Mathias; Sandach, Patrick; Darwiche, Kaid; Theegarten, Dirk; Moter, Annette; Schaarschmidt, Benedikt Michael; Herrmann, Ken; Fendler, Wolfgang; Hautzel, Hubertus; Opitz, Marcel

Rabbit fever : granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer ¹⁸FDG and ⁶⁸Ga-FAPI PET/CT

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 8, S. 2567 – 2569

DOI (Open Access)
Oeverhaus, Michael; Koenen, Jana; Bechrakis, Nikolaos; Stöhr, Mareile; Herrmann, Ken; Fendler, Wolfgang; Eckstein, Anja; Weber, Manuel

Radioiodine Ablation of Thyroid Remnants in Patients with Graves' Orbitopathy

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 4, S. 561 – 566

DOI (Open Access)
Bugani, Valentina; Battistelli, Luca; Sansovini, Maddalena; Monti, Manuela; Paganelli, Giovanni; Gich, Ignasi; Flotats, Albert; Erba, Paola Anna; Blay, Jean-Yves; la Fougère, Christian; Van Poppel, Hendrik; Charalambous, Andreas; Herrmann, Ken; Giordano, Alessandro; Györke, Tamás; Deroose, Christophe; Matteucci, Federica; Carrió, Ignasi

Radioligand therapies in cancer : Mapping the educational landscape in Europe

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 9, S. 2692 – 2698

DOI (Open Access)
Klümper, Niklas; Eckstein, Markus; Hölzel, Michael; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor

Re: First-in-Human Study of the Radioligand ⁶⁸Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma : Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT

In: European Urology, Jg. 84, 2023, Nr. 5, S. 514 – 515

DOI
Fragoso Costa, Pedro; Jentzen, Walter; Süßelbeck, Finja; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Conti, Maurizio; Kersting, David; Weber, Manuel

Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision : A phantom study

In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 67, 2023, Nr. 1, S. 57 – 68

DOI
Papathanasiou, Maria; Kessler, Lukas; Bengel, Frank M.; Jakstaite, Aiste-Monika; Kersting, David; Varasteh, Zohreh; Lüdike, Peter; Carpinteiro, Alexander; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph

Regression of Myocardial ⁹⁹mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1083 – 1086

DOI (Open Access)
Gafita, Andrei; Djaileb, Loïc; Rauscher, Isabel; Fendler, Wolfgang P.; Hadaschik, Boris; Rowe, Steven P.; Herrmann, Ken; Calais, Jeremie; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.; Farolfi, Andrea

Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer

In: Radiology, Jg. 308, 2023, Nr. 1, e222148

DOI, Online Volltext (Open Access)
Hope, Thomas A.; Allen-Auerbach, Martin; Bodei, Lisa; Calais, Jeremie; Dahlbom, Magnus; Dunnwald, Lisa K.; Graham, Michael M.; Jacene, Heather A.; Heath, Courtney Lawhn; Mittra, Erik S.; Wright, Chadwick L.; Fendler, Wolfgang; Herrmann, Ken; Taïeb, David; Kjaer, Andreas

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET : Imaging Neuroendocrine Tumors

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 2, S. 204 – 210

DOI (Open Access)
Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin

SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 8, S. 1191 – 1194

DOI (Open Access)
Seifert, Robert; Emmett, Louise; Rowe, Steven P.; Herrmann, Ken; Hadaschik, Boris; Calais, Jeremie; Giesel, Frederik L.; Reiter, Robert; Maurer, Tobias; Heck, Matthias; Gafita, Andrei; Morris, Michael J.; Fanti, Stefano; Weber, Wolfgang A.; Hope, Thomas A.; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)

In: European Urology, Jg. 83, 2023, Nr. 5, S. 405 – 412

DOI (Open Access)
Seifert, Robert; Gafita, Andrei; Telli, Tugce; Voter, Andrew; Herrmann, Ken; Pomper, Martin; Hadaschik, Boris; Rowe, Steven P.; Fendler, Wolfgang

Standardized PSMA-PET Imaging of Advanced Prostate Cancer

In: Seminars in Nuclear Medicine, Jg. 54, 2023, Nr. 1, S. 60 – 68

DOI
Pabst, Kim M.; Trajkovic-Arsic, Marija; Cheung, Phyllis F Y; Ballke, Simone; Steiger, Katja; Bartel, Timo; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Seifert, Robert; Nader, Michael; Kessler, Lukas; Siveke, Jens T.; Lückerath, Katharina; Kasper, Stefan; Herrmann, Ken; Hirmas, Nader; Schmidt, Hartmut; Hamacher, Rainer; Fendler, Wolfgang

Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1049 – 1055

DOI (Open Access)
Pomykala, Kelsey L.; Würker, Marcus; Herrmann, Ken

Tackling the Last Mile : A Major Component to Successfully Establish Radioligand Therapy

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 3, S. 347 – 348

DOI (Open Access)
Strosberg, Jonathan; Herrmann, Ken; Bodei, Lisa

The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 2, S. 219 – 220

DOI (Open Access)
Jannusch, Kai; Lindemann, Maike E.; Bruckmann, Nils Martin; Morawitz, Janna; Dietzel, Frederic; Pomykala, Kelsey L.; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Umutlu, Lale; Antoch, Gerald; Quick, Harald H.; Kirchner, Julian

Towards a fast PET/MRI protocol for breast cancer imaging : maintaining diagnostic confidence while reducing PET and MRI acquisition times

In: European Radiology, Jg. 33, 2023, Nr. 9, S. 6179 – 6188

DOI (Open Access)
Seifert, Robert; Telli, Tugce; Opitz, Marcel; Barbato, Francesco; Berliner, Christoph; Nader, Michael; Umutlu, Lale; Stuschke, Martin; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang

Unspecific ¹⁸F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 738 – 743

DOI (Open Access)
Bröcker-Preuß, Martina; Simon, Dietmar; Fries, Mirka; Kornely, Elisabeth; Weber, Manuel; Vardarli, Irfan; Gilman, Elena; Herrmann, Ken; Görges, Rainer

Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules

In: Cancers, Jg. 15, 2023, Nr. 8, 2333

DOI (Open Access)
Kupusovic, Jana; Kessler, Lukas; Bruns, Florian; Bohnen, Jan-Eric; Nekolla, Stephan G.; Weber, Manuel; Lauenroth, Anna; Rattka, Manuel; Herrmann, Ken; Dobrev, Dobromir; Rassaf, Tienush; Wakili, Reza; Rischpler, Christoph; Siebermair, Johannes

Visualization of fibroblast activation using ⁶⁸Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation

In: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 5, S. 2018 – 2028

DOI (Open Access)
Watanabe, Masao; Grafe, Hong; Theysohn, Jens; Schaarschmidt, Benedikt; Ludwig, Johannes; Jochheim, Leonie; Jeschke, Matthias; Schmidt, Hartmut; Fendler, Wolfgang; Moraitis, Alexandros; Herrmann, Ken; Pomykala, Kelsey L.; Weber, Manuel

Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with ⁹⁰Y Glass Microspheres

In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1102 – 1108

DOI (Open Access)
Telli, Tugce; Desaulniers, Mélanie; Pyka, Thomas; Caobelli, Federico; Forstmann, Sophia; Umutlu, Lale; Fendler, Wolfgang; Rominger, Axel; Herrmann, Ken; Seifert, Robert

What Role Does PET/MRI Play in Musculoskeletal Disorders?

In: Seminars in Nuclear Medicine, Jg. 55, 2023, Nr. 2, S. 277 – 289

DOI
Jannusch, Kai; Morawitz, Janna; Schweiger, Bernd; Weiss, Daniel; Schimmöller, Lars; Minko, Peter; Herrmann, Ken; Fendler, Wolfgang; Quick, Harald H.; Antoch, Gerald; Umutlu, Lale; Kirchner, Julian; Bruckmann, Nils-Martin

[¹⁸F]FDG PET/MRI in children suffering from lymphoma : does MRI contrast media make a difference?

In: European Radiology, Jg. 33, 2023, Nr. 11, S. 8366 – 8375

DOI (Open Access)
Sartor, Oliver; Herrmann, Ken

前列腺癌治疗 : ¹⁷⁷Lu－PSMA－617的注意事项、观点和局限性

In: Chinese Journal of Nuclear Medicine and Molecular Imaging, Jg. 43, 2023, Nr. 4, S. 252 – 256

DOI
Benz, Matthias R.; Armstrong, Wesley R.; Ceci, Francesco; Polverari, Giulia; Donahue, Timothy R.; Wainberg, Zev A.; Quon, Andrew; Auerbach, Martin; Girgis, Mark D.; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie

18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 2, S. 199 – 204

DOI (Open Access)
Vardarli, Irfan; Brandenburg, Tim; Hegedüs, Laszlo; Attanasio, Roberto; Nagy, EndreV.; Papini, Enrico; Perros, Petros; Weidemann, Frank; Herrmann, Ken; Führer, Dagmar

A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients : The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) Collaborative

In: Experimental and Clinical Endocrinology & Diabetes, Jg. 130, 2022, Nr. 9, S. 577 – 586

DOI (Open Access)
Sandach, Patrick; Seifert, Robert; Fendler, Wolfgang; Hautzel, Hubertus; Herrmann, Ken; Maier, Sandra; Plönes, Till; Metzenmacher, Martin; Ferdinandus, Justin

A Role for PET/CT in response assessment of malignant pleural mesothelioma

In: Seminars in Nuclear Medicine, Jg. 52, 2022, Nr. 6, S. 816 – 823

DOI
Bruckmann, Nils Martin; Morawitz, Janna; Fendler, Wolfgang P.; Ruckhäberle, Eugen; Bittner, Ann-Kathrin; Giesel, Frederik L.; Herrmann, Ken; Antoch, Gerald; Umutlu, Lale; Kirchner, Julian

A Role of PET/MR in Breast Cancer?

In: Seminars in Nuclear Medicine, Jg. 52, 2022, Nr. 5, S. 611 – 618

DOI
Lam, Marnix; Garin, Etienne; Maccauro, Marco; Kappadath, S. Cheenu; Sze, Daniel Y.; Turkmen, Cuneyt; Cantasdemir, Murat; Haste, Paul; Herrmann, Ken; Alsuhaibani, Hamad Saleh; Dreher, Matthew; Fowers, Kirk D.; Salem, Riad

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90 : The TARGET study

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 10, S. 3340 – 3352

DOI (Open Access)
Klose, Jasmin M.; Wosniack, Jasmin; Iking, Janette; Staniszewska, Magdalena; Zarrad, Fadi; Trajkovic-Arsic, Marija; Herrmann, Ken; Costa, Pedro Fragoso; Lückerath, Katharina; Fendler, Wolfgang

Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in Mice

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 9, S. 1357 – 1363

DOI, Online Volltext (Open Access)
Hosch, René; Weber, Manuel; Sraieb, Miriam; Flaschel, Nils; Haubold, Johannes; Kim, Moon-Sung; Umutlu, Lale; Kleesiek, Jens; Herrmann, Ken; Nensa, Felix; Rischpler, Christoph; Koitka, Sven; Seifert, Robert; Kersting, David

Artificial intelligence guided enhancement of digital PET : Scans as fast as CT?

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 13, S. 4503 – 4515

DOI (Open Access)
Freudenberg, Lutz; Pomykala, Kelsey L.; Herrmann, Ken

COVID-19 Pandemic : What Have We Learned and What to Expect in the Future?

In: Seminars in Nuclear Medicine, Jg. 52, 2022, Nr. 1, S. 86 – 89

DOI (Open Access)
Weidemann, Frank; Jovanovic, Ana; Herrmann, Ken; Vardarli, Irfan

Chaperone Therapy in Fabry Disease

In: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 3, 1887

DOI (Open Access)
Seifert, Robert; Kersting, David; Rischpler, Christoph; Opitz, Marcel; Kirchner, Julian; Pabst, Kim M.; Mavroeidi, Ilektra-Antonia; Laschinsky, Christina; Grueneisen, Johannes; Schaarschmidt, Benedikt; Catalano, Onofrio Antonio; Herrmann, Ken; Umutlu, Lale

Clinical Use of PET/MR in Oncology : An Update

In: Seminars in Nuclear Medicine, Jg. 52, 2022, Nr. 3, S. 356 – 364

DOI
Morawitz, Janna; Bruckmann, Nils-Martin; Dietzel, Frederic; Ullrich, Tim; Bittner, Ann-Kathrin; Hoffmann, Oliver; Ruckhäberle, Eugen; Mohrmann, Svjetlana; Häberle, Lena; Ingenwerth, Marc; Abrar, Daniel Benjamin; Sawicki, Lino Morris; Breuckmann, Katharina; Fendler, Wolfgang; Herrmann, Ken; Buchbender, Christian; Antoch, Gerald; Umutlu, Lale; Kirchner, Julian

Comparison of nodal staging between CT, MRI, and [¹⁸F]-FDG PET/MRI in patients with newly diagnosed breast cancer

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, S. 992 – 1001

DOI (Open Access)
Thimm, Andreas; Carpinteiro, Alexander; Oubari, Sara; Papathanasiou, Maria; Kessler, Lukas; Rischpler, Christoph; Malik, Rayaz Ahmed; Reinhardt, Hans Christian; Rassaf, Tienush; Herrmann, Ken; Kleinschnitz, Christoph; Stettner, Mark; Hagenacker, Tim

Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosis

In: Annals of Clinical and Translational Neurology, Jg. 9, 2022, Nr. 6, S. 853 – 863

DOI, Online Volltext (Open Access)
Vaz, Sofia C.; Adam, Judit A.; Delgado Bolton, Roberto C.; Vera, Pierre; van Elmpt, Wouter; Herrmann, Ken; Hicks, Rodney J.; Lievens, Yolande; Santos, Andrea; Schöder, Heiko; Dubray, Bernard; Visvikis, Dimitris; Troost, Esther G. C.; de Geus-Oei, Lioe-Fee

Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 4, (1386-1406), 10.1007/s00259-021-05624-5)

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 9, S. 3300 – 3301

DOI (Open Access)
Schmidt, Matthias; Bartenstein, Peter; Bucerius, Jan; Dietlein, Markus; Drzezga, Alexander; Herrmann, Ken; Lapa, Constantin; Lorenz, Kerstin; Musholt, Thomas J.; Nagarajah, James; Reiners, Christoph; Sahlmann, Carsten O.; Kreissl, Michael C.

Correction: Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine

In: Nuklearmedizin = Nuclear Medicine, Jg. 61, 2022, Nr. 3, S. 280

DOI
Weber, Manuel; Schmitz, Jochen; Maric, Ines; Pabst, Kim; Umutlu, Lale; Walz, Martin; Herrmann, Ken; Rischpler, Christoph; Weber, Frank; Jentzen, Walter; Theurer, Sarah; Poeppel, Thorsten D.; Unger, Nicole; Fendler, Wolfgang

Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 6, S. 869 – 874

DOI (Open Access)
Schenke, Simone Agnes; Kreissl, Michael C.; Grunert, Michael; Hach, Anja; Haghghi, Sarvar; Kandror, Tatjana; Peppert, Eckhard; Rosenbaum-Krumme, Sandra; Ruhlmann, Verena; Stahl, Alexander; Wanjura, Dieter; Zaplatnikov, Konstantin; Zimny, Michael; Gilman, Elena; Herrmann, Ken; Görges, Rainer

Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany

In: Nuklearmedizin = Nuclear Medicine, Jg. 61, 2022, Nr. 5, S. 376 – 384

DOI
Weber, Manuel; Lam, Marnix; Chiesa, Carlo; Konijnenberg, Mark W.; Cremonesi, Marta; Flamen, Patrick B.; Gnesin, Silvano; Bodei, Lisa; Kracmerova, T.; Luster, Markus; Garin, Etienne; Herrmann, Ken

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 5, S. 1682 – 1699

DOI (Open Access)
Fanti, Stefano; Briganti, Alberto; Emmett, Louise; Fizazi, Karim; Gillessen, Silke; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Kunikowska, Jolanta; Maurer, Tobias; MacLennan, Steven; Mottet, Nicolas; Murphy, Declan G.; Oprea-Lager, Daniela E.; O'Sullivan, Joe M.; Oyen, Wim J G; Rouvière, Olivier; Sartor, Oliver; Stenzl, Arnulf; Van Poppel, Hendrik; Walz, Jochen; Witjes, Wim; Bjartell, Anders

EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy

In: European Urology Oncology, Jg. 5, 2022, Nr. 5, S. 530 – 536

DOI (Open Access)
Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors

In: Immunotherapy, Jg. 14, 2022, Nr. 12, S. 927 – 944

DOI (Open Access)
Bruckmann, Nils Martin; Rischpler, Christoph; Tsiami, Styliani; Kirchner, Julian; Abrar, Daniel B.; Bartel, Timo; Theysohn, Jens; Umutlu, Lale; Herrmann, Ken; Fendler, Wolfgang; Buchbender, Christian; Antoch, Gerald; Sawicki, Lino M.; Tsobanelis, Athanasios; Braun, Juergen; Baraliakos, Xenofon

Effects of Anti-Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis : A Prospective Proof-of-Concept Study Using Positron Emission Tomography/Magnetic Resonance Imaging of the Sacroiliac Joints and Spine

In: Arthritis & Rheumatology, Jg. 74, 2022, Nr. 9, S. 1497 – 1505

DOI (Open Access)
Weber, Manuel; Kersting, David; Riemann, Burkhard; Brandenburg, Tim; Führer, Dagmar; Grünwald, Frank; Kreissl, Michael C.; Dralle, Henning; Weber, Frank; Schmid, Kurt Werner; Herrmann, Ken; Jentzen, Walter; Grafe, Hong; Rischpler, Christoph; Theurer, Sarah; Bockisch, Andreas; Nagarajah, James; Fendler, Wolfgang

Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm Study

In: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4194 – 4202

DOI (Open Access)
Sandach, Patrick; Kleibrink, Björn; Maier, Sandra; Herrmann, Ken; Hautzel, Hubertus

False Positive Ventilation/Perfusion SPECT/CT Mismatch Mimicking Pulmonary Embolism in a Patient With Bilateral Lung Transplant

In: Clinical Nuclear Medicine, Jg. 47, 2022, Nr. 11, S. e718 – e721

DOI
Kersting, David; Sraieb, Miriam; Seifert, Robert; Costa, Pedro Fragoso; Kazek, Sandra; Kessler, Lukas; Umutlu, Lale; Fendler, Wolfgang; Jentzen, Walter; Herrmann, Ken; Büther, Florian; Nader, Michael; Rischpler, Christoph

First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 10, S. 3373 – 3386

DOI (Open Access)
Lazaridis, Lazaros; Bumes, Elisabeth; Cäcilia Spille, Dorothee; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Feldheim, Jonas; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Breuer, Stella; Hattingen, Elke; Scheffler, Björn; Kebir, Sied; Glas, Martin

First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma

In: Neuro-Oncology Advances, Jg. 4, 2022, Nr. 1, S. vdac137

DOI (Open Access)
Bruckmann, Nils Martin; Kirchner, Julian; Morawitz, Janna; Umutlu, Lale; Fendler, Wolfgang; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Fehm, Tanja; Lindemann, Maike E.; Buchbender, Christian; Antoch, Gerald; Sawicki, Lino M.

Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRI

In: EJNMMI Physics, Jg. 9, 2022, Nr. 1, 11

DOI (Open Access)
Pacelli, Anna; Zarrad, Fadi; Fendler, Wolfgang; Herrmann, Ken; Nader, Michael

Fully Automated, High-Dose Radiosynthesis of [18F]PARPi

In: Pharmaceuticals, Jg. 15, 2022, Nr. 7, 865

DOI, Online Volltext (Open Access)
Nadig, Vanessa; Herrmann, Ken; Mottaghy, Felix M.; Schulz, Volkmar

Hybrid total-body pet scanners : current status and future perspectives

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, S. 445 – 459

DOI (Open Access)
Unterrainer, Marcus; Deroose, Christophe M.; Herrmann, Ken; Moehler, Markus; Blomqvist, Lennart; Cannella, Roberto; Caramella, Caroline; Caruso, Damiano; Chouhan, Manil D.; Denecke, Timm; De la Pinta, Carolina; De Geus-Oei, Lioe-Fee; Dulskas, Audrius; Eisenblätter, Michel; Foley, Kieran G.; Gourtsoyianni, Sofia; Lecouvet, Frederic E.; Lopci, Egesta; Maas, Monique; Obmann, Markus M.; Oprea-Lager, Daniela E.; Verhoeff, Joost J.C.; Santiago, Ines; Terraz, Sylvain; D'Anastasi, Melvin; Regge, Daniele; Laghi, Andrea; Beets-Tan, Regina G.H.; Heinemann, Volker; Lordick, Florian; Smyth, Elizabeth C.; Ricke, Jens; Kunz, Wolfgang G.

Imaging standardisation in metastatic colorectal cancer : A joint EORTC-ESOI-ESGAR expert consensus recommendation

In: European Journal of Cancer (EJC), Jg. 176, 2022, S. 193 – 206

DOI (Open Access)
Rischpler, Christoph; Rassaf, Tienush; Umutlu, Lale; Herrmann, Ken; Schlosser, Thomas Wilfried; Totzeck, Matthias

Imaging the Inflammatory Response in Checkpoint Inhibition Myocarditis

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 1, S. 14 – 16

DOI (Open Access)
Nader, M.; Herrmann, Ken; Kunkel, F.; Zarrad, F.; Pacelli, A.; Fendler, Wolfgang; Koplin, S.

Improved production of ⁶⁸Ga-Pentixafor using cartridge mediated cation exchange purification

In: Applied Radiation and Isotopes, Jg. 189, 2022, 110447

DOI
Schmidt, Matthias; Bartenstein, Peter; Bucerius, Jan; Dietlein, Markus; Drzezga, Alexander; Herrmann, Ken; Lapa, Constantin; Lorenz, Kerstin; Musholt, Thomas J.; Nagarajah, James; Reiners, Christoph; Sahlmann, Carsten O.; Kreissl, Michael C.

Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine

In: Nuklearmedizin = Nuclear Medicine, Jg. 61, 2022, Nr. 02, S. 87 – 96

DOI (Open Access)
Ferdinandus, Justin; Costa, Pedro Fragoso; Kessler, Lukas; Weber, Manuel; Hirmas, Nader; Kostbade, Karina; Bauer, Sebastian; Schuler, Martin; Ahrens, Marit; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Grafe, Hong; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.; Hamacher, Rainer

Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 Patients

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 5, S. 727 – 734

DOI (Open Access)
Seifert, Robert; Kersting, David; Rischpler, Christoph; Sandach, Patrick; Ferdinandus, Justin; Fendler, Wolfgang; Rahbar, Kambiz; Weckesser, Matthias; Umutlu, Lale; Hanoun, Christine; Hüttmann, Andreas; Reinhardt, Hans Christian; von Tresckow, Bastian; Herrmann, Ken; Dührsen, Ulrich; Schäfers, Michael

Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trial

In: Leukemia, Jg. 36, 2022, Nr. 12, S. 2845 – 2852

DOI (Open Access)
Grafe, Hong; Lindemann, Maike E.; Weber, Manuel; Kirchner, Julian; Binse, Ina; Umutlu, Lale; Herrmann, Ken; Quick, Harald H.

Intra-Individual Comparison of 124I-PET/CT and 124I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma : Aspects of Attenuation Correction

In: Cancers, Jg. 14, 2022, Nr. 13, 3040

DOI, Online Volltext (Open Access)
Herrmann, Ken; Giovanella, Luca; Santos, Andrea; Gear, Jonathan; Kiratli, Pinar Ozgen; Kurth, Jens; Denis-Bacelar, Ana M.; Hustinx, Roland; Patt, Marianne; Wahl, Richard L.; Paez, Diana; Giammarile, Francesco; Jadvar, Hossein; Pandit-Taskar, Neeta; Ghesani, Munir; Kunikowska, Jolanta

Joint EANM, SNMMI and IAEA enabling guide : How to set up a theranostics centre

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 7, S. 2300 – 2309

DOI (Open Access)
Herrmann, Ken; Giovanella, Luca; Santos, Andrea; Gear, Jonathan; Ozgen Kiratli, Pinar; Kurth, Jens; Denis-Bacelar, Ana M.; Hustinx, Roland; Patt, Marianne; Wahl, Richard L.; Paez, Diana; Giammarile, Francesco; Jadvar, Hossein; Pandit-Taskar, Neeta; Ghesani, Munir; Kunikowska, Jolanta

Joint EANM, SNMMI, and IAEA Enabling Guide : How to Set up a Theranostics Center

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 12, S. 1836 – 1843

DOI
Vaz, Sofia C.; Adam, Judit A.; Bolton, Roberto C. Delgado; Vera, Pierre; van Elmpt, Wouter; Herrmann, Ken; Hicks, Rodney J.; Lievens, Yolande; Santos, Andrea; Schöder, Heiko; Dubray, Bernard; Visvikis, Dimitris; Troost, Esther G. C.; de Geus-Oei, Lioe-Fee

Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 4, S. 1386 – 1406

DOI (Open Access)
Murphy, Declan; Herrmann, Ken; Hofman, Michael

Leading in Urology and Pioneering in Social Media Outreach : A Conversation Among Declan Murphy, Ken Herrmann, and Michael Hofman

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 12, S. 1783 – 1785

DOI
Leyh, Catherine; Heucke, Niklas; Schotten, Clemens; Büchter, Matthias; Bechmann, Lars P.; Wichert, Marc; Dechene, Alexander; Herrmann, Ken; Heider, Dominik; Sydor, Svenja; Lemmer, Peter; Ludwig, Johannes M.; Pospiech, Josef; Theysohn, Jens; Damm, Robert; March, Christine; Powerski, Maciej; Pech, Maciej; Özcürümez, Mustafa; Weigt, Jochen; Keitel, Verena; Lange, Christian M.; Schmidt, Hartmut; Canbay, Aliekber; Best, Jan; Gerken, Guido; Manka, Paul

LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis

In: Cancers, Jg. 14, 2022, Nr. 19, 4584

DOI (Open Access)
Jannusch, Kai; Bruckmann, Nils Martin; Geuting, Charlotte Johanna; Morawitz, Janna; Dietzel, Frederic; Rischpler, Christoph; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Quick, Harald H.; Umutlu, Lale; Antoch, Gerald; Kirchner, Julian

Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI : Clinically Relevant?

In: Cancers, Jg. 14, 2022, Nr. 14, 3454

DOI (Open Access)
Oprea-Lager, Daniela E.; Ceci, Francesco; Eiber, Matthias; Fanti, Stefano; Herrmann, Ken

Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2022, Nr. 1, S. 10 – 11

DOI
Gafita, Andrei; Rauscher, Isabel; Fendler, Wolfgang; Murthy, Vishnu; Hui, Wang; Armstrong, Wesley R.; Herrmann, Ken; Weber, Wolfgang A.; Calais, Jeremie; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT : comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 12, S. 4271 – 4281

DOI (Open Access)
Ferdinandus, Justin; Zaremba-Montenari, Anne; Zimmer, Lisa; Umutlu, Lale; Seifert, Robert; Barbato, Francesco; Ugurel, Selma; Chorti, Eleftheria; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth

Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

In: Cancer Imaging, Jg. 22, 2022, Nr. 1

DOI, Online Volltext (Open Access)
Umutlu, Lale; Kirchner, Julian; Bruckmann, Nils-Martin; Morawitz, Janna; Antoch, Gerald; Ting, Saskia; Bittner, Ann-Kathrin; Hoffmann, Oliver; Häberle, Lena; Ruckhäberle, Eugen; Catalano, Onofrio Antonio; Chodyla, Michal; Grueneisen, Johannes; Quick, Harald H.; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Gibbs, Peter; Pinker, Katja

Multiparametric¹⁸F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

In: Cancers, Jg. 14, 2022, Nr. 7, 1727

DOI (Open Access)
Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0) : An International Multicenter Study

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 11, S. 1651 – 1658

DOI (Open Access)
Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick

Onkologische Theranostik in der Nuklearmedizin

In: Die Radiologie, Jg. 62, 2022, Nr. 10, S. 875 – 884

DOI
Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick

Onkologische Theranostik in der Nuklearmedizin

In: Die Onkologie, Jg. 28, 2022, Nr. 7, S. 612 – 622

DOI
Ferdinandus, Justin; Fendler, Wolfgang; Farolfi, Andrea; Washington, Samuel; Mohamad, Osama; Pampaloni, Miguel H.; Scott, Peter J.H.; Rodnick, Melissa; Viglianti, Benjamin L.; Eiber, Matthias; Herrmann, Ken; Czernin, Johannes; Armstrong, Wesley R.; Calais, Jeremie; Hope, Thomas A.; Piert, Morand; Mohammad, Osama

PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups : An International Multicenter Study

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 1, S. 76 – 80

DOI (Open Access)
Mattoni, Susanna; Farolfi, Andrea; Formaggio, Fabio; Bruno, Gabriel; Caroli, Paola; Cerci, Juliano Julio; Eiber, Matthias; Fendler, Wolfgang; Golfieri, Rita; Herrmann, Ken; Matteucci, Federica; Mosconi, Cristina; Paolani, Giulia; Santoro, Miriam; Strigari, Lidia; Nanni, Cristina; Castellucci, Paolo; Fanti, Stefano

PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients : A Multicenter Retrospective Study

In: Cancers, Jg. 14, 2022, Nr. 22, 5680

DOI (Open Access)
Vaz, Sofia C.; Adam, Judit A.; Delgado Bolton, Roberto C.; Vera, Pierre; van Elmpt, Wouter; Herrmann, Ken; Hicks, Rodney J.; Lievens, Yolande; Santos, Andrea; Schöder, Heiko; Dubray, Bernard; Visvikis, Dimitris; Troost, Esther G.C.; de Geus-Oei, Lioe-Fee

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG-PET/CT external beam radiation treatment planning in lung cancer

In: Radiotherapy and Oncology (The Green Journal), Jg. 168, 2022, S. 37 – 39

DOI (Open Access)
Fragoso Costa, Pedro; Jentzen, Walter; Brahmer, Alissa; Mavroeidi, Ilektra-Antonia; Zarrad, Fadi; Umutlu, Lale; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Conti, Maurizio; Seifert, Robert; Sraieb, Miriam; Weber, Manuel; Kersting, David

Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system

In: BMC Cancer, Jg. 22, 2022, Nr. 1, 899

DOI, Online Volltext (Open Access)
Kmetyuk, Yaroslav; Czernin, Johannes; Herrmann, Ken

Practicing Medicine in Wartime Ukraine : A Conversation Between Yaroslav Kmetyuk, Johannes Czernin, and Ken Herrmann

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 8, S. 1127 – 1130

DOI (Open Access)
Theysohn, Jens; Demircioglu, Aydin; Kleditzsch, Malte; Ludwig, Johannes M.; Weber, Manuel; Umutlu, Lale; Li, Yan; Kircher, Malte; Lapa, Constantin; Buck, Andreas; Koehler, Michael; Wildgruber, Moritz; Lange, Christian M.; Palard, Xavier; Garin, Etienne; Herrmann, Ken; Forsting, Michael; Nensa, Felix

Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation

In: Scientific Reports, Jg. 12, 2022, Nr. 1, 20718

DOI, Online Volltext (Open Access)
Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

In: Scientific Reports, Jg. 12, 2022, Nr. 1, 17511

DOI, Online Volltext (Open Access)
Sartor, Oliver; Herrmann, Ken

Prostate Cancer Treatment : 177Lu-PSMA-617 Considerations, Concepts, and Limitations

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 6, S. 823 – 829

DOI (Open Access)
Costa, Pedro Fragoso; Fendler, Wolfgang; Herrmann, Ken; Sandach, Patrick; Grafe, Hong; Grootendorst, Maarten R.; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Radtke, Jan P.; Tschirdewahn, Stephan; Hadaschik, Boris; Darr, Christopher

Radiation Protection and Occupational Exposure on ⁶⁸Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 9, S. 1349 – 1356

DOI (Open Access)
Bodei, Lisa; Herrmann, Ken; Schöder, Heiko; Scott, Andrew M.; Lewis, Jason S.

Radiotheranostics in oncology : current challenges and emerging opportunities

In: Nature Reviews Clinical Oncology, Jg. 19, 2022, Nr. 8, S. 534 – 550

DOI, Online Volltext (Open Access)
Sartor, O.; de Bono, J.; Chi, K.N.; Fizazi, K.; Herrmann, Ken; Rahbar, K.; Tagawa, S.T.; Nordquist, L.T.; Vaishampayan, N.; El-Haddad, G.; Park, C.H.; Beer, T.M.; Armour, A.; Perez-Contreras, W.J.; DeSilvio, M.; Kpamegan, E.; Gericke, G.; Messmann, R.A.; Morris, M.J.; Krause, B.J.

Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

In: The Journal of Urology, Jg. 207, 2022, Nr. 2, S. 467 – 468

DOI
Seifert, Robert; Sandach, Patrick; Kersting, David; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Sunderland, John J.; Pollard, Janet H.

Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor Volume

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 5, S. 746 – 753

DOI (Open Access)
Ferdinandus, Justin; Fendler, Wolfgang; Lückerath, Katharina; Berliner, Christoph; Kurzidem, Sabine; Hadaschik, Eva; Klode, Joachim; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Herrmann, Ken; Becker, Jürgen; Ugurel, Selma

Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 3, S. 396 – 398

DOI (Open Access)
Fendler, Wolfgang P.; Pabst, Kim M.; Kessler, Lukas; Fragoso Costa, Pedro; Ferdinandus, Justin; Weber, Manuel; Lippert, Maria; Lückerath, Katharina; Umutlu, Lale; Kostbade, Karina; Mavroeidi, Ilektra A.; Schuler, Martin; Ahrens, Marit; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens T.; Hamacher, Rainer

Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities

In: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4346 – 4353

DOI (Open Access)
Kersting, David; Settelmeier, Stephan; Mavroeidi, Ilektra-Antonia; Herrmann, Ken; Seifert, Robert; Rischpler, Christoph

Shining Damaged Hearts : Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology

In: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 7, 3802

DOI, Online Volltext (Open Access)
Lahner, Harald; Mathew, Annie; Klocker, Anna Lisa; Unger, Nicole; Theysohn, Jens; Rekowski, Jan; Jöckel, Karl-Heinz; Theurer, Sarah; Schmid, Kurt Werner; Herrmann, Ken; Führer, Dagmar

Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy

In: Endocrine, Jg. 75, 2022, Nr. 1, S. 293 – 302

DOI (Open Access)
Michel, Lars; Helfrich, Iris; Hendgen-Cotta, Ulrike Barbara; Mincu, Raluca-Ileana; Korste, Sebastian; Mrotzek, Simone Maria; Spomer, Armin; Odersky, Andrea; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Coman, Cristina; Ahrends, Robert; Sickmann, Albert; Löffek, Stefanie; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Gunzer, Matthias; Schadendorf, Dirk; Totzeck, Matthias; Rassaf, Tienush

Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

In: European Heart Journal, Jg. 43, 2022, Nr. 4, S. 316 – 329

DOI
Pabst, Kim M.; Decker, Thomas; Kersting, David; Bartel, Timo; Sraieb, Miriam; Herrmann, Ken; Seifert, Robert

The Future Role of PET Imaging in Metastatic Breast Cancer

In: Oncology Research and Treatment, Jg. 45, 2022, Nr. 1-2, S. 18 – 25

DOI
Weich, Alexander; Higuchi, Takahiro; Bundschuh, Ralph A.; Lapa, Constantin; Serfling, Sebastian E.; Rowe, Steven P.; Pomper, Martin G.; Herrmann, Ken; Buck, Andreas K.; Derlin, Thorsten; Werner, Rudolf A.

Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers

In: Molecular Imaging and Biology, Jg. 24, 2022, Nr. 4, S. 631 – 640

DOI (Open Access)
Gafita, Andrei; Wang, Hui; Robertson, Andrew; Armstrong, Wesley R.; Zaum, Raphael; Weber, Manuel; Yagubbayli, Farid; Kratochwil, Clemens; Grogan, Tristan R.; Nguyen, Kathleen; Navarro, Fernando; Esfandiari, Rouzbeh; Rauscher, Isabel; Menze, Bjoern; Elashoff, David; Delpassand, Ebrahim S.; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S.; Calais, Jeremie; Fendler, Wolfgang; Eiber, Matthias

Tumor Sink Effect in ⁶⁸Ga-PSMA-11 PET : Myth or Reality?

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 2, S. 226 – 232

DOI (Open Access)
Chodyla, Michal; Barbato, Francesco; Dirksen, Uta; Kirchner, Julian; Schaarschmidt, Benedikt M.; Schweiger, Bernd; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grueneisen, Johannes

Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma : Preliminary Results

In: Diagnostics, Jg. 12, 2022, Nr. 10, 2278

DOI, Online Volltext (Open Access)
Murray, Jacob M.; Wiegand, Bodo; Hadaschik, Boris; Herrmann, Ken; Kleesiek, Jens

Virtual Biopsy : Just an AI Software or a Medical Procedure?

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 4, S. 511 – 513

DOI, Online Volltext (Open Access)
Pomykala, Kelsey L.; Herrmann, Ken; Emmett, Louise; Lalumera, Elisabetta; Fanti, Stefano

Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging : Closer to Reality in a Subgroup of Prostate Cancer Patients?

In: European Urology Open Science, Jg. 44, 2022, S. 11 – 12

DOI (Open Access)
Freudenberg, Lutz; Freudenberg, Ben J.; Klett, Rigobert; Herrmann, Ken

Vom Aussterben bedroht? : Eine Demografie der Nuklearmedizin in Deutschland 1996–2021 anhand der Zahlen der Bundesärztekammer

In: Nuklearmedizin = Nuclear Medicine, Jg. 61, 2022, Nr. 05, S. 358 – 366

DOI
Nader, Michael; Valla, D. F.; Vriamont, Charles; Masset, Julien; Pacelli, Anna; Herrmann, Ken; Zarrad, Fadi

[⁶⁸Ga]/[⁹⁰Y]FAPI-46 : Automated production and analytical validation of a theranostic pair

In: Nuclear Medicine and Biology, Jg. 110-111, 2022, S. 37 – 44

DOI
Crompton, Joseph G.; Armstrong, Wesley R.; Eckardt, Mark A.; Seyedroudbari, Ameen; Tap, William D.; Dry, Sarah M.; Abt, Evan R.; Calais, Jeremie; Herrmann, Ken; Czernin, Johannes; Eilber, Fritz C.; Benz, Matthias R.

¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma

In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 5, S. 708 – 712

DOI (Open Access)
Papathanasiou, Maria; Kessler, Lukas; Carpinteiro, Alexander; Hagenacker, Tim; Nensa, Felix; Umutlu, Lale; Forsting, Michael; Brainman, Alexandra; Kleinschnitz, Christoph; Antoch, Gerald; Dührsen, Ulrich; Schlosser, Thomas Wilfried; Herrmann, Ken; Rassaf, Tienush; Lüdike, Peter; Rischpler, Christoph

¹⁸F-flutemetamol positron emission tomography in cardiac amyloidosis

In: Journal of Nuclear Cardiology, Jg. 29, 2022, Nr. 2, S. 779 – 789

DOI (Open Access)
Guberina, Nika; Kessler, Lukas; Pöttgen, Christoph; Guberina, Maja; Metzenmacher, Martin; Herrmann, Ken; Mucha, Maja; Rischpler, Christoph; Indenkämpen, Frank; Siveke, Jens T.; Treckmann, Jürgen-Walter; Umutlu, Lale; Kasper, Stefan; Fendler, Wolfgang; Stuschke, Martin

⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas

In: Scientific Reports, Jg. 12, 2022, Nr. 1, 16261

DOI, Online Volltext (Open Access)
Husseini, Jad S.; Amorim, Bárbara Juarez; Torrado-Carvajal, Angel; Prabhu, Vinay; Groshar, David; Umutlu, Lale; Herrmann, Ken; Cañamaque, Lina García; Garzón, José Ramón García; Palmer, William E.; Heidari, Pedram; Shih, Tiffany Ting-Fang; Sosna, Jacob; Matushita, Cristina; Cerci, Juliano; Queiroz, Marcelo; Muglia, Valdair Francisco; Nogueira-Barbosa, Marcello H.; Borra, Ronald J. H.; Kwee, Thomas C.; Glaudemans, Andor W. J. M.; Evangelista, Laura; Salvatore, Marco; Cuocolo, Alberto; Soricelli, Andrea; Herold, Christian; Laghi, Andrea; Mayerhoefer, Marius; Mahmood, Umar; Catana, Ciprian; Daldrup-Link, Heike E.; Rosen, Bruce; Catalano, Onofrio A.

An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 5, S. 1522 – 1537

DOI, Online Volltext (Open Access)
Weber, Manuel; Binse, Ina; Oebbecke, Karin; Brandenburg, Tim; Herrmann, Ken; Theurer, Sarah; Weber, Frank; Ehrlich, Ann-Kathrin; Schmid, Kurt Werner; Führer-Sakel, Dagmar; Vardarli, Irfan; Fendler, Wolfgang; Gilman, Elena; Görges, Rainer

Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension

In: BMC Endocrine Disorders, Jg. 21, 2021, Nr. 1, 161

DOI, Online Volltext (Open Access)
Kersting, David; Rischpler, Christoph; Plönes, Till; Aigner, Clemens; Umutlu, Lale; Herrmann, Ken; Hautzel, Hubertus

Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancer

In: European Journal of Hybrid Imaging: EJNMMI Multimodality Journal, Jg. 5, 2021, Nr. 1, 25

DOI, Online Volltext (Open Access)
Freudenberg, Lutz; Essler, Markus; Herrmann, Ken

Auswirkungen von COVID-19 auf nuklearmedizinische Untersuchungen und Therapien im Verlauf von 2020 : Ergebnisse einer nationalen Umfrage

In: Nuklearmedizin = Nuclear Medicine, Jg. 60, 2021, Nr. 3, S. 210 – 215

DOI
Oprea-Lager, Daniela E.; Cysouw, Matthijs C.F.; Boellaard, Ronald; Deroose, Christophe M.; de Geus-Oei, Lioe-Fee; Lopci, Egesta; Bidaut, Luc; Herrmann, Ken; Fournier, Laure S.; Bäuerle, Tobias; deSouza, Nandita M.; Lecouvet, Frederic E.

Bone Metastases Are Measurable : The Role of Whole-Body MRI and Positron Emission Tomography

In: Frontiers in Oncology, Jg. 11, 2021, 772530

DOI (Open Access)
Bäumer, Christian; Bäcker, Markus; Conti, M; Fragoso Costa, P; Herrmann, Ken; Kazek, S L; Jentzen, Walter; Panin, V; Siegel, S.; Teimoorisichani, M; Wulff, J; Timmermann, Beate

Can a ToF-PET photon attenuation reconstruction test stopping-power estimations in proton therapy? : A phantom study

In: Physics in Medicine and Biology, Jg. 66, 2021, Nr. 21, 215010

DOI
Giammarile, Francesco; Bolton, Roberto C. Delgado; El-Haj, Noura; Freudenberg, Lutz; Herrmann, Ken; Mikhail, Miriam; Morozova, Olga; Orellana, Pilar; Pellet, Olivier; Estrada L, Enrique; Vinjamuri, Sobhan; Gnanasegaran, Gopinath; Pynda, Yaroslav; Navarro-Marulanda, Maria C.; Choudhury, Partha S.; Paez, Diana

Changes in the global impact of COVID-19 on nuclear medicine departments during 2020 : An international follow-up survey

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 13, S. 4318 – 4330

DOI (Open Access)
Kersting, David; Jentzen, Walter; Sraieb, Miriam; Costa, Pedro Fragoso; Conti, Maurizio; Umutlu, Lale; Antoch, Gerald; Nader, Michael; Herrmann, Ken; Fendler, Wolfgang Peter; Rischpler, Christoph; Weber, Manuel

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer

In: EJNMMI Physics, Jg. 8, 2021, Nr. 1, 14

DOI, Online Volltext (Open Access)
Bruckmann, Nils Martin; Lindemann, Maike E.; Grueneisen, Johannes; Grafe, Hong; Li, Yan; Sawicki, Lino M.; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Quick, Harald H.; Schaarschmidt, Benedikt Michael

Comparison of pre- and post-contrast-enhanced attenuation correction using a CAIPI-accelerated T1-weighted Dixon 3D-VIBE sequence in ⁶⁸Ga-DOTATOC PET/MRI

In: European Journal of Radiology, Jg. 139, 2021, S. 109691

DOI
Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Lukas; Umutlu, Lale; Aigner, Clemens; Karl, Kambartel Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang Peter; Herrmann, Ken; Faehling, Martin; Christoph, Daniel

Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy

In: Journal for ImmunoTherapy of Cancer, Jg. 9, 2021, Nr. 3, S. 002262

DOI, Online Volltext (Open Access)
Ambrosini, Valentina; Kunikowska, Jolanta; Baudin, Eric; Bodei, Lisa; Bouvier, Catherine; Capdevila, Jaume; Cremonesi, Marta; de Herder, Wouter W.; Dromain, Clarisse; Falconi, Massimo; Fani, Melpomeni; Fanti, Stefano; Hicks, Rodney J.; Kabasakal, Levent; Kaltsas, Gregory; Lewington, Val; Minozzi, Silvia; Cinquini, Michela; Öberg, Kjell; Oyen, Wim. J.G.; O'Toole, Dermot; Pavel, Marianne; Ruszniewski, Philippe; Scarpa, Aldo; Strosberg, Jonathan; Sundin, Anders; Taïeb, David; Virgolini, Irene; Wild, Damian; Herrmann, Ken; Yao, James

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

In: European Journal of Cancer (EJC), Jg. 146, 2021, S. 56 – 73

DOI, Online Volltext (Open Access)
Fanti, Stefano; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Maurer, Tobias; MacLennan, Steven; Oprea-Lager, Daniela E.; Oyen, Wim Jg; Rouvière, Olivier; Mottet, Nicolas; Bjartell, Anders

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 2, S. 469 – 476

DOI (Open Access)
Bruckmann, Nils Martin; Rischpler, Christoph; Kirchner, Julian; Umutlu, Lale; Herrmann, Ken; Ingenwerth, Marc; Theurer, Sarah; Lahner, Harald; Antoch, Gerald; Sawicki, Lino M.

Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid ⁶⁸Ga-DOTATOC PET/MRI

In: European Journal of Radiology, Jg. 137, 2021, S. 109588

DOI
Bruckmann, Nils Martin; Kirchner, Julian; Grueneisen, Johannes; Li, Yan; McCutcheon, Angela; Aigner, Clemens; Rischpler, Christoph; Sawicki, Lino M.; Herrmann, Ken; Umutlu, Lale; Schaarschmidt, Benedikt Michael

Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using ¹⁸F-FDG PET/MRI

In: European Journal of Radiology, Jg. 134, 2021, S. 109422

DOI
Morawitz, Janna; Bruckmann, Nils-Martin; Dietzel, Frederic; Ullrich, Tim; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Häberle, Lena; Ingenwerth, Marc; Umutlu, Lale; Fendler, Wolfgang; Fehm, Tanja; Herrmann, Ken; Antoch, Gerald; Sawicki, Lino Morris; Kirchner, Julian

Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer : A Comparative Study Using Histopathology as the Reference Standard

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 12, S. 1677 – 1683

DOI (Open Access)
Hope, Thomas A.; Eiber, Matthias; Armstrong, Wesley R.; Juarez, Roxanna; Murthy, Vishnu; Lawhn-Heath, Courtney; Behr, Spencer C.; Zhang, Li; Barbato, Francesco; Ceci, Francesco; Farolfi, Andrea; Schwarzenböck, Sarah M.; Unterrainer, Marcus; Zacho, Helle D.; Nguyen, Hao G.; Cooperberg, Matthew R.; Carroll, Peter R.; Reiter, Robert E.; Holden, Stuart; Herrmann, Ken; Zhu, Shaojun; Fendler, Wolfgang; Czernin, Johannes; Calais, Jeremie

Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging Trial

In: JAMA Oncology, Jg. 7, 2021, Nr. 11, S. 1635 – 1642

DOI
Vardarli, Irfan; Weber, Manuel; Weidemann, Frank; Führer, Dagmar; Herrmann, Ken; Görges, Rainer

Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease : A meta-analysis

In: Endocrine Connections, Jg. 10, 2021, Nr. 3, S. 358 – 370

DOI (Open Access)
Seifert, Philipp; Schenke, Simone; Zimny, Michael; Stahl, Alexander; Grunert, Michael; Klemenz, Burkhard; Freesmeyer, Martin; Kreissl, Michael C.; Herrmann, Ken; Görges, Rainer

Diagnostic performance of kwak, eu, acr, and korean tirads as well as ata guidelines for the ultrasound risk stratification of non-autonomously functioning thyroid nodules in a region with long history of iodine deficiency : A German multicenter trial

In: Cancers, Jg. 13, 2021, Nr. 17, 4467

DOI (Open Access)
Bartel, T.; Fendler, Wolfgang; Pabst, K.; Barbato, F.; Rischpler, Christoph; Herrmann, Ken; Hautzel, H.

Digital and respiratory-gated FDG PET/CT for characterization of lung lesions

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. Suppl. 1, S. 83
España, Samuel; Sánchez-Parcerisa, Daniel; Ibáñez, Paula; Sánchez-Tembleque, Víctor; Udías, Jose Manuel; Onecha, Víctor V.; Gutierrez-Uzquiza, Alvaro; Bäcker, Claus Maximilian; Bäumer, Christian; Herrmann, Ken; Fragoso Costa, Pedro; Timmermann, Beate; Fraile, Luis Mario

Direct proton range verification using oxygen-18 enriched water as a contrast agent

In: Radiation Physics and Chemistry, Jg. 182, 2021, 109385

DOI (Open Access)
Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin

Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trial

In: Radiation Oncology, Jg. 16, 2021, Nr. 1, S. 59

DOI, Online Volltext (Open Access)
Staniszewska, Magdalena; Iking, Janette; Lückerath, Katharina; Hadaschik, Boris; Herrmann, Ken; Ferdinandus, Justin; Fendler, Wolfgang

Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer

In: Nuclear Medicine and Biology, Jg. 96-97, 2021, S. 101 – 111

DOI (Open Access)
Ceci, Francesco; Oprea-Lager, Daniela E.; Emmett, Louise; Adam, Judit A.; Bomanji, Jamshed; Czernin, Johannes; Eiber, Matthias; Haberkorn, Uwe; Hofman, Michael S.; Hope, Thomas A.; Kumar, Rakesh; Rowe, Steven P.; Schwarzenboeck, Sarah M.; Fanti, Stefano; Herrmann, Ken

E-PSMA : The EANM standardized reporting guidelines v1.0 for PSMA-PET

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 5, S. 1626 – 1638

DOI (Open Access)
Konijnenberg, Mark; Herrmann, Ken; Kobe, Carsten; Verburg, Frederik; Hindorf, Cecilia; Hustinx, Roland; Lassmann, Michael

EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, S. 67 – 72

DOI (Open Access)
Staniszewska, Magdalena; Fragoso Costa, Pedro; Eiber, Matthias; Klose, Jasmin M.; Wosniack, Jasmin; Reis, Henning; Szarvas, Tibor; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Iking, Janette

Enzalutamide enhances psma expression of psma-low prostate cancer

In: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 14, 7431

DOI, Online Volltext (Open Access)
Partelli, Stefano; Sclafani, Francesco; Barbu, Sorin Traian; Beishon, Marc; Bonomo, Pierluigi; Braz, Graça; de Braud, Filippo; Brunner, Thomas; Cavestro, Giulia Martina; Crul, Mirjam; Trill, Maria Die; Ferollà, Piero; Herrmann, Ken; Karamitopoulou, Eva; Neuzillet, Cindy; Orsi, Franco; Seppänen, Hanna; Torchio, Martina; Valenti, Danila; Zamboni, Giulia; Zins, Marc; Costa, Alberto; Poortmans, Philip

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) : Pancreatic Cancer

In: Cancer Treatment Reviews, Jg. 99, 2021, 102208

DOI
Weber, Manuel; Jentzen, Walter; Hofferber, Regina; Herrmann, Ken; Fendler, Wolfgang Peter; Conti, Maurizio; Wetter, Axel; Kersting, David; Rischpler, Christoph; Fragoso Costa, Pedro

Evaluation of [⁶⁸Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision

In: EJNMMI Research, Jg. 11, 2021, Nr. 1, S. 21

DOI, Online Volltext (Open Access)
Bröcker-Preuß, Martina; Mehnert, Irina; Gilman, Elena; Herrmann, Ken; Weber, Manuel; Görges, Rainer

Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assays

In: Practical Laboratory Medicine, Jg. 26, 2021, e00250

DOI, Online Volltext (Open Access)
Zhang, Caiyuan; O'Shea, Aileen; Parente, Chiara Anna; Amorim, Barbara Juarez; Caravan, Peter; Ferrone, Christina R.; Blaszkowsky, Lawrence S.; Soricelli, Andrea; Salvatore, Marco; Groshar, David; Bernstine, Hanna; Domachevsky, Liran; Canamaque, Lina Garcia; Umutlu, Lale; Herrmann, Ken; Catana, Ciprian; Mahmood, Umar; Catalano, Onofrio Antonio

Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases

In: Investigative Radiology, Jg. 56, 2021, Nr. 10, S. 621 – 628

DOI
Chodyla, Michal; Demircioglu, Aydin; Schaarschmidt, Benedikt M.; Bertram, Stefanie; Morawitz, Janna; Bauer, Sebastian; Podleska, Lars; Rischpler, Christoph; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grüneisen, Johannes

Evaluation of the predictive potential of 18F-FDG PET and DWI data sets for relevant prognostic parameters of primary soft-tissue sarcomas

In: Cancers, Jg. 13, 2021, Nr. 11, 2753

DOI (Open Access)
Chodyla, Michal; Demircioglu, Aydin; Schaarschmidt, Benedikt M.; Bertram, Stefanie; Bruckmann, Nils Martin; Haferkamp, Jennifer; Li, Yan; Bauer, Sebastian; Podleska, Lars; Rischpler, Christoph; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grüneisen, Johannes

Evaluation of ¹⁸F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb Perfusion

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 3, S. 348 – 353

DOI (Open Access)
Weber, Manuel; Jentzen, Walter; Hofferber, Regina; Herrmann, Ken; Fendler, Wolfgang Peter; Rischpler, Christoph; Umutlu, Lale; Conti, Maurizio; Costa, Pedro Fragoso; Sraieb, Miriam; Kersting, David

Evaluation of ¹⁸F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision

In: BMC Cancer, Jg. 21, 2021, Nr. 1, 62

DOI, Online Volltext (Open Access)
Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 11, S. 3550 – 3559

DOI (Open Access)
Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 11, S. 3550 – 3559

DOI (Open Access)
Pilkington, Patrick; Lopci, Egesta; Adam, Judit A.; Kobe, Carsten; Goffin, Karolien; Herrmann, Ken

FDG-PET/CT Variants and Pitfalls in Haematological Malignancies

In: Seminars in Nuclear Medicine, Jg. 51, 2021, Nr. 6, S. 554 – 571

DOI
Vardarli, Irfan; Weber, Manuel; Rischpler, Christoph; Führer, Dagmar; Herrmann, Ken; Weidemann, Frank

Fabry Cardiomyopathy : Current Treatment and Future Options

In: Journal of Clinical Medicine (JCM), Jg. 10, 2021, Nr. 14, 3026

DOI (Open Access)
Manafi-Farid, Reyhaneh; Harsini, Sara; Saidi, Bahare; Ahmadzadehfar, Hojat; Herrmann, Ken; Briganti, Alberto; Walz, Jochen; Beheshti, Mohsen

Factors predicting biochemical response and survival benefits following radioligand therapy with [¹⁷⁷Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer : A review

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 12, S. 4028 – 4041

DOI (Open Access)
Fendler, Wolfgang; Calais, Jeremie; Eiber, Matthias; Simko, Jeffrey P.; Kurhanewicz, John; Santos, Romelyn Delos; Feng, Felix Y.; Reiter, Robert E.; Rettig, Matthew B.; Nickols, Nicholas G.; Kishan, Amar U.; Shozo, Okamoto; Emmett, Louise; Zacho, Helle D.; Ilhan, Harun; Rischpler, Christoph; Wetter, Axel; Schoder, Heiko; Burger, Irene A.; Slavik, Roger; Carroll, Peter R.; Lawhn-Heath, Courtney; Herrmann, Ken; Czernin, Johannes; Hope, Thomas A.

False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 2, S. 501 – 508

DOI (Open Access)
Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Herrmann, Ken; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Fendler, Wolfgang

Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging : A Multicenter Retrospective Study

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 5, S. 675 – 678

DOI (Open Access)
Iking, Janette; Staniszewska, Magdalena; Kessler, Lukas; Klose, Jasmin M.; Lückerath, Katharina; Fendler, Wolfgang; Herrmann, Ken; Rischpler, Christoph

Imaging Inflammation with Positron Emission Tomography

In: Biomedicines, Jg. 9, 2021, Nr. 2, S. 212

DOI, Online Volltext (Open Access)
Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Ploenes, Till; Pöttgen, Christoph; Guberina, Nika; Herrmann, Ken; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Stuschke, Martin

Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, S. 2894 – 2903

DOI (Open Access)
Schottelius, Margret; Herrmann, Ken; Lapa, Constantin

In vivo targeting of cxcr4 : new horizons

In: Cancers, Jg. 13, 2021, Nr. 23, 5920

DOI (Open Access)
Dönmez, Tugba; Höhne, Kerstin; Zissel, Gernot; Herrmann, Ken; Hautzel, Hubertus; Aigner, Clemens; Hegedüs, Balazs; Ploenes, Till

Insights into immunometabolism : A dataset correlating the ¹⁸FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer

In: Data in Brief, Jg. 35, 2021, 106859

DOI, Online Volltext (Open Access)
Buvat, Irène; Herrmann, Ken; Stremitzer, Alexander; Tobia, Kevin; Nielsen, Aileen

Irène Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen Nielsen

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 1, S. 3 – 5

DOI (Open Access)
Weber, Manuel; Kersting, David; Umutlu, Lale; Schäfers, Michael; Rischpler, Christoph; Fendler, Wolfgang; Buvat, Irène; Herrmann, Ken; Seifert, Robert

Just another “Clever Hans”? : Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 10, S. 3141 – 3150

DOI (Open Access)
Sartor, Oliver; de Bono, Johann; Chi, Kim N; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H.; Beer, Tomasz M.; Armour, Alison; Pérez-Contreras, Wendy J.; DeSilvio, Michelle; Kpamegan, Euloge; Gericke, Germo; Messmann, Richard A.; Morris, Michael J.; Krause, Bernd J.; VISION Investigators

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

In: The New England Journal of Medicine, Jg. 385, 2021, S. 1091 – 1103

DOI, Online Volltext (Open Access)
Kebir, Sied; Rauschenbach, Laurèl; Weber, Manuel; Lazaridis, Lazaros; Schmidt, Teresa; Keyvani, Kathy; Schäfer, Niklas; Milia, Asma; Umutlu, Lale; Pierscianek, Daniela; Stuschke, Martin; Forsting, Michael; Sure, Ulrich; Kleinschnitz, Christoph; Antoch, Gerald; Colletti, Patrick M.; Rubello, Domenico; Herrmann, Ken; Herrlinger, Ulrich; Scheffler, Björn; Bundschuh, Ralph A.; Glas, Martin

Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography

In: Journal of Neuro-Oncology, Jg. 152, 2021, S. 325 – 332

DOI
Bäuerle, Alexander; Musche, Venja; Schmidt, Kira; Schweda, Adam; Fink, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin

Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairment

In: International Journal of Environmental Research and Public Health = IJERPH, Jg. 18, 2021, Nr. 5, 2318

DOI, Online Volltext (Open Access)
Umutlu, Lale; Kirchner, Julian; Bruckmann, Nils Martin; Morawitz, Janna; Antoch, Gerald; Ingenwerth, Marc; Bittner, Ann-Kathrin; Hoffmann, Oliver; Haubold, Johannes; Grueneisen, Johannes; Quick, Harald H.; Rischpler, Christoph; Herrmann, Ken; Gibbs, Peter; Pinker-Domenig, Katja

Multiparametric integrated¹⁸f-fdg pet/mri-based radiomics for breast cancer phenotyping and tumor decoding

In: Cancers, Jg. 13, 2021, Nr. 12, 2928

DOI (Open Access)
Hautzel, Hubertus; Alnajdawi, Yazan; Fendler, Wolfgang; Rischpler, Christoph; Darwiche, Kaid; Eberhardt, Wilfried; Umutlu, Lale; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till

N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standard

In: EJNMMI Research, Jg. 11, 2021, Nr. 1, 68

DOI, Online Volltext (Open Access)
Aide, Nicolas; Lasnon, Charline; Kesner, Adam; Levin, Craig S.; Buvat, Irene; Iagaru, Andrei; Herrmann, Ken; Badawi, Ramsey D.; Cherry, Simon R.; Bradley, Kevin M.; McGowan, Daniel R.

New PET technologies : embracing progress and pushing the limits

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, S. 2711 – 2726

DOI (Open Access)
Gafita, Andrei; Calais, Jeremie; Grogan, Tristan R.; Hadaschik, Boris; Wang, Hui; Weber, Manuel; Sandhu, Shahneen; Kratochwil, Clemens; Esfandiari, Rouzbeh; Tauber, Robert; Zeldin, Anna; Rathke, Hendrik; Armstrong, Wesley R.; Robertson, Andrew; Thin, Pan; D'Alessandria, Calogero; Rettig, Matthew B.; Delpassand, Ebrahim S.; Haberkorn, Uwe; Elashoff, David; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias

Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective study

In: The Lancet Oncology, Jg. 22, 2021, Nr. 8, S. 1115 – 1125

DOI (Open Access)
Heinze, Britta; Schirbel, Andreas; Nannen, Lukas; Michelmann, David; Hartrampf, Philipp E.; Bluemel, Christina; Schneider, Magdalena; Herrmann, Ken; Haenscheid, Heribert; Fassnacht, Martin; Buck, Andreas K.; Hahner, Stefanie

Novel CYP11B-ligand [¹²³/¹³¹I]IMAZA as promising theranostic tool for adrenocortical tumors : Comprehensive preclinical characterization and first clinical experience

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2021, S. 301 – 310

DOI (Open Access)
Herrmann, Ken; Kraus, Bernd Joachim; Hadaschik, Boris; Kunikowska, Jolanta; van Poppel, Hendrik; N'Dow, James; Sartor, Oliver; Oyen, Wim J. G.

Nuclear medicine theranostics comes of age

In: The Lancet Oncology, Jg. 22, 2021, Nr. 11, S. 1497 – 1498

DOI
Berliner, Christoph; Boss, Kristina; Pape, Anke; Kribben, Andreas; Fendler, Wolfgang; Herrmann, Ken

Oldies (but Goldies) : Die Peritonealszintigrafie bei Peritonealdialyse

In: Nuklearmedizin = Nuclear Medicine, Jg. 60, 2021, Nr. 06, S. 450 – 453

DOI
Seifert, Robert; Kessel, Katharina; Schlack, Katrin; Weber, Manuel; Herrmann, Ken; Spanke, Maximilian; Fendler, Wolfgang; Hadaschik, Boris; Kleesiek, Jens; Schäfers, Michael; Weckesser, Matthias; Boegemann, Martin; Rahbar, Kambiz

PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 4, S. 1200 – 1210

DOI (Open Access)
Barbato, Francesco; Fendler, Wolfgang; Rauscher, Isabel; Herrmann, Ken; Wetter, Axel; Ferdinandus, Justin; Seifert, Robert; Nader, Michael; Rahbar, Kambiz; Hadaschik, Boris; Eiber, Matthias; Gafita, Andrei; Weber, Manuel

PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 12, S. 1747 – 1750

DOI (Open Access)
Weber, Manuel; Kurek, Claudia Ewa; Barbato, Francesco; Eiber, Matthias; Maurer, Tobias; Nader, Michael; Hadaschik, Boris; Grünwald, Viktor; Herrmann, Ken; Wetter, Axel; Fendler, Wolfgang P.

PSMA-ligand PET for early castration-resistant prostate cancer : a retrospective single-center study

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 1, S. 88 – 91

DOI (Open Access)
Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin

Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition

In: Radiation Oncology, Jg. 16, 2021, Nr. 1, 176

DOI, Online Volltext (Open Access)
Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang P.

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : study protocol

In: BMC Cancer, Jg. 21, 2021, 512

DOI (Open Access)
Farolfi, Andrea; Hadaschik, Boris; Hamdy, Freddie C.; Herrmann, Ken; Hofman, Michael S.; Murphy, Declan G.; Ost, Piet; Padhani, Anwar R.; Fanti, Stefano

Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment : A Systematic Review

In: European Urology Oncology, Jg. 4, 2021, Nr. 5, S. 714 – 730

DOI
Rodriguez-Freixinos, Víctor; Capdevila, Jaume; Pavel, Marianne; Thawer, Alia; Baudin, Eric; O'Toole, Dermot; Herrmann, Ken; Welin, Staffan; Grozinsky-Glasberg, Simona; de Herder, Wouter W.; Valle, Juan W.; Herman, Jackie; Kolarova, Teodora; Bouvier, Catherine; Falconi, Massimo; Ferone, Diego; Singh, Simron

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era

In: European Journal of Cancer (EJC), Jg. 144, 2021, S. 200 – 214

DOI, Online Volltext (Open Access)
Kersting, David; Seifert, Robert; Kessler, Lukas; Herrmann, Ken; Theurer, Sarah; Brandenburg, Tim; Dralle, Henning; Weber, Frank; Umutlu, Lale; Führer-Sakel, Dagmar; Görges, Rainer; Rischpler, Christoph; Weber, Manuel

Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC

In: Cancers, Jg. 13, 2021, Nr. 7, S. 1728

DOI, Online Volltext (Open Access)
Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 12, S. 1684 – 1691

DOI, Online Volltext (Open Access)
Morawitz, Janna; Kirchner, Julian; Martin, Ole; Bruckmann, Nils-Martin; Dietzel, Frederic; Li, Yan; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Bittner, Ann-Kathrin; Mohrmann, Svjetlana; Ingenwerth, Marc; Häberle, Lena; Esposito, Irene; Antoch, Gerald; Buchbender, Christian; Sawicki, Lino M.

Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast Cancer

In: Clinical Nuclear Medicine, Jg. 46, 2021, Nr. 3, S. 201 – 205

DOI
Bruckmann, Nils Martin; Kirchner, Julian; Morawitz, Janna; Umutlu, Lale; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Ingenwerth, Marc; Schaarschmidt, Benedikt M.; Li, Yan; Stang, Andreas; Antoch, Gerald; Sawicki, Lino M.; Buchbender, Christian

Prospective comparison of CT and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patients : Initial results

In: PLoS ONE, Jg. 16, 2021, e0260804

DOI (Open Access)
Bruckmann, Nils Martin; Kirchner, Julian; Umutlu, Lale; Fendler, Wolfgang Peter; Seifert, Robert; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Antke, Christina; Schimmöller, Lars; Ingenwerth, Marc; Breuckmann, Katharina; Stang, Andreas; Buchbender, Christian; Antoch, Gerald; Sawicki, Lino M.

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients

In: European Radiology, Jg. 31, 2021, Nr. 11, S. 8714 – 8724

DOI (Open Access)
Calais, Jeremie; Gafita, Andrei; Eiber, Matthias; Armstrong, Wesley R.; Gartmann, Jeannine; Thin, Pan; Nguyen, Kathleen; Lok, Vincent; Gosa, Laura; Grogan, Tristan; Esfandiari, Rouzbeh; Allen-Auerbach, Martin; Quon, Andrew; Bahri, Shadfar; Gupta, Pawan; Gardner, Linda; Ranganathan, David; Slavik, Roger; Dahlbom, Magnus; Herrmann, Ken; Delpassand, Ebrahim; Fendler, Wolfgang; Czernin, Johannes

Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC) : efficacy results of the UCLA cohort

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 10, S. 1440 – 1446

DOI, Online Volltext (Open Access)
Darr, Christopher; Costa, Pedro Fragoso; Kesch, Claudia; Krafft, Ulrich; Püllen, Lukas; Harke, Nina; Heß, Jochen A.; Szarvas, Tibor; Haubold, Johannes; Reis, Henning; Fendler, Wolfgang; Herrmann, Ken; Radtke, Jan Philipp; Hadaschik, Boris; Tschirdewahn, Stephan

Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfalls

In: Translational Andrology and Urology, Jg. 10, 2021, Nr. 10, S. 3972 – 3985

DOI (Open Access)
Weber, Manuel; Hadaschik, Boris; Ferdinandus, Justin; Rahbar, Kambiz; Bögemann, Martin; Herrmann, Ken; Fendler, Wolfgang; Kesch, Claudia

Prostate-specific Membrane Antigen–based Imaging of Castration-resistant Prostate Cancer

In: European Urology Focus, Jg. 7, 2021, Nr. 2, S. 279 – 287

DOI
Mulcahy, Mary F.; Mahvash, Armeen; Pracht, Marc; Montazeri, Amir H.; Bandula, Steve; Martin, Robert C. G.; Herrmann, Ken; Brown, Ewan; Zuckerman, Darryl; Wilson, Gregory; Kim, Tae-You; Weaver, Andrew; Ross, Paul; Harris, William P.; Graham, Janet; Mills, Jamie; Yubero Esteban, Alfonso; Johnson, Matthew S.; Sofocleous, Constantinos T.; Padia, Siddharth A.; Lewandowski, Robert J.; Garin, Etienne; Sinclair, Philip; Salem, Riad

Radioembolization With Chemotherapy for Colorectal Liver Metastases : A Randomized, Open-Label, International, Multicenter, Phase III Trial

In: Journal of Clinical Oncology (JCO), Jg. 39, 2021, Nr. 35, S. 3897 – 3907

DOI (Open Access)
Hadaschik, Boris; Herrmann, Ken

Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

In: European Urology, Jg. 80, 2021, Nr. 4, S. 520 – 521

DOI
Calais, Jeremie; Czernin, Johannes; Thin, Pan; Gartmann, Jeannine; Nguyen, Kathleen; Armstrong, Wesley R.; Allen-Auerbach, Martin; Quon, Andrew; Bahri, Shadfar; Gupta, Pawan; Gardner, Linda; Dahlbom, Magnus; He, Beilei; Esfandiari, Rouzbeh; Ranganathan, David; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang; Delpassand, Ebrahim

Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617 : Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 10, S. 1447 – 1456

DOI, Online Volltext (Open Access)
Kersting, David; Jentzen, Walter; Fragoso Costa, P.; Sraieb, Miriam; Sandach, Patrick; Umutlu, Lale; Conti, Maurizio; Zarrad, Fadi; Rischpler, Christoph; Fendler, Wolfgang P.; Herrmann, Ken; Weber, Manuel

Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124

In: Scientific Reports, Jg. 11, 2021, Nr. 1, 17477

DOI, Online Volltext (Open Access)
Johannes, Czernin; Herrmann, Ken

The Disappearing Act of Nuclear Medicine in The Netherlands : Just a New Trick by the Great Harry Houdini?

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 7, S. 903 – 904

DOI (Open Access)
Al-Ibraheem, Akram; Abuhijla, Fawzi; Salah, Samer; Shahait, Mohamed; Khader, Jamal; Mohamad, Issa; Al-Rasheed, Ula; Pomykala, Kelsey L.; Herrmann, Ken; Abu-Hijlih, Ramiz

The influence of ⁶⁸Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapy

In: Nuclear Medicine Communications, Jg. 42, 2021, Nr. 7, S. 811 – 817

DOI
Heynickx, Nathalie; Herrmann, Ken; Vermeulen, Koen; Baatout, Sarah; Aerts, An

The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy : A review of the lessons learnt so far

In: Nuclear Medicine and Biology, Jg. 98-99, 2021, S. 30 – 39

DOI (Open Access)
Sauerwein, Wolfgang; Sancey, Lucie; Hey-Hawkins, Evamarie; Kellert, Martin; Panza, Luigi; Imperio, Daniela; Balcerzyk, Marcin; Rizzo, Giovanna; Scalco, Elisa; Herrmann, Ken; Mauri, Pierluigi; Palma, Antonella De; Wittig, Andrea

Theranostics in Boron neutron capture therapy

In: Life, Jg. 11, 2021, Nr. 4, S. 330

DOI (Open Access)
von Tresckow, Julia; von Tresckow, Bastian; Reinhardt, H. Christian; Herrmann, Ken; Berliner, Christoph; Herrmann, Ken

Thymic hyperplasia after mRNA based Covid-19 vaccination

In: Radiology Case Reports, Jg. 16, 2021, Nr. 12, S. 3744 – 3745

DOI (Open Access)
Bäcker, Claus Maximilian; Bäumer, Christian; Bley, Aaron; Fragoso Costa, Pedro; Gerhardt, Marcel; Herrmann, Ken; Kauer, Samantha; Kröninger, Kevin; Nitsch, Christian; Siregar, Hilda Milani; Timmermann, Beate; Verbeek, Nico; Weingarten, Jens; Wulff, Jörg; Yazgan, Azad

Towards using secondary gamma-rays from proton-induced radioactivation of titanium implants for off-line field verification

In: Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, Jg. 492, 2021, S. 56 – 63

DOI
Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Pomykala, Kelsey L.; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Umutlu, Lale; Herrmann, Ken; Christoph, Daniel

Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 2, S. 191 – 194

DOI (Open Access)
Seifert, Robert; Küper, Alina; Tewes, Mitra; Heuschmid, Martin; Welt, Anja; Fendler, Wolfgang P.; Herrmann, Ken; Decker, Thomas

[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors

In: Oncology Research and Treatment, Jg. 44, 2021, Nr. 7-8, S. 400 – 407

DOI (Open Access)
Hirmas, Nader; Leyh, Catherine; Sraieb, Miriam; Barbato, Francesco; Schaarschmidt, Benedikt M.; Umutlu, Lale; Nader, Michael; Wedemeyer, Heiner; Ferdinandus, Justin; Rischpler, Christoph; Herrmann, Ken; Costa, Pedro Fragoso; Lange, Christian M.; Weber, Manuel; Fendler, Wolfgang

[⁶⁸Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma

In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 9, S. 1235 – 1241

DOI (Open Access)
Li, Yan; Mueller, Laura Isabel; Neuhaus, Jan Peter; Bertram, Stefanie; Schaarschmidt, Benedikt Michael; Demircioglu, Aydin; Ludwig, Johannes Maximilian; Kirchner, Julian; Rischpler, Christoph; Herrmann, Ken; Catalano, Onofrio Antonio; Umutlu, Lale

18F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer : What Is the Benefit of PET?

In: Journal of Clinical Medicine (JCM), Jg. 9, 2020, Nr. 10, 3163

DOI, Online Volltext (Open Access)
Carrió, Ignasi; Herrmann, Ken

A conversation between Ignasi Carrió and Ken Herrmann

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 5, S. 638 – 640

DOI (Open Access)
Witjes, J. Alfred; Babjuk, Marek; Bellmunt, Joaquim; Maxim Bruins, H.; De Reijke, Theo M.; De Santis, Maria; Gillessen, Silke; James, Nicholas; Maclennan, Steven; Palou, Juan; Powles, Tom; Ribal, Maria J.; Shariat, Shahrokh F.; Van Der Kwast, Theo; Xylinas, Evanguelos; Agarwal, Neeraj; Arends, Tom; Bamias, Aristotle; Birtle, Alison; Black, Peter C.; Bochner, Bernard H.; Bolla, Michel; Boormans, Joost L.; Bossi, Alberto; Briganti, Alberto; Brummelhuis, Iris; Burger, Max; Castellano, Daniel; Cathomas, Richard; Chiti, Arturo; Choudhury, Ananya; Compérat, Eva; Crabb, Simon; Culine, Stephane; De Bari, Berardino; De Blok, Willem; De Visschere, Pieter J.L.; Decaestecker, Karel; Dimitropoulos, Konstantinos; Dominguez-Escrig, Jose L.; Fanti, Stefano; Fonteyne, Valerie; Frydenberg, Mark; Futterer, Jurgen J.; Gakis, Georgios; Geavlete, Bogdan; Gontero, Paolo; Grubmüller, Bernhard; Hafeez, Shaista; Hansel, Donna E.; Hartmann, Arndt; Hayne, Dickon; Henry, Ann M.; Hernandez, Virginia; Herr, Harry; Herrmann, Ken; Hoskin, Peter; Huguet, Jorge; Jereczek-Fossa, Barbara A.; Jones, Rob; Kamat, Ashish M.; Khoo, Vincent; Kiltie, Anne E.; Krege, Susanne; Ladoire, Sylvain; Lara, Pedro C.; Leliveld, Annemarie; Linares-Espinós, Estefania; Løgager, Vibeke; Lorch, Anja; Loriot, Yohann; Meijer, Richard; Carmen Mir, M.; Moschini, Marco; Mostafid, Hugh; Müller, Arndt-Christian; Müller, Christoph R.; N’dow, James; Necchi, Andrea; Neuzillet, Yann; Oddens, Jorg R.; Oldenburg, Jan; Osanto, Susanne; Oyen, Wim J.G.; Pacheco-Figueiredo, Luís; Pappot, Helle; Patel, Manish I.; Pieters, Bradley R.; Plass, Karin; Remzi, Mesut; Retz, Margitta; Richenberg, Jonathan; Rink, Michael; Roghmann, Florian; Rosenberg, Jonathan E.; Rouprêt, Morgan; Rouvière, Olivier; Salembier, Carl; Salminen, Antti; Sargos, Paul; Sengupta, Shomik; Sherif, Amir; Smeenk, Robert J.; Smits, Anita; Stenzl, Arnulf; Thalmann, George N.; Tombal, Bertrand; Turkbey, Baris; Lauridsen, Susanne Vahr; Valdagni, Riccardo; Van Der Heijden, Antoine G.; Van Poppel, Hein; Vartolomei, Mihai D.; Veskimäe, Erik; Vilaseca, Antoni; Vives Rivera, Franklin A.; Wiegel, Thomas; Wiklund, Peter; Williams, Andrew; Zigeuner, Richard; Horwich, Alan

AU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort : Under the Auspices of the EAU-ESMO Guidelines Committees

In: European Urology, Jg. 77, 2020, Nr. 2, S. 223 – 250

DOI (Open Access)
Seifert, Robert; Seitzer, Konstantin; Herrmann, Ken; Kessel, Katharina; Schäfers, Michael; Kleesiek, Jens; Weckesser, Matthias; Boegemann, Martin; Rahbar, Kambiz

Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand Therapy

In: Theranostics, Jg. 10, 2020, Nr. 17, S. 7812 – 7820

DOI (Open Access)
Sraieb, Miriam; Hirmas, Nader; Conrad, Rupert; Marinova, Milka; Essler, Markus; Herrmann, Ken; Ahmadzadehfar, Hojjat

Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy

In: Medicine, Jg. 99, 2020, Nr. 38, e22287

DOI (Open Access)
Guberina, Nika; Gäckler, Anja; Grueneisen, Johannes; Wetter, Axel; Witzke, Oliver; Herrmann, Ken; Rischpler, Christoph; Fendler, Wolfgang; Umutlu, Lale; Sawicki, Lino Morris; Forsting, Michael; Rohn, Hana

Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [¹⁸F]FDG PET/CT and [¹⁸F]FDG PET/MRI

In: Nuclear Medicine and Molecular Imaging, Jg. 54, 2020, Nr. 4, S. 183 – 191

DOI, Online Volltext (Open Access)
Musche, Venja; Bäuerle, Alexander; Steinbach, Jasmin; Schweda, Adam; Hetkamp, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Beckmann, Mingo; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin

COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients

In: Frontiers in Psychology, Jg. 11, 2020, S. 1984

DOI (Open Access)
Rauscher, Isabel; Fendler, Wolfgang P.; Hope, Thomas A.; Quon, Andrew; Nekolla, Stephan G.; Calais, Jeremie; Richter, Antonia; Haller, Bernhard; Herrmann, Ken; Weber, Wolfgang A.; Czernin, Johannes; Eiber, Matthias

Can the injected dose be reduced in ⁶⁸Ga-PSMA-11 PET/CT while maintaining high image quality for lesion detection?

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 2, S. 189 – 193

DOI (Open Access)
Rischpler, Christoph; Siebermair, Johannes; Kessler, L.; Quick, Harald H.; Umutlu, Lale; Rassaf, Tienush; Antoch, G.; Herrmann, Ken; Nensa, Felix

Cardiac PET/MRI : Current Clinical Status and Future Perspectives

In: Seminars in Nuclear Medicine, Jg. 50, 2020, Nr. 3, S. 260 – 269

DOI
Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin

Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation

In: Lung Cancer, Jg. 139, 2020, S. 165 – 168

DOI
Li, Yan; Langhorst, Jost; Koch, Anna K.; Demircioglu, Aydin; Schaarschmidt, Benedikt; Theysohn, Jens; Martin, Ole; Herrmann, Ken; Catalano, Onofrio; Umutlu, Lale

Comparison of acceptance of PET/MR enterography and ileocolonoscopy in patients with inflammatory bowel diseases

In: Clinical Imaging, Jg. 64, 2020, S. 11 – 17

DOI
Li, Yan; Khamou, Michael; Schaarschmidt, Benedikt Michael; Umutlu, Lale; Forsting, Michael; Demircioglu, Aydin; Haubold, Johannes; Koch, Anna Katharina; Bruckmann, Nils-Martin; Sawicki, Lino Morris; Herrmann, Ken; Boone, James Hunter; Langhorst, Jost

Comparison of ¹⁸F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis

In: The British Journal of Radiology (BJR), Jg. 93, 2020, Nr. 1112, S. 20200167

DOI (Open Access)
Krause, Bernd Joachim; Bartenstein, Peter; Freudenberg, Lutz Stefan; Herrmann, Ken; Jonas, Götz; Luster, Markus; Moka, Detlef; Schäfer, Wolfgang; Schwarzenböck, Sarah Marie; Meyer, Philipp Tobias

Coronavirus SARS-CoV-2 : Empfehlungen für die nuklearmedizinische Versorgung in nuklearmedizinischen Kliniken/Abteilungen mit Therapiestation und Praxen, Instituten sowie Ordinationen

In: Nuklearmedizin = Nuclear Medicine, Jg. 59, 2020, Nr. 2, S. E1 – E4

DOI (Open Access)
Happel, C.; Kranert, W.T.; Gröner, D.; Bockisch, B.; Sabet, A.; Vardarli, I.; Görges, Rainer; Herrmann, Ken; Grünwald, F.

Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases

In: Endocrine, Jg. 69, 2020, Nr. 2, S. 466 – 473

DOI
Huang, H.L.; Gnanasegaran, G.; Paez, D.; Fanti, S.; Hacker, M.; Sathekge, M.; Bom, H.S.; Cerci, J.J.; Chiti, A.; Lan, X.; Herrmann, Ken; Scott, A.M.; Vinjamuri, S.; Dorbala, S.; Estrada, E.; Pellet, O.; Orellana, P.; El-Haj, N.; Giammarile, F.; Abdel-Wahab, M.; Bomanji, Jamshed

Correction to: Nuclear medicine services after COVID-19: gearing up back to normality

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 9, S. 2220

DOI (Open Access)
Witjes, J. Alfred; Babjuk, Marek; Bellmunt, Joaquim; Bruins, H. Maxim; De Reijke, Theo M.; De Santis, Maria; Gillessen, Silke; James, Nicholas; Maclennan, Steven; Palou, Juan; Powles, Tom; Ribal, Maria J.; Shariat, Shahrokh F.; Van Der Kwast, Theo; Xylinas, Evanguelos; Agarwal, Neeraj; Arends, Tom; Bamias, Aristotle; Birtle, Alison; Black, Peter C.; Bochner, Bernard H.; Bolla, Michel; Boormans, Joost L.; Bossi, Alberto; Briganti, Alberto; Brummelhuis, Iris; Burger, Max; Castellano, Daniel; Cathomas, Richard; Chiti, Arturo; Choudhury, Ananya; Compérat, Eva; Crabb, Simon; Culine, Stephane; De Bari, Berardino; De Blok, Willem; De Visschere, Pieter J.L.; Decaestecker, Karel; Dimitropoulos, Konstantinos; Dominguez-Escrig, Jose L.; Fanti, Stefano; Fonteyne, Valerie; Frydenberg, Mark; Futterer, Jurgen J.; Gakis, Georgios; Geavlete, Bogdan; Gontero, Paolo; Grubmüller, Bernhard; Hafeez, Shaista; Hansel, Donna E.; Hartmann, Arndt; Hayne, Dickon; Henry, Ann M.; Hernandez, Virginia; Herr, Harry; Herrmann, Ken; Hoskin, Peter; Huguet, Jorge; Jereczek-Fossa, Barbara A.; Jones, Rob; Kamat, Ashish M.; Khoo, Vincent; Kiltie, Anne E.; Krege, Susanne; Ladoire, Sylvain; Lara, Pedro C.; Leliveld, Annemarie; Linares-Espinós, Estefania; Løgager, Vibeke; Lorch, Anja; Loriot, Yohann; Meijer, Richard; Mir, M. Carmen; Moschini, Marco; Mostafid, Hugh; Müller, Arndt-Christian; Müller, Christoph R.; N'Dow, James; Necchi, Andrea; Neuzillet, Yann; Oddens, Jorg R.; Oldenburg, Jan; Osanto, Susanne; Oyen, Wim J.G.; Pacheco-Figueiredo, Luís; Pappot, Helle; Patel, Manish I.; Pieters, Bradley R.; Plass, Karin; Remzi, Mesut; Retz, Margitta; Richenberg, Jonathan; Rink, Michael; Roghmann, Florian; Rosenberg, Jonathan E.; Rouprêt, Morgan; Rouvière, Olivier; Salembier, Carl; Salminen, Antti; Sargos, Paul; Sengupta, Shomik; Sherif, Amir; Smeenk, Robert J.; Smits, Anita; Stenzl, Arnulf; Thalmann, George N.; Tombal, Bertrand; Turkbey, Baris; Lauridsen, Susanne Vahr; Valdagni, Riccardo; Van Der Heijden, Antoine G.; Van Poppel, Hein; Vartolomei, Mihai D.; Veskimäe, Erik; Vilaseca, Antoni; Rivera, Franklin A. Vives; Wiegel, Thomas; Wiklund, Peter; Willemse, Peter-Paul M.; Williams, Andrew; Zigeuner, Richard; Horwich, Alan

Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees

In: European Urology, Jg. 78, 2020, Nr. 1, S. e48 – e50

DOI, Online Volltext (Open Access)
Vardarli, Irfan; Herrmann, Ken; Weidemann, Frank

Diagnosis and screening of patients with fabry disease

In: Therapeutics and Clinical Risk Management, Jg. 16, 2020, S. 551 – 558

DOI (Open Access)
Langhorst, Jost; Umutlu, Lale; Schaarschmidt, Benedikt Michael; Grueneisen, Johannes; Demircioglu, Aydin; Forsting, Michael; Beiderwellen, Karsten; Haubold, Johannes; Theysohn, Jens; Koch, Anna Katharina; Dobos, Gustav; Dechene, Alexander; Herrmann, Ken; Bruckmann, Nils Martin; Lauenstein, Thomas; Li, Yan

Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis : A Prospective Study

In: Journal of Clinical Medicine (JCM), Jg. 9, 2020, Nr. 8, 2474

DOI (Open Access)
Gafita, Andrei; Fendler, Wolfgang P.; Hui, Wang; Sandhu, Shahneen; Weber, Manuel; Esfandiari, Rouzbeh; Calais, Jeremie; Rauscher, Isabel; Rathke, Hendrik; Tauber, Robert; Delpassand, Ebrahim S.; Weber, Wolfgang A.; Herrmann, Ken; Czernin, Johannes; Eiber, Matthias; Hofman, Michael S.

Efficacy and Safety of ¹⁷⁷Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement : A Multicenter Retrospective Study

In: European Urology, Jg. 78, 2020, Nr. 2, S. 148 – 154

DOI
Grafe, Hong; Lindemann, Maike E.; Ruhlmann, Verena; Oehmigen, Mark; Hirmas, Nader; Umutlu, Lale; Herrmann, Ken; Quick, Harald H.

Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracers

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 10, S. 2269 – 2279

DOI (Open Access)
Darr, Christopher; Krafft, Ulrich; Fendler, Wolfgang P.; Costa, P. Fragoso; Barbato, F.; Praus, C.; Reis, Henning; Hager, T.; Tschirdewahn, Stephan; Radtke, J.P.; Herrmann, Ken; Hadaschik, Boris

First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 13, S. 3194 – 3195

DOI
Freudenberg, Lutz S.; Paez, Diana; Giammarile, Francesco; Cerci, Juliano; Modiselle, Moshe; Pascual, Thomas N.B.; El-Haj, Noura; Orellana, Pilar; Pynda, Yaroslav; Carrió, Ignasi; Fanti, Stefano; Matushita, Cristina; Herrmann, Ken

Global impact of COVID-19 on nuclear medicine departments : An international survey in April 2020

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 9, S. 1278 – 1283

DOI (Open Access)
Iking, Janette; Klose, Jasmin; Staniszewska, Magdalena; Fendler, Wolfgang P.; Herrmann, Ken; Rischpler, Christoph

Imaging inflammation after myocardial infarction : implications for prognosis and therapeutic guidance

In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 64, 2020, Nr. 1, S. 35 – 50

DOI
Theurer, Sarah; Ingenwerth, Marc; Herold, Thomas; Herrmann, Ken; Schmid, Kurt Werner

Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal Carcinoids

In: Endocrine Pathology, Jg. 31, 2020, S. 101 – 107

DOI (Open Access)
Fendler, Wolfgang P.; Ferdinandus, Justin; Czernin, Johannes; Eiber, Matthias; Flavell, Robert R; Behr, Spencer C; Wu, I-Wei K; Lawhn-Heath, Courtney; Pampaloni, Miguel H; Reiter, Robert E; Rettig, Matthew B; Gartmann, Jeannine; Murthy, Vishnu; Slavik, Roger; Carroll, Peter R; Herrmann, Ken; Calais, Jeremie; Hope, Thomas A

Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 12, S. 1793 – 1799

DOI (Open Access)
Freudenberg, Lutz; Dittmer, Ulf; Herrmann, Ken

Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland : An International Survey in April 2020

In: Nuklearmedizin = Nuclear Medicine, Jg. 59, 2020, Nr. 4, S. 294 – 299

DOI
Kirchner, Julian; Martin, Ole; Umutlu, Lale; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Swetlana; Gauler, Thomas; Theurer, Sarah; Antke, Christina; Esposito, Irene; Kinner, Sonja; Schaarschmidt, Benedikt M.; Kowall, Bernd; Lütke-Brintrup, Diana; Stang, Andreas; Becker, Anton S.; Antoch, Gerald; Buchbender, Christian

Impact of ¹⁸F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients : A prospective evaluation of staging algorithms

In: European Journal of Radiology, Jg. 128, 2020, S. 108975

DOI, Online Volltext (Open Access)
Kollenda, Sebastian; Klose, Jasmin; Knuschke, Torben; Sokolova, Viktoriya; Schmitz, Jochen; Staniszewska, Magdalena; Costa, Pedro Fragoso; Herrmann, Ken; Westendorf, Astrid; Fendler, Wolfgang; Epple, Matthias

In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT

In: Acta Biomaterialia, Jg. 109, 2020, S. 244 – 253

DOI
Darr, Christopher; Harke, Nina; Radtke, Jan Philipp; Yirga, Leubet; Kesch, Claudia; Grootendorst, Maarten; Fendler, Wolfgang P.; Fragoso Costa, Pedro; Rischpler, Christoph; Praus, Christine; Haubold, Johannes; Reis, Henning; Hager, Thomas; Herrmann, Ken; Binse, Ina; Hadaschik, Boris

Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy : A feasibility study

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 10, S. 1500 – 1506

DOI, Online Volltext (Open Access)
Martin, Ole; Bruckmann, Nils-Martin; Kirchner, Julian; Ullrich, Tim; Ingenwerth, Marc; Bogner, Simon; Eze, Chukwuka; Nensa, Felix; Herrmann, Ken; Umutlu, Lale; Antoch, Gerald; Sawicki, Lino M.

Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?

In: Journal of Medical Imaging and Radiation Oncology, Jg. 64, 2020, Nr. 6, S. 779 – 786

DOI
Scherer, Jonas; Nolden, Marco; Kleesiek, Jens; Metzger, Jasmin; Kades, Klaus; Schneider, Verena; Bach, Michael; Sedlaczek, Oliver; Bucher, Andreas M.; Vogl, Thomas J.; Grünwald, Frank; Kühn, Jens-Peter; Hoffmann, Ralf-Thorsten; Kotzerke, Jörg; Bethge, Oliver; Schimmöller, Lars; Antoch, Gerald; Müller, Hans-Wilhelm; Daul, Andreas; Nikolaou, Konstantin; la Fougère, Christian; Kunz, Wolfgang G.; Ingrisch, Michael; Schachtner, Balthasar; Ricke, Jens; Bartenstein, Peter; Nensa, Felix; Radbruch, Alexander; Umutlu, Lale; Forsting, Michael; Seifert, Robert; Herrmann, Ken; Mayer, Philipp; Kauczor, Hans-Ulrich; Penzkofer, Tobias; Hamm, Bernd; Brenner, Winfried; Kloeckner, Roman; Düber, Christoph; Schreckenberger, Mathias; Braren, Rickmer; Kaissis, Georgios; Makowski, Marcus; Eiber, Matthias; Gafita, Andrei; Trager, Rupert; Weber, Wolfgang A.; Neubauer, Jakob; Reisert, Marco; Bock, Michael; Bamberg, Fabian; Hennig, Jürgen; Meyer, Philipp Tobias; Ruf, Juri; Haberkorn, Uwe; Schoenberg, Stefan O.; Kuder, Tristan; Neher, Peter; Floca, Ralf; Schlemmer, Heinz-Peter; Maier-Hein, Klaus

Joint Imaging Platform for Federated Clinical Data Analytics

In: JCO Clinical Cancer Informatics (JCO CCI), Jg. 4, 2020, S. 1027 – 1038

DOI (Open Access)
Derlin, Thorsten; Gatidis, Sergios; Krause, Bernd Joachim; Antoch, Gerald; Kotzerke, Jörg; Pinto Dos Santos, Daniel; Eiber, Matthias; Weber, Marc-André; Giesel, Frederik; Pfannenberg, Christina; Schlemmer, Heinz-Peter; Persigehl, Thorsten; Herrmann, Ken; Umutlu, Lale

Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-Hybridbildgebung

In: Nuklearmedizin = Nuclear Medicine, Jg. 59, 2020, Nr. 4, S. 288 – 293

DOI (Open Access)
Derlin, Thorsten; Gatidis, Sergios; Krause, Bernd Joachim; Antoch, Gerald; Kotzerke, Jörg; Pinto Dos Santos, Daniel; Eiber, Matthias; Weber, Marc-André; Giesel, Frederik; Pfannenberg, Christina; Schlemmer, Heinz-Peter; Persigehl, Thorsten; Herrmann, Ken; Umutlu, Lale; Anton, Frank; Barkhausen, Jörg; Bartenstein, Peter; Luster, Markus; Neumann, Stefan; Schönberg, Stefan O.

Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-Hybridbildgebung*

In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 192, 2020, Nr. 8, S. 739 – 744

DOI (Open Access)
Vardarli, I.; Weidemann, F.; Aboukoura, M.; Herrmann, Ken; Binse, Ina; Görges, Rainer

Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients : a meta-analysis

In: BMC Cancer, Jg. 20, 2020, Nr. 1, 550

DOI (Open Access)
Ferrone, Cristina; Goyal, Lipika; Qadan, Motaz; Gervais, Debra; Sahani, Dushyant V.; Zhu, Andrew X.; Hong, Theodore S.; Blaszkowsky, Lawrence S.; Tanabe, Kenneth K.; Vangel, Mark; Amorim, Barbara J.; Wo, Jennifer Y.; Mahmood, Umar; Pandharipande, Pari V.; Catana, Ciprian; Duenas, Virginia P.; Collazo, Yolanda Q.; Canamaque, Lina G.; Domachevsky, Liran; Bernstine, Hanna H.; Groshar, David; Shih, Tiffany Tsing-Fang; Li, Yan; Herrmann, Ken; Umutlu, Lale; Rosen, Bruce R.; Catalano, Onofrio A.

Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 8, S. 1871 – 1884

DOI
Farolfi, Andrea; Ilhan, Harun; Gafita, Andrei; Calais, Jeremie; Barbato, Francesco; Weber, Manuel; Afshar-Oromieh, Ali; Spohn, Fabian; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang Peter

Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 7, S. 1037 – 1042

DOI, Online Volltext (Open Access)
Sandach, Patrick; Kasper-Virchow, Stefan; Rischpler, Christoph; Herrmann, Ken

Molecular Imaging and Therapy of Colorectal and Anal Cancer

In: Seminars in Nuclear Medicine, Jg. 50, 2020, Nr. 5, S. 465 – 470

DOI
Sandach, Patrick; Rischpler, Christoph; Herrmann, Ken

Molecular imaging and theranostics

In: Der Onkologe, Jg. 26, 2020, Nr. 1, S. 14 – 21

DOI
Bodei, Lisa; Schöder, Heiko; Baum, Richard P; Herrmann, Ken; Strosberg, Jonathan; Caplin, Martyn; Öberg, Kjell; Modlin, Irvin M

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

In: The Lancet Oncology, Jg. 21, 2020, Nr. 9, S. e431 – e443

DOI, Online Volltext (Open Access)
Lahner, Harald; Fendler, Wolfgang P.; Theurer, Sarah; Unger, Nicole; Herrmann, Ken; Schmid, Kurt Werner; Führer, Dagmar

Neuroendokrine Neoplasien des Verdauungstrakts

In: Best Practice Onkologie, Jg. 15, 2020, Nr. 7-8, S. 320 – 333

DOI
Haubold, Johannes; Demircioglu, Aydin; Gratz, Marcel; Glas, Martin; Wrede, Karsten; Sure, Ulrich; Antoch, Gerald; Keyvani, Kathy; Nittka, Mathias; Kannengiesser, Stephan; Gulani, Vikas; Griswold, Mark; Herrmann, Ken; Forsting, Michael; Nensa, Felix; Umutlu, Lale

Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric ¹⁸F-FET PET-MRI and MR Fingerprinting

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 6, S. 1435 – 1445

DOI
Vaz, Sofia C.; Oliveira, Francisco; Herrmann, Ken; Veit-Haibach, Patrick

Nuclear medicine and molecular imaging advances in the 21st century

In: The British Journal of Radiology (BJR), Jg. 93, 2020, Nr. 1110, S. 20200095

DOI, Online Volltext (Open Access)
Czernin, Johannes; Fanti, Stefano; Meyer, Philipp T.; Allen-Auerbach, Martin; Hacker, Marcus; Sathekge, Mike; Hicks, Rodney; Scott, Andrew M.; Hatazawa, Jun; Yun, Mijin; Schöder, Heiko; Bartenstein, Peter; Herrmann, Ken

Nuclear medicine operations in the times of COVID-19: Strategies, precautions, and experiences

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 5, S. 626 – 629

DOI (Open Access)
Martin, Ole; Schaarschmidt, Benedikt M.; Kirchner, Julian; Suntharalingam, Saravanabavaan; Grueneisen, Johannes; Demircioglu, Aydin; Heusch, Philipp; Quick, Harald H.; Forsting, Michael; Antoch, Gerald; Herrmann, Ken; Umutlu, Lale

PET/MRI Versus PET/CT for Whole-Body Staging : Results from a Single-Center Observational Study on 1,003 Sequential Examinations

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 8, S. 1131 – 1136

DOI (Open Access)
Bodei, Lisa; Bergsland, Emily; de Herder, Wouter W.; Ferone, Diego; Hicks, Rodney J.; Hope, Thomas A.; Kunikowska, Jolanta; Pavel, Marianne; Reidy-Lagunes, Diane; Siveke, Jens; Strosberg, Jonathan; Dittmer, Ulf; Herrmann, Ken

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic : Are There Any Concerns?

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 8, S. 1094 – 1095

DOI (Open Access)
Köhler, Michael; Harders, Fabian; Lohöfer, Fabian; Paprottka, Philipp M; Schaarschmidt, Benedikt M; Theysohn, Jens; Herrmann, Ken; Heindel, Walter; Schmidt, Hartmut H; Pascher, Andreas; Stegger, Lars; Rahbar, Kambiz; Wildgruber, Moritz

Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization

In: Journal of Clinical Medicine (JCM), Jg. 9, 2020, Nr. 1, 56

DOI (Open Access)
Bruckmann, Nils Martin; Sawicki, Lino M.; Kirchner, Julian; Martin, Ole; Umutlu, Lale; Herrmann, Ken; Fendler, Wolfgang; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Dietzel, Frederic; Ingenwerth, Marc; Schaarschmidt, Benedikt M.; Li, Yan; Kowall, Bernd; Stang, Andreas; Antoch, Gerald; Buchbender, Christian

Prospective evaluation of whole-body MRI and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patients

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 12, S. 2816 – 2825

DOI (Open Access)
Ferdinandus, Justin; Fendler, Wolfgang Peter; Hadaschik, Boris; Herrmann, Ken

Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence

In: Current Opinion in Urology, Jg. 30, 2020, Nr. 5, S. 635 – 640

DOI
Papathanasiou, Maria; Carpinteiro, Alexander; Hagenacker, Tim; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph; Lüdike, Peter

Publisher Correction to: 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 13, S. 3196

DOI (Open Access)
Umutlu, Lale; Nensa, Felix; Demircioglu, Aydin; Antoch, Gerald; Herrmann, Ken; Forsting, Michael; Grueneisen, Johannes Stefan

Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer

In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 192, 2020, Nr. 8, S. 754 – 763

DOI
Bögemann, M.; Herrmann, Ken; Radtke, J.P.; Rahbar, K.

Radionuklidtherapie mit PSMA-Liganden bei fortgeschrittenem Prostatakarzinom

In: Der Urologe, Jg. 59, 2020, Nr. 6, S. 680 – 686

DOI
Herrmann, Ken; Schwaiger, Markus; Lewis, Jason S.; Solomon, Stephen B.; McNeil, Barbara J.; Baumann, Michael; Gambhir, Sanjiv S.; Hricak, Hedvig; Weissleder, Ralph

Radiotheranostics : A roadmap for future development

In: The Lancet Oncology, Jg. 21, 2020, Nr. 3, S. e146 – e156

DOI, Online Volltext (Open Access)
Hadaschik, Boris; Herrmann, Ken

Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA) : A Prospective, Randomised, Multi-centre Study

In: European Urology, Jg. 78, 2020, Nr. 3, S. 470 – 471

DOI
Seifert, Robert; Herrmann, Ken; Kleesiek, Jens; Schäfers, Michael; Shah, Vijay; Xu, Zhoubing; Chabin, Guillaume; Grbic, Sasa; Spottiswoode, Bruce; Rahbar, Kambiz

Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancer

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 12, S. 1786 – 1792

DOI (Open Access)
Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; Fendler, Wolfgang Peter; Lahner, Harald; Antoch, Gerald; Umutlu, Lale; Herrmann, Ken; Rischpler, Christoph

Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors

In: Nuclear Medicine Communications, Jg. 41, 2020, Nr. 4, S. 363 – 369

DOI
Weber, Wolfgang A.; Czernin, Johannes; Anderson, Carolyn J.; Badawi, Ramsey D.; Barthel, Henryk; Bengel, Frank; Bodei, Lisa; Buvat, Irène; DiCarli, Marcelo; Graham, Michael M.; Grimm, Jan; Herrmann, Ken; Kostakoglu, Lale; Lewis, Jason S.; Mankoff, David A.; Peterson, Todd E.; Schelbert, Heinrich; Schöder, Heiko; Siegel, Barry A.; Strauss, H William

The Future of Nuclear Medicine, Molecular Imaging, and Theranostics

In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. Supplement 2, S. 263S – 272S

DOI, Online Volltext (Open Access)
Theruvath, Ashok J.; Siedek, Florian; Muehe, Anne M.; Garcia-Diaz, Jordi; Kirchner, Julian; Martin, Ole; Link, Michael P.; Spunt, Sheri; Pribnow, Allison; Rosenberg, Jarrett; Herrmann, Ken; Gatidis, Sergios; Schäfer, Jürgen F.; Moseley, Michael; Umutlu, Lale; Daldrup-Link, Heike E.

Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI

In: Radiology, Jg. 296, 2020, Nr. 1, S. 143 – 151

DOI, Online Volltext (Open Access)
Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; Fendler, Wolfgang Peter; Lahner, Harald; Antoch, Gerald; Umutlu, Lale; Herrmann, Ken; Rischpler, Christoph

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from ⁶⁸Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient

In: BMC Cancer, Jg. 20, 2020, Nr. 1, 326

DOI, Online Volltext (Open Access)
Guberina, Nika; Hetkamp, Philipp; Rübben, Herbert; Fendler, Wolfgang; Grueneisen, J.; Suntharalingam, S.; Kirchner, J.; Püllen, Lukas; Harke, Nina; Radtke, J.P.; Umutlu, Lale; Hadaschik, Boris; Herrmann, Ken; Forsting, Michael; Wetter, Axel

Whole-Body Integrated [⁶⁸Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer : Comparison with Whole-Body PET/CT as the Standard of Reference

In: Molecular Imaging and Biology, Jg. 22, 2020, Nr. 3, S. 788 – 796

DOI
Li, Yan; Schaarschmidt, Benedikt; Umutlu, Lale; Forsting, Michael; Demircioglu, Aydin; Koch, Anna Katharina; Martin, Ole; Herrmann, Ken; Juette, Hendrik; Tannapfel, Andrea; Langhorst, Jost

¹⁸F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis : A randomized controlled trial

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 4, S. 768 – 777

DOI
Deuschl, Cornelius; Rüber, Theodor; Ernst, Leon; Fendler, Wolfgang P.; Kirchner, Julian; Mönninghoff, Christoph; Herrmann, Ken; Quesada, Carlos M.; Forsting, Michael; Elger, Christian E.; Umutlu, Lale

¹⁸F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis

In: PLoS ONE, Jg. 15, 2020, Nr. 1, S. e0227906

DOI, Online Volltext (Open Access)
Papathanasiou, Maria; Carpinteiro, Alexander; Hagenacker, Tim; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph; Lüdike, Peter

¹⁸F-florbetaben positron computed tomography detects cardiac involvement in systemic AA amyloidosis

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 13, S. 3186 – 3187

DOI (Open Access)
Carrio, Ignasi; Essler, Markus; Freudenberg, Lutz; Herrmann, Ken

“COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty” based on a report of Prof. Dr. Ignasi Carrio

In: Nuklearmedizin = Nuclear Medicine, Jg. 59, 2020, Nr. 6, S. 405 – 408

DOI
Grueneisen, Johannes; Schaarschmidt, Benedikt; Demircioglu, Aydin; Chodyla, Michal; Martin, Ole; Bertram, Stefanie; Wetter, Axel; Bauer, Sebastian; Fendler, Wolfgang Peter; Podleska, Lars; Forsting, Michael; Herrmann, Ken; Umutlu, Lale

18F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas

In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 11, S. 1537 – 1542

DOI (Open Access)
Buono, Stefano; Herrmann, Ken

A conversation between Stefano Buono and Ken Herrmann

In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 12, S. 1659 – 1662

DOI (Open Access)
Schaffert, Susanne; Herrmann, Ken

A conversation between Susanne Schaffert and Ken Herrmann

In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 7, S. 875 – 878

DOI (Open Access)
Li, Yan; Langhorst, Jost; Koch, Anna Katharina; Demircioglu, Aydin; Nensa, Felix; Kirchner, Julian; Beiderwellen, Karsten; Catalano, Onofrio; Forsting, Michael; Herrmann, Ken; Umutlu, Lale

Assessment of ileocolonic inflammation in Crohn’s disease : Which surrogate marker is better—MAria, Clermont, or PET/MR index? Initial results of a feasibility trial

In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 6, S. 851 – 857

DOI (Open Access)
Fendler, Wolfgang P.; Calais, Jeremie; Eiber, Matthias; Flavell, Robert R.; Mishoe, Ashley; Feng, Felix Y.; Nguyen, Hao G.; Reiter, Robert E.; Rettig, Matthew B.; Okamoto, Shozo; Emmett, Louise; Zacho, Helle D.; Ilhan, Harun; Wetter, Axel; Rischpler, Christoph; Schoder, Heiko; Burger, Irene A.; Gartmann, Jeannine; Smith, Raven; Small, Eric J.; Slavik, Roger; Carroll, Peter R.; Herrmann, Ken; Czernin, Johannes; Hope, Thomas A.

Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer : A Prospective Single-Arm Clinical Trial

In: JAMA Oncology, Jg. 5, 2019, Nr. 6, S. 856 – 863

DOI (Open Access)
Rischpler, Christoph; Nekolla, S.G.; Heusch, Gerd; Umutlu, Lale; Rassaf, Tienush; Heusch, P.; Herrmann, Ken; Nensa, Felix

Cardiac PET/MRI—an update

In: European Journal of Hybrid Imaging: EJNMMI Multimodality Journal, Jg. 3, 2019, Nr. 1, 2

DOI (Open Access)
Farahati, Jamshid; Mäder, Uwe; Gilman, Elena; Görges, Rainer; Maric, Ines; Binse, Ina; Hänscheid, Heribert; Herrmann, Ken; Buck, Andreas; Bockisch, Andreas

Changing trends of incidence and prognosis of thyroid carcinoma

In: Nuklearmedizin = Nuclear Medicine, Jg. 58, 2019, Nr. 2, S. 86 – 92

DOI
Kebir, Sied; Lazaridis, Lazaros; Weber, Manuel; Deuschl, Cornelius; Stoppek, Ann-Kathrin; Schmidt, Teresa; Mönninghoff, Christoph; Blau, Tobias; Keyvani, Kathy; Umutlu, Lale; Pierscianek, Daniela; Forsting, Michael; Stuschke, Martin; Antoch, Gerald; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Colletti, Patrick M.; Rubello, Domenico; Herrmann, Ken; Glas, Martin

Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed Glioma

In: Clinical Nuclear Medicine, Jg. 44, 2019, Nr. 6, S. e375 – e381

DOI
Boerman, Otto C.; Heskamp, Sandra; Fracasso, Giulio; Colombatti, Marco; Franssen, Gerben M.; Frielink, Cathelijne; Kip, Annemarie; Gotthardt, Martin; Lütje, Susanne; Hekman, Marlène; Rijpkema, Mark; Herrmann, Ken

Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors

In: Theranostics, Jg. 9, 2019, S. 2924 – 2938

DOI (Open Access)
Herrmann, Ken; Veit-Haibach, Patrick; Weber, Wolfgang A.

Driving the Future of Nuclear Medicine

In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 9, S. 1S – 2S

DOI (Open Access)
Kratochwil, Clemens; Fendler, Wolfgang Peter; Eiber, Matthias; Baum, Richard; Bozkurt, Murat Fani; Czernin, Johannes; Delgado Bolton, Roberto C.; Ezziddin, Samer; Forrer, Flavio; Hicks, Rodney J.; Hope, Thomas A.; Kabasakal, Levant; Konijnenberg, Mark; Kopka, Klaus; Lassmann, Michael; Mottaghy, Felix M.; Oyen, Wim; Rahbar, Kambiz; Schöder, Heiko; Virgolini, Irene; Wester, Hans-Jürgen; Bodei, Lisa; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken

EANM procedure guidelines for radionuclide therapy with ¹⁷⁷Lu-labelled PSMA-ligands (¹⁷⁷Lu-PSMA-RLT)

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 46, 2019, Nr. 12, S. 2536 – 2544

DOI
Horwich, Alan; Babjuk, Marko; Bellmunt, Joaquim; Bruins, Harman M.; Reijke, Theo M. de; Santis, Maria C. de; Gillessen, S.; James, N.; Maclennan, S.; Palou, J.; Powles, T.; Ribal, M. J.; Shariat, S. F.; Kwast, Theodorus van der; Xylinas, E.; Agarwal, N.; Arends, T.; Bamias, A.; Birtle, A.; Black, P. C.; Bochner, B. H.; Bolla, M.; Boormans, J. L.; Bossi, A.; Briganti, A.; Brummelhuis, I.; Burger, M.; Castellano, D.; Cathomas, R.; Chiti, A.; Choudhury, A.; Compérat, E.; Crabb, S.; Culine, S.; De Bari, B.; DeBlok, W.; De Visschere, P. J. L.; Decaestecker, K.; Dimitropoulos, K.; Dominguez-Escrig, J. L.; Fanti, S.; Fonteyne, V.; Frydenberg, M.; Futterer, J. J.; Gakis, G.; Geavlete, B.; Gontero, P.; Grubmüller, B.; Hafeez, S.; Hansel, D. E.; Hartmann, A.; Hayne, D.; Henry, A. M.; Hernandez, V.; Herr, H.; Herrmann, Ken; Hoskin, P.; Huguet, J.; Jereczek-Fossa, B. A.; Jones, R.; Kamat, A. M.; Khoo, V.; Kiltie, A. E.; Krege, Susanne; Ladoire, S.; Lara, P. C.; Leliveld, A.; Linares-Espinós, E.; Løgager, V.; Lorch, A.; Loriot, Y.; Meijer, R.; Carmen Mir, M.; Moschini, M.; Mostafid, H.; Müller, A.-C.; Müller, C. R.; N'Dow, J.; Necchi, A.; Neuzillet, Y.; Oddens, J. R.; Oldenburg, J.; Osanto, S.; Oyen, W. J. G.; Pacheco-Figueiredo, L.; Pappot, H.; Patel, M. I.; Pieters, B.R.; Plass, K.; Remzi, M.; Retz, M.; Richenberg, J.; Rink, M.; Roghmann, F.; Rosenberg, J. E.; Rouprêt, M.; Rouvière, O.; Salembier, C.; Salminen, A.; Sargos, P.; Sengupta, S.; Sherif, A.; Smeenk, R. J.; Smits, A.; Stenzl, A.; Thalmann, G. N.; Tombal, B.; Turkbey, B.; Vahr Lauridsen, S.; Valdagni, R.; Heijden, A. G. van der; Poppel, H. van; Vartolomei, M. D.; Veskimäe, E.; Vilaseca, A.; Vives Rivera, F. A.; Wiegel, T.; Wiklund, P.; Williams, A.; Zigeuner, R.; Witjes, J. A.

EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees

In: Annals of Oncology, Jg. 30, 2019, Nr. 11, S. 1697 – 1727

DOI (Open Access)
Farolfi, Andrea; Gafita, Andrei; Calais, Jeremie; Eiber, Matthias; Afshar-Oromieh, Ali; Spohn, Fabian; Barbato, Francesco; Weber, Manuel; Ilhan, Harun; Cervati, Veronica; Wetter, Axel; Hadaschik, Boris; Briganti, Alberto; Walz, Jochen; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken; Fendler, Wolfgang Peter

Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study

In: The Journal of Urology, Jg. 202, 2019, Nr. 6, S. 1174 – 1181

DOI
Lütje, Susanne; Franssen, Gerben M.; Herrmann, Ken; Boerman, Otto C.; Rijpkema, Mark; Gotthardt, Martin; Heskamp, Sandra

In vitro and in vivo characterization of an ¹⁸F-ALF-labeled PSMA ligand for imaging of PSMA-expressing xenografts

In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 7, S. 1017 – 1022

DOI (Open Access)
Pomykala, Kelsey L.; Farolfi, Andrea; Hadaschik, Boris; Fendler, Wolfgang P.; Herrmann, Ken

Molecular Imaging for Primary Staging of Prostate Cancer

In: Seminars in Nuclear Medicine, Jg. 49, 2019, Nr. 4, S. 271 – 279

DOI
Theurer, Sarah; Dralle, Henning; Führer, Dagmar; Herrmann, Ken; Schmid, Kurt Werner

Morphologische Diagnosekriterien der nichtinvasiven follikulären Neoplasie mit PTC-äquivalenten Kernmerkmalen (NIFTP) : Eine diagnostische Herausforderung zum Nutzen des Patienten

In: Der Pathologe, Jg. 40, 2019, Nr. 3, S. 220 – 226

DOI
Schotten, Clemens; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, Amr; Barbato, Francesco; Neumann, Ursula; Radünz, Sonia; Sydor, Svenja; Heider, Dominik; Venerito, Marino; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan; Bechmann, Lars P.; El Fouly, Amr

NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization

In: Liver Cancer, Jg. 8, 2019, Nr. 6, S. 491 – 504

DOI, Online Volltext (Open Access)
Werner, Rudolf A.; Bundschuh, Ralph A.; Bundschuh, Lena; Fanti, Stefano; Javadi, Mehrbod S.; Higuchi, Takahiro; Weich, Alexander; Pienta, Kenneth J.; Buck, Andreas K.; Pomper, Martin G.; Gorin, Michael A.; Herrmann, Ken; Lapa, Constantin; Rowe, Steven P.

Novel structured reporting systems for theranostic radiotracers

In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 5, S. 577 – 584

DOI, Online Volltext (Open Access)
Kessler, L.; Hautzel, H.; Rassaf, Tienush; Herrmann, Ken; Nensa, Felix; Wessendorf, Thomas; Lüdike, Peter; Rischpler, Christoph

Nuklearmedizinische Diagnostik der Sarkoidose

In: Atemwegs- und Lungenkrankheiten, Jg. 45, 2019, Nr. 12, S. 573 – 580

DOI
Umutlu, Lale; Antoch, Gerald; Herrmann, Ken; Grueneisen, Johannes

PET/MR Imaging of the Female Pelvis

In: Seminars in Nuclear Medicine, Jg. 49, 2019, Nr. 6, S. 512 – 520

DOI
Maurer, Tobias; Hadaschik, Boris; Budäus, Lars Henrik; Steuber, Thomas; Salomon, Georg; Horn, Thomas; Herrmann, Ken; Weber, Manuel; Giesel, Frederik Lars; Berliner, C.; Eiber, Matthias J.

PSA-Anstieg nach definitiver Therapie

In: Der Urologe, Jg. 58, 2019, Nr. 5, S. 569 – 582

DOI
Farahati, Jamshid; Kazek, Sandra; Maric, Ines; Soestwoehner, Thomas; Kalle, Patrick; Costa, Pedro Fragoso; Jentzen, Walter; Stein, Linda; Jalilian, Amirreza; Kumm, Dietmar; Bockisch, Andreas; Herrmann, Ken; Jalilian, Amir

Post-radiosynovectomy imaging utilizing Erbium-169 citrate

In: Applied Radiation and Isotopes, Jg. 154, 2019, 108853

DOI
Guberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trial

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 46, 2019, Nr. 7, S. 1439 – 1447

DOI
Nader, Michael; Oberdorfer, Franz; Herrmann, Ken

Production of [¹¹C]Formaldehyde by the XeF2 mediated oxidation of [¹¹C]Methanol and its application in the labeling of α-(N-[¹¹C]Methylamino)isobutyric acid

In: Applied Radiation and Isotopes, Jg. 148, 2019, S. 178 – 183

DOI
Kirchner, Julian; Sawicki, Lino M.; Nensa, Felix; Schaarschmidt, Benedikt M.; Reis, Henning; Ingenwerth, Marc; Bogner, Simon; Aigner, Clemens; Buchbender, Christian; Umutlu, Lale; Antoch, Gerald; Herrmann, Ken; Heusch, Philipp

Prospective comparison of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT for thoracic staging of non-small cell lung cancer

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 46, 2019, Nr. 2, S. 437 – 445

DOI
Fendler, Wolfgang P.; Weber, Manuel; Iravani, Amir; Hofman, Michael S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Rauscher, Isabel; Londhe, Anil; Lopez-Gitlitz, Angela; Cheng, Shinta; Maurer, Tobias; Herrmann, Ken; Eiber, Matthias; Hadaschik, Boris

Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancer

In: Clinical Cancer Research, Jg. 25, 2019, Nr. 24, S. 7448 – 7454

DOI (Open Access)
Barbato, Francesco; Farolfi, Andrea; Gafita, Andrei; Calais, Jeremie; Weber, Manuel; Wetter, Axel; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang Peter; et al.

Reply by Authors

In: The Journal of Urology, Jg. 202, 2019, Nr. 6, S. 1181

DOI
Stoffels, Ingo; Herrmann, Ken; Rekowski, Jan; Jansen, Philipp; Schadendorf, Dirk; Stang, Andreas; Klode, Joachim

Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trial

In: Trials, Jg. 20, 2019, Nr. 1, S. 99

DOI, Online Volltext (Open Access)
Gerwing, Mirjam; Herrmann, Ken; Helfen, Anne; Schliemann, Christoph; Berdel, Wolfgang E.; Eisenblätter, Michel; Wildgruber, Moritz

The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches

In: Nature Reviews Clinical Oncology, Jg. 16, 2019, Nr. 7, S. 442 – 458

DOI
Weber, Manuel; Binse, Ina; Nagarajah, James; Bockisch, Andreas; Herrmann, Ken; Jentzen, Walter

The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer

In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 63, 2019, Nr. 3, S. 235 – 252

DOI
Farolfi, Andrea; Fendler, Wolfgang; Iravani, Amir; Haberkorn, Uwe; Hicks, Rodney; Herrmann, Ken; Walz, Jochen; Fanti, Stefano

Theranostics for Advanced Prostate Cancer : Current Indications and Future Developments

In: European Urology Oncology, Jg. 2, 2019, Nr. 2, S. 152 – 162

DOI
Sandach, Patrick; Fendler, Wolfgang P.; Herrmann, Ken

Theranostik von soliden Tumoren : Renaissance eines alten Konzepts

In: Best Practice Onkologie, Jg. 14, 2019, Nr. 12, S. 526 – 534

DOI
Happel, Christian; Kranert, Wolfgang Tilman; Ackermann, Hanns; Binse, Ina; Bockisch, Benjamin; Gröner, Daniel; Herrmann, Ken; Grünwald, Frank

Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases

In: Endocrine, Jg. 63, 2019, Nr. 3, S. 537 – 544

DOI
Umutlu, Lale; Beyer, Thomas; Grüneisen, Johannes Stefan; Rischpler, Christoph; Quick, Harald H.; Veit-Haibach, Patrick; Eiber, Matthias; Purz, Sandra; Antoch, Gerald; Gatidis, Sergios; Nikolaou, Konstantin; Schäfer, Jürgen F.; Rausch, Ivo; Herrmann, Ken

Whole-Body [18F]-FDG-PET/MRI for Oncology : A Consensus Recommendation

In: Nuklearmedizin = Nuclear Medicine, Jg. 191, 2019, Nr. 2, S. 68 – 76

DOI
Umutlu, Lale; Beyer, Thomas; Grüneisen, Johannes; Rischpler, Christoph; Quick, Harald H.; Veit-Haibach, Patrick; Eiber, Matthias; Purz, Sandra; Antoch, Gerald; Gatidis, Sergios; Nikolaou, Konstantin; Schäfer, Jürgen F.; Rausch, Yvo; Herrmann, Ken

Whole-Body [18F]-FDG-PET/MRI for oncology : a consensus recommendation

In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 191, 2019, Nr. 4, S. 289 – 297

DOI
Hirmas, Nader; Al-Ibraheem, Akram; Herrmann, Ken; Alsharif, Abedalatif; Muhsin, Haider; Khader, Jamal; Al-Daghmin, Ali; Salah, Samer

[⁶⁸Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer

In: Molecular Imaging and Biology, Jg. 21, 2019, Nr. 3, S. 574 – 581

DOI
Deutschl, Cornelius; Kirchner, Julian; Pöppel, Thorsten; Schaarschmidt, Benedikt Michael; Kebir, Sied; El Hindy, Nicolai; Hense, Jörg; Quick, Harald H.; Glas, Martin; Herrmann, Ken; Umutlu, Lale; Mönninghoff, Christoph; Radbruch, A.; Forsting, Michael; Schlamann, Marc

11C-MET PET/MRI for detection of recurrent glioma

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 4, S. 593 – 601

DOI
Wieder, Hinrich; Beer, Ambros J.; Siveke, Jens; Schuster, Tibor; Buck, Andreas K.; Herrmann, Ken; Stollfuss, Jens C.

18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer

In: OncoTarget, Jg. 9, 2018, Nr. 11, S. 10128 – 10134

DOI (Open Access)
Hope, Thomas A.; Bergsland, Emily K.; Bozkurt, Murat Fani; Graham, Michael; Heaney, Anthony P.; Herrmann, Ken; Howe, James R.; Kulke, Matthew H.; Kunz, Pamela L.; Mailman, Josh; May, Lawrence; Metz, David C.; Millo, Corina; O’Dorisio, Sue; Reidy-Lagunes, Diane L.; Soulen, Michael C.; Strosberg, Jonathan R.

Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 1, S. 66 – 74

DOI (Open Access)
Zaun, Gregor; Schuler, Martin; Herrmann, Ken; Tannapfel, Andrea

CUP syndrome : Metastatic malignancy with unknown primary tumor

In: Deutsches Ärzteblatt International, Jg. 115, 2018, Nr. 10, S. 157 – 162

DOI (Open Access)
Lutje, Susanne; Gerrits, Danny; Molkenboer-Kuenen, Janneke D.; Herrmann, Ken; Fracasso, Giulio; Colombatti, Marco; Boerman, Otto C.; Heskamp, Sandra

Characterization of site-specifically conjugated monomethyl auristatin E-and duocarmycin-based anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 3, S. 494 – 501

DOI (Open Access)
Catalano, Onofrio A.; Umutlu, Lale; Fuin, Niccolo; Hibert, Matthew Louis; Scipioni, Michele; Pedemonte, Stefano; Vangel, Mark; Catana, Andreea Maria; Herrmann, Ken; Nensa, Felix; Groshar, David; Mahmood, Umar; Rosen, Bruce R.; Catana, Ciprian

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 12, S. 2147 – 2154

DOI
Sarabhai, Theresia; Schaarschmidt, Benedikt M.; Wetter, Axel; Kirchner, Julian; Aktas, Bahriye; Forsting, Michael; Ruhlmann, Verena; Herrmann, Ken; Umutlu, Lale; Grueneisen, Johannes

Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 1, S. 67 – 76

DOI
Sawicki, Lino M.; Kirchner, Julian; Grueneisen, Johannes; Ruhlmann, Verena; Aktas, Bahriye; Schaarschmidt, Benedikt M.; Forsting, Michael; Herrmann, Ken; Antoch, Gerald; Umutlu, Lale

Comparison of ¹⁸F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer : a follow-up study

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 4, S. 622 – 629

DOI
Calais, Jeremie; Fendler, Wolfgang P.; Herrmann, Ken; Eiber, Matthias; Ceci, Francesco

Comparison of ⁶⁸Ga-PSMA-11 and ¹⁸F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 5, S. 789 – 794

DOI (Open Access)
Fanti, Stefano; Minozzi, Silvia; Antoch, Gerald; Banks, Ian; Briganti, Alberto; Carrio, Ignasi; Chiti, Arturo; Clarke, Noel; Eiber, Matthias; De Bono, Johann; Fizazi, Karim; Gillessen, Silke; Gledhill, Sam; Haberkorn, Uwe; Herrmann, Ken; Hicks, Rodney J.; Lecouvet, Frederic; Montironi, Rodolfo; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Schalken, Jack A.; Scher, Howard I.; Tombal, Bertrand; van Moorselaar, Reindert Jeroen A.; Van Poppel, Heindrik; Vargas, Hebert Alberto; Walz, Jochen; Weber, Wolfgang A.; Wester, Hans-Jürgen; Oyen, Wim J.G.

Consensus on molecular imaging and theranostics in prostate cancer

In: The Lancet Oncology, Jg. 19, 2018, Nr. 12, S. e696 – e708

DOI
Martin, O.; Kirchner, J.; Heusch, P.; Antoch, G.; Herrmann, Ken; Umutlu, Lale; Sawicki, L.

Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRI

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. Suppl. 1, S. 176
Lückerath, Katharina; Stuparu, Andreea D.; Wei, Liu; Kim, Woosuk; Radu, Caius G.; Mona, Christine E.; Calais, Jeremie; Rettig, Matthew; Reiter, Robert E.; Czernin, Johannes; Slavik, Roger; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang P.

Detection Threshold and Reproducibility of ⁶⁸Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 9, S. 1392 – 1397

DOI (Open Access)
Sawicki, Lino M; Lütje, Susanne; Baraliakos, Xenofon; Braun, Jürgen; Kirchner, Julian; Boos, Johannes; Heusch, Philipp; Ruhlmann, Verena; Herrmann, Ken; Umutlu, Lale; Quick, Harald H.; Antoch, Gerald; Buchbender, Christian

Dual‐phase hybrid 18F‐Fluoride Positron emission tomography/MRI in ankylosing spondylitis : Investigating the link between MRI bone changes, regional hyperaemia and increased osteoblastic activity

In: Journal of Medical Imaging and Radiation Oncology, Jg. 62, 2018, Nr. 3, S. 313 – 319

DOI
Schotten, C.; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, A.; Muller, S.; Schulze, Maren; Neumann, U.; Radunz, S.; Heider, Dominik; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan

Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCC

In: Hepatology, Jg. 68, 2018, Nr. Suppl. 1, S. 852A – 853A
Calais, Jérémie; Fendler, Wolfgang P.; Eiber, Matthias; Gartmann, Jeannine; Chu, Fang-I; Nickols, Nicholas G; Reiter, Robert R; Rettig, Matthew B; Marks, Leonard S; Ahlering, Thomas E; Huynh, Lynda; Slavik, Roger; Gupta, Pawan; Quon, Andrew; Allen-Auerbach, Martin S; Czernin, Johannes; Herrmann, Ken

Impact of Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 3, S. 434 – 441

DOI (Open Access)
Wierts, Roel; Conti, Maurizio; Claessen, Anouk G.G.; Herrmann, Ken; Kemerink, Gerrit J.; Binse, Ina; Wildberger, Joachim E.; Mottaghy, Felix M.; Backes, Walter H.; Jentzen, Walter

Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124 i PET/CT imaging

In: Nuclear Medicine Communications, Jg. 39, 2018, Nr. 12, S. 1156 – 1164

DOI
Al-Bayati, Mohammad; Grueneisen, Johannes; Lütje, Susanne; Sawicki, Lino M.; Suntharalingam, Saravanabavaan; Tschirdewahn, Stephan; Forsting, Michael; Rübben, Herbert; Herrmann, Ken; Umutlu, Lale; Wetter, Axel

Integrated ⁶⁸Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging

In: Urologia Internationalis, Jg. 100, 2018, Nr. 2, S. 164 – 171

DOI
Kirchner, J.; Grueneisen, J.; Sawicki, L. M.; Oehmigen, M.; Quick, Harald H.; Antoch, G.; Herrmann, Ken; Umutlu, Lale

Local and whole-body staging in patients with primary breast cancer : A comparison of one-step to two-step-staging utilizing F-18-FDG-PET/MRI

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. Suppl. 1, S. 456
Kirchner, Julian; Grueneisen, Johannes; Martin, Ole; Oehmigen, Mark; Quick, Harald H.; Bittner, Ann-Kathrin; Hoffmann, Oliver; Ingenwerth, Marc; Catalano, Onofrio Antonio; Heusch, Philipp; Buchbender, Christian; Forsting, Michael; Antoch, Gerald; Herrmann, Ken; Umutlu, Lale

Local and whole-body staging in patients with primary breast cancer : a comparison of one-step to two-step staging utilizing ¹⁸F-FDG-PET/MRI

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 13, S. 2328 – 2337

DOI
Ahmadzadehfar, H.; Albers, P.; Bockisch, Andreas; Boegemann, M.; Böhme, C.; Burchert, W.; Dietlein, M.; Drzezga, A.; Fabry, U.; Feldmann, G.; Heidenreich, A.; Heinzel, A.; Herrmann, Ken; Heyll, A.; Höhling, C.; Kreuzer, C.; Laufer, D.; Mengel, R.; Mottaghy, F.M.; Müller, H.-W.; Müller, S.C.; Ost, E.; Rahbar, K.; Reifenhäuser, W.; Schäfers, M.; Schlenkhoff, C.; Schmidt, M.; Schmidt-Wolf, I.; Wildenhain, C.; Zimmer, B.; Essler, M.

Lutetium-177-PSMA-Radioligandentherapie : Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK Nordrhein

In: Der Urologe, Jg. 57, 2018, Nr. 6, S. 709 – 713

DOI
Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel

MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

In: Clinical Lung Cancer, Jg. 19, 2018, Nr. 4, S. e441 – e463

DOI
Lisova, Ksenia; Sergeev, Maxim; Evans-Axelsson, Susan; Stuparu, Andreea D.; Beykan, Seval; Collins, Jeffrey; Jones, Jason; Lassmann, Michael; Herrmann, Ken; Perrin, David; Lee, Jason T.; Slavik, Roger; van Dam, R. Michael

Microscale radiosynthesis, preclinical imaging and dosimetry study of [¹⁸F]AMBF₃-TATE : A potential PET tracer for clinical imaging of somatostatin receptors

In: Nuclear Medicine and Biology, Jg. 61, 2018, S. 36 – 44

DOI, Online Volltext (Open Access)
Calais, Jeremie; Kishan, Amar U.; Cao, Minsong; Fendler, Wolfgang P.; Eiber, Matthias; Herrmann, Ken; Ceci, Francesco; Reiter, Robert E.; Rettig, Matthew B.; Hegde, John V.; Shaverdian, Narek; King, Chris R.; Steinberg, Michael L.; Czernin, Johannes; Nickols, Nicholas G.

Potential impact of ⁶⁸Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 11, S. 1714 – 1721

DOI (Open Access)
Lückerath, Katharina; Wei, Liu; Fendler, Wolfgang; Evans-Axelsson, Susan; Stuparu, Andreea D.; Slavik, Roger; Mona, Christine E.; Calais, Jeremie; Rettig, Matthew; Reiter, Robert E.; Herrmann, Ken; Radu, Caius G.; Czernin, Johannes; Eiber, Matthias

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

In: EJNMMI Research, Jg. 8, 2018, Nr. 1, 96

DOI (Open Access)
Ruhlmann, Marcus; Sonnenschein, Wilfried; Nagarajah, James; Binse, Ina; Herrmann, Ken; Jentzen, Walter

Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activities

In: Nuclear Medicine Communications, Jg. 39, 2018, Nr. 5, S. 457 – 464

DOI
Eiber, Matthias; Herrmann, Ken; Calais, Jeremie; Hadaschik, Boris; Giesel, Frederik L.; Hartenbach, Markus; Hope, Thomas; Reiter, Robert; Maurer, Tobias; Weber, Wolfgang A.; Fendler, Wolfgang P.

Prostate cancer molecular imaging standardized evaluation (PROMISE) : Proposed miTNM classification for the interpretation of PSMA-ligand PET/CT

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 3, S. 469 – 478

DOI (Open Access)
Wierts, Roel; Jentzen, Walter; Quick, Harald H.; Wisselink, Hendrik J.; Pooters, Ivo N.A.; Wildberger, Joachim E.; Herrmann, Ken; Kemerink, Gerrit J.; Backes, Walter H.; Mottaghy, Felix M.

Quantitative performance evaluation of I PET/MRI lesion dosimetry in differentiated thyroid cancer

In: Physics in Medicine and Biology, Jg. 63, 2018, Nr. 1, S. 015014

DOI, Online Volltext (Open Access)
Jentzen, Walter; Phaosricharoen, Jinda; Gomez, Benedikt; Hetkamp, Philipp; Stebner, Vanessa; Binse, Ina; Kinner, Sonja; Herrmann, Ken; Sabet, Amir; Nagarajah, James

Quantitative performance of ¹²⁴I PET/MR of neck lesions in thyroid cancer patients using ¹²⁴I PET/CT as reference

In: EJNMMI Physics, Jg. 5, 2018, Nr. 1, 13

DOI, Online Volltext (Open Access)
Calais, Jeremie; Fendler, Wolfgang Peter; Herrmann, Ken; Eiber, Matthias; Ceci, Francesco

Reply: Comparison of Ga-PSMA-11 and F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 5, S. 861

DOI (Open Access)
Sarabhai, Theresia; Tschischka, Alexander; Stebner, Vanessa; Nensa, Felix; Wetter, Axel; Kimmig, Rainer; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grüneisen, Johannes

Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients : preliminary results

In: Clinical Imaging, Jg. 49, 2018, S. 163 – 168

DOI
deSouza, Nandita M.; Liu, Yan; Chiti, Arturo; Oprea-Lager, Daniela; Gebhart, Géraldine; Van Beers, Bernard E.; Herrmann, Ken; Lecouvet, Frederic E.

Strategies and technical challenges for imaging oligometastatic disease : Recommendations from the European Organisation for Research and Treatment of Cancer imaging group

In: European Journal of Cancer (EJC), Jg. 91, 2018, S. 153 – 163

DOI
Heinze, Britta; Fuss, Carmina T.; Mulatero, Paolo; Beuschlein, Felix; Reincke, Martin; Mustafa, Mona; Schirbel, Andreas; Deutschbein, Timo; Williams, Tracy Ann; Rhayem, Yara; Quinkler, Marcus; Rayes, Nada; Monticone, Silvia; Wild, Vanessa; Gomez-Sanchez, Celso E.; Reis, Anna-Carinna; Petersenn, Stephan; Wester, Hans-Juergen; Kropf, Saskia; Fassnacht, Martin; Lang, Katharina; Herrmann, Ken; Buck, Andreas K.; Bluemel, Christina; Hahner, Stefanie

Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma

In: Hypertension, Jg. 71, 2018, Nr. 2, S. 317 – 325

DOI (Open Access)
Ceccon, Garry; Lazaridis, Lazaros; Stoffels, Gabriele; Rapp, Marion; Weber, Manuel; Blau, Tobias; Lohmann, Phillip; Kebir, Sied; Herrmann, Ken; Fink, Gereon R.; Langen, Karl-Josef; Glas, Martin; Galldiks, Norbert

Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields : initial experience

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 9, S. 1626 – 1635

DOI
Lecouvet, Frédéric E.; Oprea-Lager, Daniela E.; Liu, Yan; Ost, Piet; Bidaut, Luc; Collette, Laurence; Deroose, Christophe M.; Goffin, Karolien; Herrmann, Ken; Hoekstra, Otto S.; Kramer, Gem; Lievens, Yolande; Lopci, Egesta; Pasquier, David; Petersen, Lars J.; Talbot, Jean-Noël; Zacho, Helle; Tombal, Bertrand; deSouza, Nandita M.

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group

In: The Lancet Oncology, Jg. 19, 2018, Nr. 10, S. e534 – e545

DOI, Online Volltext (Open Access)
Li, Yan; Beiderwellen, Karsten; Nensa, Felix; Grüneisen, Johannes; Dobos, Gustav; Herrmann, Ken; Lauenstein, Thomas; Umutlu, Lale; Langhorst, Jost

[¹⁸F]FDG PET/MR enterography for the assessment of inflammatory activity in Crohn’s disease: comparison of different MRI and PET parameters

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 8, S. 1382 – 1393

DOI
Calais, Jeremie; Czernin, Johannes; Cao, Minsong; Kishan, Amar U.; Hegde, John V.; Shaverdian, Narek; Sandler, Kiri; Chu, Fang-I; King, Chris R.; Steinberg, Michael L.; Rauscher, Isabel; Schmidt-Hegemann, Nina-Sophie; Pöppel, Thorsten; Hetkamp, Philipp; Ceci, Francesco; Herrmann, Ken; Fendler, Wolfgang P.; Eiber, Matthias; Nickols, Nicholas G.

⁶⁸Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL : Impact on salvage radiotherapy planning

In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 2, S. 230 – 237

DOI (Open Access)
Kirchner, Julian; Deuschl, Cornelius; Grueneisen, Johannes; Herrmann, Ken; Forsting, Michael; Heusch, Philipp; Antoch, Gerald; Umutlu, Lale

(18)F-FDG PET/MRI in patients suffering from lymphoma : how much MRI information is really needed?

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. 6, S. 1005 – 1013

DOI
Fendler, Wolfgang Peter; Rahbar, Kambiz; Herrmann, Ken; Kratochwil, Clemens; Eiber, Matthias J.

177Lu-PSMA Radioligand Therapy for Prostate Cancer

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 8, S. 1196 – 1200

DOI (Open Access)
Kirchner, Julian; Sawicki, Lino M; Deuschl, Cornelius; Grüneisen, Johannes; Beiderwellen, Karsten; Lauenstein, Thomas; Herrmann, Ken; Forsting, Michael; Heusch, Philipp; Umutlu, Lale

18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

In: PLoS ONE, Jg. 12, 2017, Nr. 7, S. e0180349

DOI (Open Access)
Ruhlmann, Marcus; Ruhlmann, Jürgen; Görges, Rainer; Herrmann, Ken; Antoch, Gerald; Keller, Hans Wilhelm; Ruhlmann, Verena

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography May Exclude Malignancy in Sonographically Suspicious and Scintigraphically Hypofunctional Thyroid Nodules and Reduce Unnecessary Thyroid Surgeries

In: Thyroid, Jg. 27, 2017, Nr. 10, S. 1300 – 1306

DOI
Fendler, Wolfgang Peter; Barrio, Martin; Spick, Claudio; Allen-Auerbach, Martin; Ambrosini, Valentina; Benz, Matthias; Bluemel, Christina; Grewal, Ravinder Kaur; Lapa, Constantin; Miederer, Matthias; Nicolas, Guillaume; Schuster, Tibor; Czernin, Johannes; Herrmann, Ken

68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment : Results of a Prospective Study on 50 Patients

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 2, S. 307 – 311

DOI, Online Volltext (Open Access)
Fendler, Wolfgang P.; Eiber, Matthias; Beheshti, Mohsen; Bomanji, Jamshed; Ceci, Francesco; Cho, Steven; Giesel, Frederik; Haberkorn, Uwe; Hope, Thomas A.; Kopka, Klaus; Krause, Bernd J.; Mottaghy, Felix M.; Schöder, Heiko; Sunderland, John; Wan, Simon; Wester, Hans-Jürgen; Fanti, Stefano; Herrmann, Ken

68Ga-PSMA PET/CT : Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. 6, S. 1014 – 1024

DOI
Fendler, Wolfgang Peter; Calais, Jérémie; Allen-Auerbach, Martin S.; Bluemel, Christina; Eberhardt, Nina; Emmett, Louise M.; Gupta, Pawan K.; Hartenbach, Markus; Hope, Thomas A.; Okamoto, Shozo; Pfob, Christian H.; Pöppel, Thorsten; Rischpler, Christoph; Schwarzenböck, Sarah Marie; Stebner, Vanessa; Unterrainer, Marcus; Zacho, Helle Damgaard; Maurer, Tobias; Gratzke, Christian; Crispin, Alexander A.; Czernin, Johannes G.; Herrmann, Ken; Eiber, Matthias J.

68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments : An International Multicenter Prospective Study

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 10, S. 1617 – 1623

DOI
Fendler, Wolfgang P.; Eiber, Matthias; Stief, Christian G.; Herrmann, Ken

A PET for All Seasons : 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?

In: European Urology, Jg. 71, 2017, Nr. 6, S. 934 – 935

DOI
Walenkamp, Annemiek M.E.; Lapa, Constantin; Herrmann, Ken; Wester, Hans-Jürgen

CXCR4 ligands : The next big hit?

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. Suppl. 2, S. 77S – 82S

DOI
Lapa, Constantin; Herrmann, Ken; Schirbel, Andreas; Hänscheid, Heribert; Lückerath, Katharina; Schottelius, Margret; Kircher, Malte; Werner, Rudolf A.; Schreder, Martin; Samnick, Samuel; Kropf, Saskia; Knop, Stefan; Buck, Andreas K.; Einsele, Hermann; Wester, Hans-Juergen; Kortüm, K. Martin

CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma

In: Theranostics, Jg. 7, 2017, Nr. 6, S. 1589 – 1597

DOI (Open Access)
Brumberg, Joachim; Küsters, Sebastian; Al-Momani, Ehab; Marotta, Giorgio; Cosgrove, Kelly P.; van Dyck, Christopher H.; Herrmann, Ken; Homola, György A.; Pezzoli, Gianni; Buck, Andreas K.; Volkmann, Jens; Samnick, Samuel; Isaias, Ioannis U.

Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study

In: Annals of Clinical and Translational Neurology, Jg. 4, 2017, Nr. 9, S. 632 – 639

DOI (Open Access)
Bodei, Lisa; Ambrosini, Valentina; Herrmann, Ken; Modlin, Irvin

Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms : Interpretation, Biodistribution, Dosimetry, and Molecular Strategies

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 11, S. 1718 – 1726

DOI (Open Access)
Ruhlmann, Verena; Pöppel, Thorsten; Veit, Johannes; Nagarajah, James; Umutlu, Lale; Hoffmann, Thomas K.; Bockisch, Andreas; Herrmann, Ken; Sauerwein, Wolfgang

Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma

In: BMC Cancer, Jg. 17, 2017, Nr. 1, S. 887

DOI, Online Volltext (Open Access)
Fendler, Wolfgang; Stuparu, Andreea D.; Evans-Axelsson, Susan; Lückerath, Katharina; Wei, Liu; Kim, Woosuk; Poddar, Soumya; Said, Jonathan; Radu, Caius G.; Eiber, Matthias; Czernin, Johannes; Slavik, Roger; Herrmann, Ken

Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 11, S. 1786 – 1792

DOI (Open Access)
Sawicki, Lino M; Deuschl, Cornelius; Beiderwellen, Karsten; Ruhlmann, Verena; Pöppel, Thorsten; Heusch, Philipp; Lahner, Harald; Führer, Dagmar; Bockisch, Andreas; Herrmann, Ken; Forsting, Michael; Antoch, Gerald; Umutlu, Lale

Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT

In: European Radiology, Jg. 27, 2017, Nr. 10, S. 4091 – 4099

DOI
Eiber, Matthias; Herrmann, Ken

From NETTER to PETTER : PSMA-Targeted radioligand therapy

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 1, S. 9 – 10

DOI
Barrio, Martin J.; Spick, Claudio; Radu, Caius G.; Lassmann, Michael; Eberlein, Uta; Allen-Auerbach, Martin; Schiepers, Christiaan; Slavik, Roger; Czernin, Johannes; Herrmann, Ken

Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 3, S. 374 – 378

DOI
Kirchner, Julian; Deuschl, Cornelius; Schweiger, Bernd; Herrmann, Ken; Forsting, Michael; Buchbender, Christian; Antoch, Gerald; Umutlu, Lale

Imaging children suffering from lymphoma : an evaluation of different ; 18F-FDG PET/MRI protocols compared to whole-body DW-MRI

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. 10, S. 1742 – 1750

DOI
Werner, Rudolf A.; Weich, Alexander; Higuchi, Takahiro; Schmid, Jan S.; Schirbel, Andreas; Lassmann, Michael; Wild, Vanessa; Rudelius, Martina; Kudlich, Theodor; Herrmann, Ken; Scheurlen, Michael; Buck, Andreas K.; Kropf, Saskia; Wester, Hans-Jürgen; Lapa, Constantin

Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach

In: Theranostics, Jg. 7, 2017, Nr. 6, S. 1489 – 1498

DOI (Open Access)
Erfanian, Youssef; Grueneisen, Johannes; Kirchner, Julian; Wetter, Axel; Podleska, Lars; Bauer, Sebastian; Pöppel, Thorsten; Forsting, Michael; Herrmann, Ken; Umutlu, Lale

Integrated 18F–FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas : a comparison trial

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. 11, S. 1823 – 1831

DOI
Bluemel, Christina; Hahner, Stefanie; Heinze, Britta; Fassnacht, Martin; Kroiss, Matthias; Bley, Thorsten A; Wester, Hans-Juergen; Kropf, Saskia; Lapa, Constantin; Schirbel, Andreas; Buck, Andreas K; Herrmann, Ken

Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients

In: Clinical Nuclear Medicine, Jg. 42, 2017, Nr. 1, S. e29 – e34

DOI
Calais, Jeremie; Czernin, Johannes; Eiber, Matthias; Fendler, Wolfgang P.; Gartmann, Jeannine; Heaney, Anthony P.; Hendifar, Andrew E.; Pisegna, Joseph R.; Randolph Hecht, J.; Wolin, Edward M.; Slavik, Roger; Gupta, Pawan; Quon, Andrew; Schiepers, Christiaan; Allen-Auerbach, Martin S.; Herrmann, Ken

Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 11, S. 1793 – 1796

DOI, Online Volltext (Open Access)
Frilling, Andrea; Herrmann, Ken; Kämmerer, Daniel; Toumpanakis, Christos

Neuroendocrine Tumors of the Gastrointestinal Tract

In: Visceral Medicine, Jg. 33, 2017, Nr. 5, S. 368 – 371

DOI (Open Access)
Schwarzenboeck, Sarah M.; Rauscher, Isabel; Bluemel, Christina; Fendler, Wolfgang P.; Rowe, Steven P.; Pomper, Martin G.; Asfhar-Oromieh, Ali; Herrmann, Ken; Eiber, Matthias

PSMA ligands for PET imaging of prostate cancer

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 10, S. 1545 – 1552

DOI
Lütje, Susanne; Slavik, Roger; Fendler, Wolfgang; Herrmann, Ken; Eiber, Matthias

PSMA ligands in prostate cancer – Probe optimization and theranostic applications

In: Methods: A Companion to Methods in Enzymology, Jg. 130, 2017, S. 42 – 50

DOI
Eiber, Matthias; Fendler, Wolfgang P.; Rowe, Steven P.; Calais, Jeremie; Hofman, Michael S.; Maurer, Tobias; Schwarzenboeck, Sarah M.; Kratowchil, Clemens; Herrmann, Ken; Giesel, Frederik L.

Prostate-specific membrane antigen ligands for imaging and therapy

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. Suppl. 2, S. 67S – 76S

DOI
Okamoto, Shozo; Thieme, Anne; Allmann, Jakob; D'Alessandria, Calogero; Maurer, Tobias; Retz, Margitta; Tauber, Robert; Heck, Matthias M; Wester, Hans-Juergen; Tamaki, Nagara; Fendler, Wolfgang P.; Herrmann, Ken; Pfob, Christian H; Scheidhauer, Klemens; Schwaiger, Markus; Ziegler, Sibylle; Eiber, Matthias

Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer : Absorbed Dose in Normal Organs and Tumor Lesions

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 3, S. 445 – 450

DOI (Open Access)
Hadaschik, Boris; Herrmann, Ken

Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate Cancer

In: European Urology, Jg. 72, 2017, Nr. 3, S. 470 – 471

DOI
Deuschl, Cornelius; Mönninghoff, Christoph; Göricke, Sophia Luise; Kirchner, Julian; Köppen, Susanne; Binse, Ina; Pöppel, Thorsten; Quick, Harald H.; Forsting, Michael; Umutlu, Lale; Herrmann, Ken; Hense, Jörg; Schlamann, Marc

Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI : a feasibility study

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. 8, S. 1285 – 1295

DOI
Lapa, Constantin; Kircher, Stefan; Schirbel, Andreas; Rosenwald, Andreas; Kropf, Saskia; Pelzer, Theo; Walles, Thorsten; Buck, Andreas K.; Weber, Wolfgang A.; Wester, Hans-Juergen; Herrmann, Ken; Lückerath, Katharina

Targeting CXCR4 with [68Ga]Pentixafor : A suitable theranostic approach in pleural mesothelioma?

In: OncoTarget, Jg. 8, 2017, Nr. 57, S. 96732 – 96737

DOI (Open Access)
Barrio, Martin; Czernin, Johannes; Fanti, Stefano; Ambrosini, Valentina; Binse, Ina; Du, Lin; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang P.

The impact of somatostatin receptor-directed PET/CT on the management of patients with neuroendocrine tumor : A systematic review and meta-analysis

In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 5, S. 756 – 761

DOI (Open Access)
Ceci, Francesco; Herrmann, Ken; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano

Therapy assessment in prostate cancer using choline and PSMA PET/CT

In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. Suppl. 1, S. S78 – S83

DOI
Lapa, Constantin; Arias-Loza, Paula; Hayakawa, Nobuyuki; Wakabayashi, Hiroshi; Werner, Rudolf A; Chen, Xinyu; Shinaji, Tetsuya; Herrmann, Ken; Pelzer, Theo; Higuchi, Takahiro

Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes Mellitus

In: Scientific Reports, Jg. 7, 2017, Nr. 1, S. 16795

DOI (Open Access)
Kirchner, Julian; Sawicki, Lino Morris; Suntharalingam, Saravanabavaan; Grueneisen, Johannes; Ruhlmann, Verena; Aktas, Bahriye; Deuschl, Cornelius; Herrmann, Ken; Antoch, Gerald; Forsting, Michael; Umutlu, Lale

Whole-body staging of female patients with recurrent pelvic malignancies : Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT

In: PLoS ONE, Jg. 12, 2017, Nr. 2, S. e0172553

DOI (Open Access)
Lapa, Constantin; Schreder, Martin; Schirbel, Andreas; Samnick, Samuel; Kortüm, Klaus Martin; Herrmann, Ken; Kropf, Saskia; Einsele, Herrmann; Buck, Andreas K; Wester, Hans-Jürgen; Knop, Stefan; Lückerath, Katharina

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values

In: Theranostics, Jg. 7, 2017, Nr. 1, S. 205 – 212

DOI (Open Access)
Lapa, Constantin; Garcia-Velloso, Maria J; Lückerath, Katharina; Samnick, Samuel; Schreder, Martin; Otero, Paula Rodriguez; Schmid, Jan-Stefan; Herrmann, Ken; Knop, Stefan; Buck, Andreas K; Einsele, Hermann; San-Miguel, Jesus; Kortüm, Klaus Martin

¹¹C-Methionine-PET in Multiple Myeloma : A Combined Study from Two Different Institutions

In: Theranostics, Jg. 7, 2017, Nr. 11, S. 2956 – 2964

DOI (Open Access)
Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang P.; Maurer, Tobias

(68)Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging : The New Kid on the Block-Early or Too Early to Draw Conclusions?

In: European Urology, Jg. 70, 2016, Nr. 6, S. 938 – 940

DOI
Herrmann, Ken; Schottelius, Margret; Lapa, Constantin; Osl, Theresa; Poschenrieder, Andreas; Hänscheid, Heribert; Lückerath, Katharina; Schreder, Martin; Bluemel, Christina; Knott, Markus; Keller, Ulrich; Schirbel, Andreas; Samnick, Samuel; Lassmann, Michael; Kropf, Saskia; Buck, Andreas K.; Einsele, Hermann; Wester, Hans-Juergen; Knop, Stefan

First-in-human experience of CXCR4-directed endoradiotherapy with ¹⁷⁷Lu-and ⁹⁰Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary disease

In: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 2, S. 248 – 251

DOI
Bluemel, Christina; Linke, Fraenze; Herrmann, Ken; Simunovic, Iva; Eiber, Matthias; Kestler, Christian; Buck, Andreas K; Schirbel, Andreas; Bley, Thorsten A; Wester, Hans-Juergen; Vergho, Daniel; Becker, Axel

Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy

In: EJNMMI Research, Jg. 6, 2016, Nr. 1, 78

DOI (Open Access)
Wakabayashi, Hiroshi; Werner, Rudolf A; Hayakawa, Nobuyuki; Javadi, Mehrbod S; Xinyu, Chen; Herrmann, Ken; Rowe, Steven P; Lapa, Constantin; Higuchi, Takahiro

Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent

In: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 10, S. 1625 – 1628

DOI
Barrio, Martin; Fendler, Wolfgang P.; Czernin, Johannes; Herrmann, Ken

Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer

In: Expert Review of Molecular Diagnostics, Jg. 16, 2016, Nr. 11, S. 1177 – 1188

DOI
Barrio, Martin; Czernin, Johannes; Yeh, Michael W; Palma Diaz, Miguel F; Gupta, Pawan; Allen-Auerbach, Martin; Schiepers, Christiaan; Herrmann, Ken

The incidence of thyroid cancer in focal hypermetabolic thyroid lesions : an 18F-FDG PET/CT study in more than 6000 patients

In: Nuclear Medicine Communications, Jg. 37, 2016, Nr. 12, S. 1290 – 1296

DOI, Online Volltext (Open Access)
Lapa, Constantin; Knop, Stefan; Schreder, Martin; Rudelius, Martina; Knott, Markus; Jörg, Gerhard; Samnick, Samuel; Herrmann, Ken; Buck, Andreas K.; Einsele, Hermann; Lückerath, Katharina

¹¹C-methionine-PET in multiple myeloma : Correlation with clinical parameters and bone marrow involvement

In: Theranostics, Jg. 6, 2016, Nr. 2, S. 254 – 261

DOI (Open Access)
Philipp-Abbrederis, Kathrin; Herrmann, Ken; Knop, Stefan; Schottelius, Margret; Eiber, Matthias; Lückerath, Katharina; Pietschmann, Elke; Habringer, Stefan; Gerngroß, Carlos; Franke, Katharina; Rudelius, Martina; Schirbel, Andreas; Lapa, Constantin; Schwamborn, Kristina; Steidle, Sabine; Hartmann, Elena; Rosenwald, Andreas; Kropf, Saskia; Beer, Ambros J.; Peschel, Christian; Einsele, Hermann; Buck, Andreas K.; Schwaiger, Markus; Götze, Katharina; Wester, Hans-Jürgen; Keller, Ulrich

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma

In: EMBO Molecular Medicine, Jg. 7, 2015, Nr. 4, S. 477 – 487

DOI (Open Access)
Lückerath, Katharina; Lapa, Constantin; Albert, Christa; Herrmann, Ken; Jörg, Gerhard; Samnick, Samuel; Einsele, Herrmann; Knop, Stefan; Buck, Andreas K.

¹¹C-Methionine-PET : A novel and sensitive tool for monitoring of early response to treatment in multiple myeloma

In: OncoTarget, Jg. 6, 2015, Nr. 10, S. 8418 – 8429

DOI (Open Access)
Buder, Kristina; Lapa, Constantin; Kreissl, Michael C.; Schirbel, Andreas; Herrmann, Ken; Schnack, Alexander; Bröcker, Eva-Bettina; Goebeler, Matthias; Buck, Andreas K.; Becker, Jürgen

Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging

In: BMC Cancer, Jg. 14, 2014, Nr. 1

DOI (Open Access)
Lapa, Constantin; Lückerath, Katharina; Malzahn, Uwe; Samnick, Samuel; Einsele, Herrmann; Buck, Andreas K.; Herrmann, Ken; Knop, Stefan

¹⁸FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation

In: OncoTarget, Jg. 5, 2014, Nr. 17, S. 7381 – 7391

DOI (Open Access)
Caldarelli, Antonio; Müller, Jörg P.; Paskowski-Rogacz, M.; Herrmann, Ken; Bauer, Reinhard F.; Koch, Sina; Heninger, Anne Kristin; Krastev, Dragomir Blazhev; Ding, Li; Kasper, Stefan; Fischer, Thomas A.; Brodhun, Michael; Böhmer, Frank Dietmar; Buchholz, Frank

A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling

In: Leukemia, Jg. 27, 2013, Nr. 12, S. 2301 – 2310

DOI

Aufsätze

Totzeck, Matthias; Aide, Nicolas; Bauersachs, Johann; Bucerius, Jan; Georgoulias, Panagiotis; Herrmann, Ken; Hyafil, Fabien; Kunikowska, Jolanta; Lubberink, Mark; Nappi, Carmela; Rassaf, Tienush; Saraste, Antti; Sciagra, Roberto; Slart, Riemer; Verberne, Hein; Rischpler, Christoph

Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity : Prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 3, S. 792 – 812

DOI (Open Access)

Vorworte / Nachworte

Fendler, Wolfgang; Grünwald, Viktor; Herrmann, Ken; Hadaschik, Boris

Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker : Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate Cancer

In: European Urology. Amsterdam: Elsevier, Jg. 87, 2025, Nr. 3, S. 275 – 277

DOI
Sartor, Oliver; Emmett, Louise; Herrmann, Ken

Resisting RECIST : PSMA PET and Regulatory Change in Prostate Cancer

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. 11, S. 1683

DOI
Murthy, Vedang; Marvaso, Giulia; Jereczek-Fossa, Barbara A.; Thoma, Stephanie A.; Vogel, Marco; Schmidt-Hegemann, Nina-Sophie; Shelan, Mohamed; Siva, Shankar; Hoelscher, Tobias; Kishan, Amar U.; Peeken, Jan C.; Gillessen, Silke; Guckenberger, Matthias; Herrmann, Ken; Fendler, Wolfgang; Zilli, Thomas; Spohn, Simon K.B.; Zamboglou, Constantinos

The Co-IMPACT Consortium : Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care

In: European Urology. Amsterdam: Elsevier, Jg. 87, 2025, Nr. 4, S. 379 – 384

DOI
Krafft, Ulrich; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken

A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?

In: European Urology. Amsterdam: Elsevier, Jg. 85, 2024, Nr. 3, S. 227 – 228

DOI
Seifert, Robert; Eiber, Matthias; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang

The novel PROMISE framework for PSMA-PET reporting : Ready for the clinical routine?

In: Clinical and Translational Imaging. Berlin: Springer, Jg. 12, 2024, Nr. 1, S. 1 – 3

DOI (Open Access)
Pouget, Jean-Pierre; Konijnenberg, Mark; Eberlein, Uta; Glatting, Gerhard; Gabina, Pablo Minguez; Herrmann, Ken; Holm, Søren; Strigari, Lidia; van Leeuwen, Fijs W B; Lassmann, Michael

An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 2, S. 242 – 246

DOI (Open Access)
Nanni, Cristina; Kobe, Carsten; Herrmann, Ken; Kunikowska, Jolanta

Defining the role of nuclear medicine in haematological tumours—EANM Focus 4 : consensus on molecular imaging and therapy in haematological tumours

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 10, S. 2925 – 2926

DOI (Open Access)
Tolboom, Nelleke; Verger, Antoine; Albert, Nathalie L.; Brendel, Matthias; Cecchin, Diego; Fernandez, Pablo Aguiar; Fraioli, Francesco; Guedj, Eric; Herrmann, Ken; Traub-Weidinger, Tatjana; Morbelli, Silvia; Yakushev, Igor; Zucchetta, Pietro; Barthel, Henryk; Van Weehaeghe, Donatienne

EANM position paper: theranostics in brain tumours : The present and the future

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 51, 2023, Nr. 1, S. 202 – 205

DOI (Open Access)
Hicks, Rodney J.; Giesel, Frederik; Herrmann, Ken

Fibroblast Activation Protein as a Diagnostic and Therapeutic Target : Where Do We Go from Here?

In: PET Clinics. Orlando: Elsevier, Jg. 18, 2023, Nr. 3, S. xv – xx

DOI
Ambrosini, Valentina; Carrilho Vaz, Sofia; Ahmadi Bidakhvidi, Niloefar; Chanchou, Marion; Cysouw, Matthijs C. F.; Serani, Francesca; Voltin, Conrad-Amadeus; Kraeber-Bodere, Francoise; Deroose, Christophe M.; De Geus-Oei, Lioe-Fee; Eiber, Matthias; Gnanasegaran, Gopinath; Gotthardt, Martin; Kobe, Carsten; Konijnenberg, Mark W.; Nanni, Cristina; Oprea Lager, Daniela E.; Rahbar, Kambiz; Taieb, David; Mottaghy, Felix M.; Goffin, Karolien; Herrmann, Ken

How to attract young talent to nuclear medicine step 1 : a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 51, 2023, Nr. 1, S. 3 – 11

DOI (Open Access)
Ayati, Narjess; Herrmann, Ken; Fanti, Stefano; Murphy, Declan G.; Hofman, Michael S.

More Accurate Imaging Is Not Stage Migration : Time To Move from “Hubble” to “Webb” in Hormone-sensitive Prostate Cancer

In: European Urology. Amsterdam: Elsevier, Jg. 83, 2023, Nr. 1, S. 6 – 9

DOI
Pomykala, Kelsey L.; Herrmann, Ken; Lalumera, Elisabetta; Fanti, Stefano

Positive Prostate-specific Membrane Antigen Findings : How To Interpret Them

In: European Urology Oncology. Amsterdam: Elsevier, Jg. 6, 2023, Nr. 2, S. 113 – 115

DOI
Allie, Rayjanah; Kayani, Irfan; Gnanasegaran, Gopinath; Vinjamuri, Sobhan; Chiti, Arturo; Paez, Diana; Giammarile, Francesco; Herrmann, Ken; Bomanji, Jamshed

Strategy planning for turbulent times in nuclear medicine : Time to begin at the beginning?

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 51, 2023, Nr. 1, S. 12 – 19

DOI (Open Access)
Weber, Wolfgang A.; Barthel, Henryk; Bengel, Frank; Eiber, Matthias; Herrmann, Ken; Schäfers, Michael

What Is Theranostics?

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. 5, S. 669 – 670

DOI (Open Access)
Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland; Lassman, Michael; Wadsak, Wolfgang; Kunikowska, Jolanta

European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2022, Nr. 1, S. 1 – 3

DOI (Open Access)
Pomykala, Kelsey L.; Herrmann, Ken; Padhani, Anwar R.; Hofman, Michael S.; Lalumera, Elisabetta; Fanti, Stefano

Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer : We Have the Answers

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 63, 2022, Nr. 10, S. 1480 – 1481

DOI (Open Access)
Herrmann, Ken; Kratochwil, Clemens; Fendler, Wolfgang P.; Eiber, Matthias; Hustinx, Roland

2021: the year [¹⁷⁷Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, 2021

DOI, Online Volltext (Open Access)
Kunikowska, Jolanta; Ambrosini, Valentina; Herrmann, Ken

EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours—the consensus in a nutshell

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, S. 1276 – 1277

DOI (Open Access)
Patt, Marianne; Bengel, Frank; Essler, Markus; Krause, Bernd-Joachim; Kuwert, Torsten; Rahbar, Kambiz; Sabri, Osama; Schäfer, Wolfgang; Schreckenberger, Matthias; Weber, Wolfgang A.; Herrmann, Ken

Kamingespräch § 13 (2b) AMG in der nuklearmedizinischen Therapie : Eine Follow-up-Veranstaltung der NuklearMedizin 2020 - Digital

In: Nuklearmedizin = Nuclear Medicine. Stuttgart: Thieme, Jg. 60, 2021, Nr. 4, S. 262 – 263

DOI
Fendler, Wolfgang; Herrmann, Ken; Eiber, Matthias

Nuclear Medicine Beyond VISION

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. 7, S. 916 – 917

DOI (Open Access)
Bourla, Ariel B.; Herrmann, Ken

Real-World Data as an Evidence Source in Nuclear Medicine

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. 2, S. 156 – 157

DOI (Open Access)
Paez, D.; Gnanasegaran, G.; Fanti, S.; Bomanji, J.; Hacker, M.; Sathekge, M.; Bom, H.S.; Cerci, J.J.; Chiti, A.; Herrmann, Ken; Scott, A.M.; Czernin, J.; El-Haj, N.; Estrada, E.; Pellet, O.; Orellana, P.; Giammarile, F.; Abdel-Wahab, M.

COVID-19 pandemic : guidance for nuclear medicine departments

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. 7, S. 1615 – 1619

DOI (Open Access)
Umutlu, Lale; Herrmann, Ken; Herold, C.

Hybridbildgebung

In: Der Radiologe. Berlin: Springer, Jg. 60, 2020, Nr. 5, S. 375

DOI
Vaz, Sofia; Hadaschik, Boris; Gabriel, Michael; Herrmann, Ken; Eiber, Matthias; Costa, Durval

Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. 1, S. 9 – 15

DOI (Open Access)
Lordick, F.; Herrmann, Ken

Metabolic response assessment and PET-guided treatment of esophageal cancer

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. 2, S. 163 – 164

DOI (Open Access)
Huang, H.L.; Gnanasegaran, G.; Paez, D.; Fanti, S.; Hacker, M.; Sathekge, M.; Bom, H.S.; Cerci, J.J.; Chiti, A.; Lan, X.; Herrmann, Ken; Scott, A.M.; Vinjamuri, S.; Dorbala, S.; Estrada, E.; Pellet, O.; Orellana, P.; El-Haj, N.; Giammarile, F.; Abdel-Wahab, M.; Bomanji, Jamshed

Nuclear medicine services after COVID-19: gearing up back to normality

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. 9, S. 2048 – 2053

DOI (Open Access)
Fanti, Stefano; Hadaschik, Boris; Herrmann, Ken

Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging : The PSMA PET Progression Criteria

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. 5, S. 678 – 682

DOI (Open Access)
Merkel, C.; Whicher, C.H.; Bomanji, J.; Herrmann, Ken; Ćwikła, J.; Jervis, N.; Wait, S.; Chiti, A.

Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. 6, S. 1335 – 1339

DOI (Open Access)
Bodei, Lisa; Herrmann, Ken; Baum, Richard P.; Kidd, Mark; Malczewska, Anna; Modlin, Irvin M.

Caveat Emptor : Let our acclaim of the apotheosis of PRRT not blind us to the error of Prometheus

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 60, 2019, Nr. 1, S. 7 – 8

DOI (Open Access)
Veit-Haibach, Patrick; Buvat, Irène; Herrmann, Ken

EJNMMI supplement : bringing AI and radiomics to nuclear medicine

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 46, 2019, S. 2627 – 2629

DOI (Open Access)
Herrmann, Ken; Freudenberg, Lutz

Zukunftsworkshop 1.0 : Aufbruch in die Zukunft oder ein Strohfeuer?

In: Nuklearmedizin = Nuclear Medicine. Stuttgart: Thieme, Jg. 58, 2019, Nr. 4, S. 297 – 300

DOI
Umutlu, Lale; Herrmann, Ken

Preface

In: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.). Cham: Springer International Publishing, 2018, S. vii

DOI
Herrmann, Ken; Larson, Steven M.; Weber, Wolfgang A.

Theranostic concepts: More than just a fashion trend-introduction and overview

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 58, 2017, S. 1S – 2S

DOI

Interviews

Behrenbruch, Christian (Interviewpartner:in); Herrmann, Ken; Czernin, Johannes (Interviewer:in)

Precision Medicine Is Critical for the Future of Oncology : Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. 9, S. 1319 – 1322

DOI
Horný, Michal (Interviewpartner:in); Herrmann, Ken; Czernin, Johannes (Interviewer:in)

U.S. Imaging Costs : Michal Horný Talks with Ken Herrmann and Johannes Czernin About the Changing Contribution of Medical Imaging to Health Care Costs.

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 65, 2024, Nr. 11, S. 1663 – 1665

DOI
Gillessen, Silke; Herrmann, Ken (Interviewpartner:in); Czernin, Johannes (Interviewer:in)

A European Oncology Leader Looks at PSMA : A Conversation Between Silke Gillessen, Johannes Czernin, and Ken Herrmann

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 63, 2022, Nr. 2, S. 169 – 171

DOI (Open Access)
Hicks, Rodney (Interviewpartner:in); Czernin, Johannes; Herrmann, Ken (Interviewer:in)

Advancing Nuclear Medicine in Australia over 3 Decades : A Conversation Between Rodney Hicks, Johannes Czernin, and Ken Herrmann

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 63, 2022, Nr. 1, 263338

DOI (Open Access)
Zindel, Christoph (Interviewpartner:in); Herrmann, Ken (Interviewer:in)

A Conversation Between Christoph Zindel and Ken Herrmann

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. 8, S. 1088 – 1090

DOI (Open Access)
Herrmann, Ken; van Houten, Frans (Interviewpartner:in)

A Conversation Between Frans van Houten and Ken Herrmann

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. 12, S. 1697 – 1700

DOI (Open Access)

Abstracts

Pabst, Kim; Bartel, Timo; Sandach, Patrick; Weber, Manuel; Laschinsky, Christina; Eckstein, Markus; Kessler, Lukas; Kueper, Alina; Hadaschik, Boris; Kesch, Claudia; Hamacher, Rainer; Nader, Michael; Siveke, Jens; von Tresckow, Bastian; Kümmel, Sherko; Podleska, Lars; Reinacher-Schick, Anke; Uhl, Waldemar; Herrmann, Ken; Fendler, Wolfgang

68Ga-FAPI-46 PET for Imaging of FAP-expressing Cancer : Results from a Prospective, Single-Arm, Interventional Phase 2 Clinical Trial

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251524

Online Volltext (Open Access)
De Bono, Johann S.; Morris, Michael J.; Sartor, Alton Oliver; Wei, Xiao X.; Fizazi, Karim; Herrmann, Ken; Piulats, Josep M.; Mahammedi, Hakim; Logothetis, Christopher; George, Daniel J.; Wong, Connie; Barys, Louise; Rajagopal, Nisha; Alanee, Shaheen; Chi, Kim N.

Association of baseline and on-treatment ctDNA fraction with clinical outcomes in patients with mCRPC in the PSMAfore study of 177Lu-PSMA-617
2025 ASCO Genitourinary Cancers Symposium, January 13-15, 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 16

DOI
Küper, Alina; Kersting, David; Welt, Anja; Vaz, Sofia; Moraitis, Alexandros; Djaileb, Loic; Seifert, Robert; Umutlu, Lale; Schuler, Martin; Herrmann, Ken; Fendler, Wolfgang; Kümmel, Sherko; Ciuciulkaite, Ieva

Clinical value of [68Ga]Ga-FAPI-46 PET in Comparison to [18F]FDG PET in Triple-negative Breast Cancer and Possible Theranostic Applications

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251520

Online Volltext (Open Access)
Koerber, Stefan A.; Grott, Christoph A.; Burger, Irene; Herrmann, Ken; Kotzerke, Joerg; Fougère, Christian La; Meyer, Philipp; Virgolini, Irene; Weber, Wolfgang; Kopka, Klaus; Haberkorn, Uwe; Debus, Juergen; Eiber, Matthias; Giesel, Frederik L.

Impact of staging PSMA-PET/CT on radiotherapy planning in men with high-risk prostate cancer : results of a prospective multicenter randomized trial

In: Radiotherapy and Oncology (The Green Journal). Amsterdam: Elsevier, Jg. 206, 2025, Nr. Supplement 1, S. S2085

DOI
Stephan, Settelmeier; Goerttler, Tsepo; Trender-Gerhard, Iris; Chodyla, Michal Kamil; Küper, Alina; Gerhard, Alex; Kessler, Lukas; Schlosser, Thomas Wilfried; Papathanasiou, Maria; Rischpler, Christoph; Deuschl, Cornelius; Rassaf, Tienush; Herrmann, Ken; Dodel, Richard; Kersting, David

Investigation of Cardiac Amyloid Deposits as a Cause of Cardiac Dysfunction in Persons with Alzheimer's Disease : The Prospective CACAO-PET Study

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 252027

Online Volltext (Open Access)
Hüsing, Anika; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang; Rahbar, Kambiz

Three-tier risk stratification of prostate cancer by PSMA-PET PROMISE (PPP2) : Results from an international multi-centre registry study

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251292

Online Volltext (Open Access)
Pavel, M.E.; Ferone, D.; Halperin, D.; Myrehaug, S.; Herrmann, Ken; Kunz, P.L.; Chasen, B.; Capdevila Castillon, J.; Tafuto, S.; Oh, D-Y.; Yoo, C.; Falk, S.; Halfdanarson, T.R.; Folitar, I.; Zhang, Y.; de Herder, W.W.; Singh, S.

A multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study
ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S753

DOI
Sathekge, M.; Ndlovu, H.; Kabunda, J.; Mdlophane, A.; Ramonaheng, K.; Mdanda, S.; Shungube, M.; Mzizi, Y.; Qebetu, M.; Sebatana, R.; Mokoala, K.; Mashigoane, K.; Zane, K.; More, S.; Vorster, M.; Nasr, K.; Morley, T.; Kovacs, J.; Horton, J.; Herrmann, Ken

AKY-1189, a novel, first-in-class miniprotein radiopharmaceutical designed to deliver Actinium-225 (225Ac) to Nectin-4 expressing tumors with broad therapeutic applications in metastatic urothelial carcinoma (mUC) and other Nectin-4 expressing tumors
36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 23-25 October 2024, Barcelona, Spain,

In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 211, 2024, Nr. Supplement 1, S. S6 – S7

DOI
De Bono, Johann S.; Morris, Michael J.; Sartor, Oliver; Wei, Xiao X.; Fizazi, Karim; Herrmann, Ken; Piulats, Josep M.; Mahammedi, Hakim; Logothetis, Christopher; George, Daniel J.; Eldjerou, Lamis K.; Wong, Connie; Barys, Louise; Rajagopal, Nisha; Rodosthenous, Theodoulos; Chi, Kim N.

Baseline ctDNA analyses and associations with outcomes in taxane-naive patients with mCRPC treated with 177Lu-PSMA-617 versus change of ARPI in PSMAfore

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 5008

DOI (Open Access)
Herrmann, Ken; Gafita, Andrei; De Bono, Johann S.; Sartor, A. Oliver; Chi, Kim N.; Krause, Bernd J.; Rahbar, Kambiz; Tagawa, Scott T.; Czernin, Johannes; El-Haddad, Ghassan; Wong, Connie; Zhang, Zhaojie; Wilke, Celine; Mirante, Osvaldo; Morris, Michael J.; Fizazi, Karim

Building a predictive model for outcomes with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer using VISION data : Preliminary results

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 4, S. 208

DOI (Open Access)
Dörr, F.; Grapatsas, G.; Baldes, N.; Oezkan, F.; Theegarten, Dirk; Darwiche, Kaid; Eberhardt, Wilfried; Stuschke, Martin; Hautzel, H.; Herrmann, Ken; Taube, Christian; Forsting, Michael; Schuler, Martin; Bölükbas, S.

Deciphering Destiny : Is Curation of NSCLC Limited to Stage IA?

In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 19, 2024, Nr. Suppl. 10, S. S552
Singh, S.; Halperin, D.; Myrehaug, S.; Herrmann, Ken; Pavel, M.E.; Kunz, P.L.; Chasen, B.; Capdevila, J.; Tafuto, S.; Oh, D-Y.; Yoo, C.; Falk, S.; Halfdanarson, T.R.; Folitar, I.; Zhang, Y.; de Herder, W.W.; Ferone, D.

First-line efficacy of [177Lu]Lu-DOTA-TATE in patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors by tumor grade and primary origin: Subgroup analysis of the phase III NETTER-2 study
ESMO Gastrointestinal Cancers Congress 2024, 26-29 June 2024, Munich, Germany,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Supplement 1, S. S92 – S93

DOI
Chi, K.N.; Sartor, O.; Fizazi, K.; de Bono, J.S.; Shore, N.D.; Herrmann, Ken; Castellano Gauna, D.E.; Piulats Rodriguez, J.M.; Flechon, A.; Wei, X.X.; Kim, H.; Schweizer, M.; Alanee, S.; Ghebremariam, S.; Hertelendi, M.; Morris, M.J.

Haematologic impact of [177Lu]Lu-PSMA-617 versus ARPI change in patients with metastatic castration-resistant prostate cancer in PSMAfore
ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S972 – S973

DOI
Fizazi, Karim; Morris, Michael J.; Shore, Neal D.; Chi, Kim N.; Crosby, Michael; De Bono, Johann S.; Herrmann, Ken; Roubaud, Guilhem; Nagarajah, James; Fleming, Mark T.; Lewis, Brian E.; Nordquist, Luke; Castellano, Daniel; Carnahan, Natalie; Ghebremariam, Samson; Hertelendi, Marianna; Sartor, Oliver

Health-related quality of life and pain in a phase 3 study of [177Lu]Lu-PSMA-617 in taxane-naïve patients with metastatic castration-resistant prostate cancer (PSMAfore)

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 5003

DOI
Grapatsas, K.; Doerr, F.; Oezkan, F.; Baldes, N.; Darwiche, Kaid; Theegarten, Dirk; Eberhardt, Wilfried; Gauler, Thomas; Stuschke, Martin; Hautzel, H.; Herrmann, Ken; Taube, Christian; Forsting, Michael; Schuler, Martin; Bölükbas, S.

Impact of Preoperative Pulmonary Function on Survival Following Lobectomy for Stage I and II Lung Cancer

In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 19, 2024, Nr. Suppl. 10, S. S531
Fendler, Wolfgang; Karpinski, M.; Hüsing, J.; Claassen, K.; Kajüter, H.; Oesterling, F.; Grünwald, Viktor; Umutlu, Lale; Telli, T.; Merkel-Jens, A.; Huesing, A.; Kesch, C.; Hoberück, S.; Meyer, P.; Kind, F.; Rahbar, K.; Schäfers, M.; Stang, Andreas; Herrmann, Ken; Hadaschik, Boris

PSMA-PET and PROMISE re-define stage and risk in patients with prostate cancer
ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S971

DOI
Djaileb, Loic; Armstrong, Wesley Robert; Thompson, Daniel; Gafita, Andrei; Farolfi, Andrea; Cooperberg, Matthew R.; Carroll, Peter; Washington, Samuel L.; Reiter, Robert Evan; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang P.; Czernin, Johannes; Hope, Thomas A.; Calais, Jeremie

Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment : A surrogate of pelvic lymph node dissection? ; Follow-up analysis of a multicenter prospective phase 3 imaging trial
2024 ASCO Genitourinary Cancers Symposium, January 25–27, 2024, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Supplement 4, S. 285 – 285

DOI
Fendler, Wolfgang; Karpinski, Madeleine J.; Hüsing, Johannes; Claassen, Kevin; Möller, Lennart; Kajüter, Hiltraud; Oesterling, Florian; Grünwald, Viktor; Umutlu, Lale; Lanzafame, Helena; Telli, Tugce; Merkel-Jens, Anja; Hüsing, Anika; Kesch, Claudia; Herrmann, Ken; Stang, Andreas; Hadaschik, Boris A.

Prognostic PSMA-PET PROMISE nomograms for patients with prostate cancer

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 5016

DOI
Kunz, Pamela L.; Ferone, Diego; Halperin, Daniel M.; Myrehaug, Sten; Herrmann, Ken; Pavel, Marianne; Chasen, Beth; Capdevila, Jaume; Tafuto, Salvatore; Oh, Do-Youn; Yoo, Changhoon; Falk, Stephen; Halfdanarson, Thorvardur Ragnar; Folitar, Ilya; Zhang, Yufen; de Herder, Wouter W.; Singh, Simron

Safety and time to response of [177Lu]Lu-DOTATATE in patients with newly diagnosed advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors : Sub-analysis of the phase 3 randomized NETTER-2 study

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 4131

DOI (Open Access)
Fizazi, K.; Morris, M.J.; Shore, N.D.; Chi, K.N.; Crosby, M.; de Bono, J.S.; Herrmann, Ken; Roubaud, G.; Nagarajah, James; Fleming, M.T.; Lewis, B.; Nordquist, L.T.; Castellano Gauna, D.E.; Carnahan, N.; Ghebremariam, S.; Hertelendi, M.; Sartor, O.

Symptomatic skeletal events, health-related quality of life and pain in a phase III study of [177Lu]Lu-PSMA-617 in taxane-naive patients with PSMA-positive metastatic castration-resistant prostate cancer : Third interim analysis of PSMAfore
ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S964 – S965

DOI
Grapatsas, K.; Dörr, F.; Oezkan, F.; Baldes, N.; Theegarten, Dirk; Darwiche, Kaid; Eberhardt, Wilfried; Gauler, Thomas; Stuschke, Martin; Hautzel, H.; Herrmann, Ken; Taube, Christian; Forsting, Michael; Schuler, Martin; Bölükbas, S.

The Influence of Smoking on Morbidity and Early Mortality after Anatomical Lung Resections for Stage I-IIIA NSCLC

In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 19, 2024, Nr. Suppl. 10, S. S143 – S144
Oster, Christoph; Kessler, Lukas; Blau, Tobias; Keyvani, Kathy; Pabst, Kim M; Fendler, Wolfgang P.; Fragoso Costa, Pedro; Lazaridis, Lazaros; Schmidt, Teresa; Feldheim, Jonas; Pierscianek, Daniela; Schildhaus, Hans-Ulrich; Sure, Ulrich; Ahmadipour, Yahya; Kleinschnitz, Christoph; Guberina, Nika; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin

The Role Of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison Of Tissue, 68ga-Fapi-46 Positron Emission Tomography and Survival Data
29th Annual Meeting and Education Day of the Society for Neuro-Oncology, November 21-24, 2024, Houston, TX, USA,

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 8, S. viii196 – viii197

DOI
Oster, C; Kessler, Lukas; Blau, T; Keyvani, Kathy; Pabst, K; Fendler, Wolfgang; Fragoso Costa, Pedro; Lazaridis, L; Schmidt, T; Feldheim, J; Pierscianek, D; Schildhaus, H; Sure, Ulrich; Ahmadipour, Y; Kleinschnitz, Christoph; Guberina, N; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin

The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, 68GA-FAPI-46 Positron Emission Tomography and Survival Data
19th Meeting of the European Association of Neuro-Oncology (EANO 2024), October 17-20, 2024, Glasgow, UK,

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 5, S. v25 – v25

DOI
de Herder, W. W.; Halperin, D.; Myrehaug, S.; Herrmann, Ken

[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors : Primary analysis of the phase 3 randomised NETTER-2 study

In: Journal of Neuroendocrinology: Wiley, Jg. 36, 2024, Nr. Suppl. 1, S. 203
Singh, Simron; Halperin, Daniel M.; Myrehaug, Sten; Herrmann, Ken; Pavel, Marianne; Kunz, Pamela L.; Chasen, Beth; Capdevila, Jaume; Tafuto, Salvatore; Oh, Do-Youn; Yoo, Changhoon; Falk, Stephen; Halfdanarson, Thorvardur Ragnar; Folitar, Ilya; Zhang, Yufen; Santoro, Paola; Aimone, Paola; de Herder, Wouter W.; Ferone, Diego

[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors : Primary analysis of the phase 3 randomized NETTER-2 study

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 3, LBA588

DOI
Bartel, Timo; Fendler, Wolfgang; Pabst, Kim; Hirmas, Nader; Umutlu, Lale; Grafe, Hong; Praus, Christine; Nader, Michael; Podleska, Lars; Barbato, Francesco; Siveke, Jens; Herrmann, Ken; Grünwald, Viktor; Hamacher, Rainer

68Ga-FAPI-46 PET for imaging of FAP expressing cancer - interim findings from a single-center prospective interventional single-arm clinical trial
55th Annual Conference of the Society of Nuclear Medicine (SNMICON), November 16-19, 2023, Jodhpur, India,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P706
Kersting, David; Lazaridis, Lazaros; Barbato, Francesco; Kebir, Sied; Kümmel, Sherko; Welt, Anja; Umutlu, Lale; Milosevic, Aleksandar; Nader, Michael; Fragoso Costa, Pedro; Schmidt, T.; Oster, Christoph; Deuschl, Cornelius; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Hautzel, Hubertus; Schuler, Martin; Glas, Martin; Fendler, Wolfgang; Herrmann, Ken

68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S265

DOI
Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Özkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, H.

68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer Patients

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 – S489

DOI
Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bolukbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus

68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer Patients

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P165
Serani, Francesca; Castellucci, Paolo; Fendler, Wolfgang; Barbato, Francesco; Herrmann, Ken; Farolfi, Andrea

A retrospective multicenter analysis of the incidence of bone only disease at PSMA PET/CT in Castration Resistant Prostate Cancer (CRPC) patients
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P299
Hautzel, Hubertus; Özkan, Filiz; Laschinsky, Christina; Kersting, David; Opitz, Marcel; Theegarten, Dirk; Darwiche, Kaid; Herrmann, Ken

Added diagnostic sensitivity of MTV and TLG in the assessment of left adrenal gland metastasis in lung cancer with [18F]FDG PET/CT
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S485

DOI
Handke, A.; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Y.; Hakansson, A.; Davicioni, E.; Hughes, J.; Song, H.; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert

Analysing the Tumour Transcriptome of Prostate Cancer to Predict Efficacy of Lu-PSMA Therapy
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S180

DOI
Gafita, A.; Djaileb, L.; Rauscher, I.; Hadaschik, Boris; Herrmann, Ken; Weber, Manuel

Assessment of Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-Resistant Prostate Cancer
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S544 – S545

DOI
Kuo, P.H.; Morris, M.; Kendi, A.T.; Herrmann, Ken

Association of baseline quantitative [68Ga]Ga-PSMA-11 PET imaging parameters with clinical outcomes in patients with mCRPC receiving [177Lu]Lu-PSMA-617 : a VISION sub-study
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S155

DOI
Oster, Christoph; Blau, Tobias; Keyvani, Kathy; Schmidt, Teresa; Lazaridis, Lazaros; Agkatsev, Sarina; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Barbato, Francesco; Herrmann, Ken; Kebir, Sied; Glas, Martin

Fet pet sensitivity in primary brain tumors according to cns who 2021 : value and pitfalls in presurgical implementation

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v204 – v205

DOI
Pabst, Kim; Hamacher, Rainer; Schaarschmidt, Benedikt; Kessler, Lukas; Cheung, Phyllis; Liffers, Sven-Thorsten; Miera, Monika; Kostbade, Karina; Lanzafame, Helena; Mavroeidi, Ilektra; Hirmas, Nader; Costa, Pedro Fragoso; Nader, Michael; Bartel, Timo; Schuler, Martin; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Schildhaus, Hans-Ulrich; Fendler, Wolfgang

Fibroblast activation protein alpha (FAPα) directed imaging and radioligand therapy in patients with solitary fibrous tumor (SFT)
55th Annual Conference of the Society of Nuclear Medicine (SNMICON), November 16-19, 2023, Jodhpur, India,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P714
Unterrainer, L.; Hope, T. A.; Ndlovu, H.; Barbato, Francesco; Fendler, Wolfgang; Herrmann, Ken; Sathekge, M.; Czernin, J.; Calais, J.

From CHAARTED low- and high-volume disease to PSMA PET imaging volume in mHSPC patients : an international multicenter retrospective study
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S230 – S231

DOI
Watanabe, Masao; Grafe, Hong; Hirmas, N.; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim; Nader, Michael; Siveke, Jens T.; Fendler, Wolfgang P.; Herrmann, Ken; Weber, Manuel

Head-to-head comparison of68Ga-FAPI46 PET/CT,18F-FDG PET/CT, and contrast- enhanced CT in patient with various solid tumors
Annual Congress of the European Association of Nuclear Medicine, 9-13 September, 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S166 – S167

DOI
Pedro, Costa Fragoso; Darr, Christopher; Moraitis, Alexandros; Kahl, T.; Engel, J.; Al-Nader, Mulham; Henning, Monika; Köllermann, J.; Kesch, Claudia; Krafft, Ulrich; Maurer, T.; Köhler, D.; Klutmann, S.; Falkenbach, F.; Kleesiek, Jens; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris

Improving radical prostatectomy with intraoperative ex-vivo PSMA-PET/CT imaging
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S586

DOI
Farolfi, A.; Armstrong, W.; Djaileb, L.; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken

Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. Suppl. 1, S. S92

DOI
Farolfi, Andrea; Armstrong, Wesley; Djaileb, Loic; Gafita, Andrei; Hotta, Masatoshi; Auerbach, Martin; Fendler, Wolfgang; Rettig, Matthew; Eiber, Matthias; Hofman, Michael; Hadaschik, Boris; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie; Benz, Matthias

Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P843
Darr, Christopher; Fragoso Costa, Pedro; Kahl, T.; Alexandros, M.; Fendler, Wolfgang P.; Barbato, F.; Bartel, T.; Reis, H.; Köllermann, J.; Pullen, L.; Kesch, C.; Krafft, Ulrich; Kleesiek, Jens; Herrmann, Ken; Hadaschik, Boris A.

Intraoperative microPET/CT imaging for PSMA-positive cancer foci in radical prostatectomy – feasibility study
38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,

In: European Urology. Amsterdam: Elsevier, Jg. 83, 2023, Nr. Supplement 1, S. S687

DOI
Guberina, Maja; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Richlitzki, Cedric; Plönes, Till; Guberina, Nika; Forsting, Michael; Herrmann, Ken; Gauler, Thomas; Hoffmann, Christian; Theegarten, Dirk; Darwiche, Kaid; Garcia, Alina Santiago; Stuschke, Martin; Schuler, Martin

Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S101 – S102

DOI (Open Access)
Siyanbola, R.; Coelho, Marta; Costa, Pedro Fragoso; Moraitis, Alexandros; Herrmann, Ken; Hautzel, Hubertus

Occupational Radiation exposure from PET/CT during patient positioning
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S150 – S150

DOI
Pabst, Kim; Hamacher, Rainer; Lanzafame, Helena; Mavroeidi, Ilektra-Antonia; Bartel, Timo; Nader, Michael; Bauer, Sebastian; Siveke, Jens T.; Weber, Manuel; Kersting, David; Jentzen, Walter; Ahrens, M.; Herrmann, Ken; Fragoso Costa, Pedro

Occurence of hematotoxic side effects during 90Y-FAPI-46 radioligand therapy (RLT) in patients with advanced metastatic tumor diseases
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S671

DOI (Open Access)
Oster, C; Blau, T; Keyvani, Kathy; Schmidt, T; Lazaridis, L; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Herrmann, Ken; Barbato, F; Kebir, Sied; Glas, Martin

P15.01.A FET PET Sensitivity in primary brain tumors according to CNS who 2021 : Value and pitfalls in presurgical implementation

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 2, S. ii109 – ii109

DOI, Online Volltext (Open Access)
Hammersen, N.; Jentzen, Walter; Stawitzki, F.; Herrmann, Ken; Kersting, David; Costa, P. Fragoso; Moraitis, Alexandros

PET Quantification Performance of the Oversize-Volume-of-Interest Approach in the Context of Tumour Dosimetry in Radionuclide Therapy Planning
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S363

DOI
Moraitis, Alexandros; Darr, Christopher; Kahl, T.; Püllen, Lukas; Jentzen, Walter; Kersting, David; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang; Costa, Pedro Fragoso

Performance Evaluation of 18F-PSMA and 68Ga-PSMA in a Novel MicroPET/CT System Dedicated to Radioguided Surgery
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S131

DOI
Sartor, O.; Castellano Gauna, D.E.; Herrmann, Ken; de Bono, J.S.; Shore, N.D.; Chi, K.N.N.; Crosby, M.; Piulats Rodriguez, J.M.; Flechon, A.; Wei, X.X.; Mahammedi, H.; Roubaud, G.; Ova, H.; Ghebremariam, S.; Kpamegan, E.; Kreisl, T.N.; Delgoshaie, N.; Lehnhoff, K.; Morris, M.J.; Fizazi, K.

Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S1324 – S1325

DOI
Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Calais, Jeremie; Rowe, Steven; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias; Farolfi, Andrea

Practical RECIP : Visual assessment of Response Evaluation Criteria In PSMA-PET/CT in metastatic castration-resistant prostate cancer
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P1619
Djaileb, Loic; Armstrong, Wesley; Gafita, Andrei; Herrmann, Ken; Fendler, Wolfgang; Carroll, Peter

Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: a surrogate of Pelvic Lymph Node Dissection? : Follow-up analysis of a Multicenter Prospective Phase 3 Imaging Trial
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P440
Leyser, Stephan; Lanzafame, Helena; Kersting, David; Seifert, Robert; Zarrad, Fadi; Lahner, Harald; Unger, Nicole; Fendler, Wolfgang; Herrmann, Ken; Weber, Manuel

Prognostic value of the post-treatment 177Lu-DOTATOC scintigraphy in NET patients undergoing PRRT
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S134

DOI
Fendler, Wolfgang; Seifert, Robert; Emmett, Louise; Herrmann, Ken; Hadaschik, Boris; Eiber, Matthias

Prostate Cancer Molecular Imaging Standardized Evaluation : The PROMISE V2 Framework Including Response Evaluation for Clinical Trials

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S150

DOI (Open Access)
Telli, Tugce; Seifert, Robert; Lapa, Constantin; Hekimsoy, T.; Weber, W.; Pfob, C.; Herrmann, Ken; Rahbar, K.; Eiber, M.; Fendler, Wolfgang

Safety and Efficacy of Extended 177Lu-PSMA Therapy: Multi-Center Retrospective Analysis
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S152

DOI
Jakstaite, A. Aiste Monika; Lüdike, Peter; Janosi, Rolf Alexander; Al-Rashid, Fadi; Carpinteiro, Alexander; Kersting, David; Kessler, Lukas; Rischpler, Christoph; Herrmann, Ken; Rassaf, Tienush; Papathanasiou, Maria

Screening for occult transthyretin amyloidosis in patients with degenerative aortic stenosis and amyloid red-flags

In: European Journal of Heart Failure. Oxford: Wiley, Jg. 25, 2023, Nr. Suppl. 2, S. 359 – 359
Lazaridis, Lazaros; Mönninghoff, Christoph; Bumes, Elisabeth; Spille, Dorothee Cäcilia; Müther, Michael; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin

Temporal muscle thickness as a prognostic marker in a real-life cohort of newly diagnosed MGMT promoter methylated glioblastoma patients : a multicentric imaging analysis

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v192 – v193

DOI
Seifert, Robert; Emmett, L.; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang

The Updated Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE V2.0) Framework for Standardized Reporting of PSMA-PET
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S177

DOI
Lanzafame, H.; Hirmas, N.; Schuler, Martin; Darwiche, Kaid; Eberhardt, Wilfried E. E.; Aigner, Clemens; Stuschke, Martin; Kessler, Lukas; Pabst, K. M.; Barbato, F.; Rischpler, Christoph; Hautzel, H.; Herrmann, Ken; Fendler, Wolfgang

68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S107

DOI (Open Access)
Halfdanarson, T.R.; Halperin, D.; Reidy-Lagunes, D.; Kong, G.; Mailman, J.; Herrmann, Ken; Sri Rajaskanthan, R.; Leyden, S.; Capdevila Castillon, J.; Sierras, C.; Harris, P.

902TiP COMPOSE : Pivotal phase III trial to compare 177Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumours
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO),

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Suppl. 7, S. S960

DOI (Open Access)
Weber, Manuel; Pettersson, O.; Seifert, R.; Schaarschmidt, B. M.; Fendler, Wolfgang P.; Rischpler, Christoph; Lahner, Harald; Herrmann, Ken; Sundin, A.

Changes in Tumor-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S80

DOI (Open Access)
Schmidt, T; Agkatsev, S; Feldheim, J; Oster, C; Blau, T; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, C; Scheffler, Björn; Kebir, S; Glas, M; Lazaridis, L

Combination of Trofosfamide and Etoposide in Recurrent Glioma

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 24, 2022, Nr. Suppl. 2, S. ii89 – ii89

DOI (Open Access)
Herrmann, Ken; Rahbar, Kambiz; Eiber, Matthias; Krause, Bernd J.; Lassmann, Michael; Jentzen, Walter; Blumenstein, Lars; Klein, Patrick; Basque, Jean-René; Kurth, Jens

Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : Results from the VISION trial sub-study

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. Suppl. 6, 97

DOI (Open Access)
Sandach, Patrick; Seifert, R.; Darwiche, Kaid; Funke, Faustina; Maier, S. C.; Herrmann, Ken; Hautzel, H.

EBUS-TBNA within 8 days prior to (18)FDG PET/CT affects (18)FDG uptake in mediastinal and hilar lymph nodes of patients during staging for lung cancer
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S166

DOI (Open Access)
Hautzel, H; Bartel, T; Darwiche, Kaid; Aigner, Clemens; Taube, Christian; Herrmann, Ken

Efficacy estimation of filter pads in expiratory filter/valve sets by means of Tc-99m-labeled graphite aerosol

In: European Respiratory Journal (ERJ). Sheffield: European Respiratory Society, Jg. 60, 2022, Nr. Suppl. 66, 1793

DOI
Pabst, K. M.; Fendler, Wolfgang P.; Hadaschik, Boris; Kesch, C.; Hirmas, N.; Kessler, Lukas; Grünwald, Viktor; Hamacher, R.; Nader, M.; Berliner, C.; Umutlu, Lale; Püllen, Lukas; Herrmann, Ken; Lückerath, Katharina; Castellucci, P.; Fanti, S.; Mei, R.

FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S118 – S119

DOI (Open Access)
Herrmann, Ken; Krause, B. J.; Rahbar, K.; Chi, K. N.; Morris, M. J.; Sartor, O.; Tagawa, S. T.; Kendi, A. T.; Vogelzang, N.; Calais, J.; Nagarajah, James; Wei, X. X.; Koshkin, V.; Beauregard, J.; Chang, B.; DeSilvio, M.; Messmann, R. A.; de Bono, J.; Fizazi, K.

Health-related quality of life (HRQoL), pain and safety outcomes in the phase 3 VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S55 – S56

DOI (Open Access)
Singh, Simron; Pavel, Marianne; Kunz, Pamela L.; de Herder, Wouter; Herrmann, Ken; D'Amelio, Anthony M., Jr.; Santoro, Paola; Folitar, Ilya; Ferone, Diego

Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) : The NETTER-2 Study
14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society: 2021 Multidisciplinary NET Medical Symposium, November 4-6, 2021, Chicago, Virtual,

In: Pancreas. Hagerstown: Lippincott Williams & Wilkins, Jg. 51, 2022, Nr. 3, Abstracts Presented at the 14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society, November 4-6, 2021, S. E58 – E58

DOI (Open Access)
Gafita, A.; Rauscher, I.; Fendler, Wolfgang; Murthy, V.; Hui, W.; Armstrong, W.; Herrmann, Ken; Weber, W.; Calais, J.; Eiber, M.; Weber, Manuel; Benz, M.

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT : Comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S267

DOI (Open Access)
Voltin, C.; Gödel, P.; Beckmann, L.; Heger, J.; Kobe, C.; Kutsch, N.; Borchmann, P.; Dietlein, M.; Herrmann, Ken; Stelljes, M.; Rahbar, K.; Lenz, G.; Reinhardt, Hans Christian; Teichert, M.; Noppeney, Richard; Albring, J. C.; Seifert, R.; von Tresckow, Bastian; Floßdorf, S.; Hanoun, Christine

Metabolic Tumor Volume for Outcome Prediction in Patients with Large B-Cell Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Treatment
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S211

DOI (Open Access)
Kurth, J.; Rahbar, K.; Eiber, M.; Sparks, R.; Baca, N.; Krause, B. J.; Lassmann, M.; Jentzen, Walter; Chicco, D.; Klein, P.; Blumenstein, L.; Basque, J.; Herrmann, Ken

Multi-cycle dosimetry of [Lu-177]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : results from the VISION trial sub-study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S129

DOI (Open Access)
Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.R.; Tauber, R.; Grogan, T.R.; Czernin, J.; Rettig, M.B.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.R.; Fendler, Wolfgang; Eiber, M.

Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : An international multicenter study
EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,

In: European Urology. Amsterdam: Elsevier, Jg. 81, 2022, Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S794 – S795

DOI
Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.; Tauber, R.; Grogan, T.; Czernin, J.; Rettig, M.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.; Fendler, Wolfgang; Eiber, M.

Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S269

DOI (Open Access)
Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley Robert; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias; Fendler, Wolfgang; Eiber, Matthias

Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
2022 ASCO Genitourinary Cancers Symposium, 17.-19.02.2022, San Fransisco,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 40, 2022, Nr. 6, Supplement: 2022 ASCO Genitourinary Cancers Symposium, jnumed.121.263072

DOI (Open Access)
Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias

Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. Suppl. 6, 42

DOI, Online Volltext (Open Access)
Herrmann, Ken; Garin, E.; Fowers, K.; Salem, R.; Lam, M.

Observer Reproducibility in the Calculation of Yttrium-90 Absorbed Dose in Patients with Hepatocellular Carcinoma : The Round Robin Sub-Study of The Global Retrospective TARGET Study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S62

DOI (Open Access)
Fendler, Wolfgang; Ferdinandus, J.; Farolfi, A.; Washington, S.; Mohamad, O.; Pampaloni, M.; Scott, P.; Rodnick, M.; Viglianti, B.; Eiber, M.; Herrmann, Ken; Czernin, J.; Armstrong, W.; Calais, J.; Hope, T.; Piert, M.

PSMA PET disease extent for European Association of Urology biochemical recurrence risk groups : An international multicentre study
EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,

In: European Urology. Amsterdam: Elsevier, Jg. 81, 2022, Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S291

DOI
Civan, C.; Kasper, Stefan; Berliner, C.; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, M.; Schaarschmidt, B. M.; Lang, Stephan; Kersting, David; Nader, M.; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel

PSMA-directed imaging and therapy of salivary gland tumors : a single-center retrospective study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S229

DOI (Open Access)
Coelho, M.; Fragoso Costa, P.; Herrmann, Ken; Hautzel, H.

Pulmonary right-to-left shunt estimation with (99)mTc-labeled macroaggregated albumin (MAA) : Establishing a normal range with correction for unbound (99)mTc
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S93 – S94

DOI (Open Access)
Moraitis, A.; Reiter, G.; Kersting, David; Weber, Manuel M.; Fendler, Wolfgang P.; Herrmann, Ken; Fragoso Costa, P.; Jentzen, Walter

Radiation Exposure of I-124-MIBG Imaging in Adult Patients with Neuroendocrine Tumours
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S36 – S37

DOI (Open Access)
Hope, T.A.; Eiber, M.; Armstrong, W.R.; Juarez, R.; Murthy, V.; Lawhn-Heath, C.; Behr, S.C.; Zhang, L.; Barbato, F.; Ceci, F.; Farolfi, A.; Schwarzenbock, S.M.; Unterrainer, M.; Zacho, H.D.; Nguyen, H.G.; Cooperberg, M.R.; Carroll, P.R.; Reiter, R.E.; Holden, S.; Herrmann, Ken; Zhu, S.; Fendler, Wolfgang; Czernin, J.; Calais, J.

Re: Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging Trial

In: The Journal of Urology. Philadelphia; Hagerstown, Md.: Lippincott Williams & Wilkins, Jg. 207, 2022, Nr. 4, S. 930

DOI
Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin

Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 198, 2022, Nr. Supplement 1, S. S15

DOI (Open Access)
Hamacher, R.W.; Pabst, K.M.; Kessler, Lukas; Costa, Pedro Fragoso; Ferdinandus, J.; Weber, Manuel; Lippert, M.; Lückerath, Katharina; Hirmas, N.; Kostbade, K.; Mavroeidi, I.A.; Schuler, Martin H. H.; Ahrens, M.; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens T.; Fendler, Wolfgang P.

Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
ESMO Congress 2022, 9 - 13 September 2022, Paris, France,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1231 – S1232

DOI (Open Access)
Pabst, K. M.; Trajkovic-Arsic, M.; Cheung, P. F.; Kessler, Lukas; Hirmas, N.; Nader, M.; Bartel, T.; Schaarschmidt, B. M.; Kasper, Stefan; Siveke, Jens T.; Hamacher, R.; Schmidt, H. H. J.; Ingenwerth, M.; Herrmann, Ken; Fendler, Wolfgang P.

Superiority of [68Ga]Ga-FAPI-46 over [18F]F-FDG PET/CT for cholangiocarcinoma imaging
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S192 – S193

DOI (Open Access)
Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Grünwald, Viktor; von Tresckow, Bastian; Hanoun, Christine; Aigner, Clemens; Glas, Martin; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.

Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S119 – S120

DOI (Open Access)
Tagawa, Scott T.; Armstrong, Andrew J.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; De Bono, Johann S.; Adra, Nabil; Desilvio, Michelle; Messmann, Richard; Holder, Geoffrey; Chi, Kim N.

Tolerability of [¹⁷⁷Lu]Lu-PSMA-617 by treatment exposure in patients with metastatic castration-resistant prostate cancer (mCRPC) : A VISION study subgroup analysis

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. 16_Suppl., S. 5047

DOI
Liu, S.; Planchard, D.; Herrmann, Ken; D'Amelio, A.; Folitar, I.; Ares, L. Paz

Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer

In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 17, 2022, Nr. 9, S. 534

DOI
Myrehaug, Sten; Singh, Simron; Pavel, Marianne; Kunz, Pamela; de Herder, Wouter; Herrmann, Ken; D’Amelio, Anthony; Santoro, Paola; Folitar, Ilya; Ferone, Diego

[177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS) : The NETTER-2 Study

In: Radiotherapy and Oncology (The Green Journal). Amsterdam: Elsevier, Jg. 174, 2022, Nr. Suppl. 1, S. 40 – S41

DOI
Kessler, Lukas; Ferdinandus, J.; Costa, P. F.; Weber, Manuel; Hirmas, N.; Kostbade, K.; Bauer, Sebastian; Dirksen, U.; Zarrad, F.; Nader, M.; Grafe, Hong; Chodyla, M.; Milosevic, A.; Umutlu, Lale; Schuler, Martin; Ahrens, M.; Podleska, Lars E.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.; Hamacher, R.

A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,

In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 11 – 12

DOI (Open Access)
Christoph, Daniel; Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Peter; Umutlu, Lale; Aigner, Clemens; Kambartel, Karl-Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang; Herrmann, Ken; Faehling, Martin

Complete metabolic response in advanced non-small cell lung cancer patients with prolonged response to immune checkpoint inhibitor therapy

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 15_Suppl, S. 9050 – 9050

DOI (Open Access)
Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang P.; Eiber, M.

Development of a novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
EANM‘21 ; 34th Annual Congress of the European Association of Nuclear Medicine ; October 20-23, 2021, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. S311 – S312

DOI (Open Access)
Kersting, David; Sraieb, Miriam; Seifert, Robert; Costa, Pedro Fragoso; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Jentzen, Walter; Herrmann, Ken; Rischpler, Christoph

Dynamic Ga-68-DOTA PET/CT and Compartmental Modelling to Non-invasively Estimate the Glomerular Filtration Rate

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. Suppl. 1, 88

Online Volltext
Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin

EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 142
Maric, I.; Weber, Manuel; Jentzen, Walter; Schmitz, Jochen; Unger, Nicole; Poeppel, T. D.; Prochnow, A.; Herrmann, Ken; Fendler, Wolfgang

Efficacy and safety of 124-I-MIBG guided high activity 131-I-MIBG therapy of metastatic pheochromocytoma and neuroblastoma

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 290 – S291
Kersting, David; Sraieb, Miriam; Seifert, Robert; Fragoso Costa, Pedro; Kazek, S.; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Jentzen, Walter; Herrmann, Ken; Rischpler, Christoph

Evaluation of Dynamic Renal Ga-68-DOTA PET/CT to Monitor the Urinary Efflux and to Estimate the Glomerular Filtration Rate Using a Compartmental Kinetic Modelling Approach

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 340
Ferdinandus, Justin; Maríc, Ines; Darr, Christopher; Kesch, Claudia; Hilser, Thomas; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor

FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. Suppl. 15, S. e16564

DOI (Open Access)
Kessler, Lukas; Hamacher, Rainer; Ferdinandus, Justin; Zarrad, Fadi; Hirmas, Nader; Schildhaus, Hans-Ulrich; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang

Ga-68-FAPI for sarcoma imaging : Data from the FAPI-PET prospective observational trial
2021 SNMMI Annual Meeting, June 11th to June 15th, 2021, virtual,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. Suppl. 1, 126

Online Volltext
Fragoso Costa, Pedro; Püllen, Lukas; Klose, J. M.; Iking, J.; Sandach, Patrick; Staniszewska, M.; Herrmann, Ken; Radtke, J. P.; Tschirdewahn, Stephan; Hadaschik, Boris; Fendler, Wolfgang; Darr, Christopher

Ga-68-versus F-18-PSMA for Cerenkov Luminescence and autoradiography in a prostate cancer mouse model
EANM‘21, Annual Congress of the European Association of Nuclear Medicine, October 20-23, 2021, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. S17

DOI (Open Access)
Fizazi, K.; Herrmann, Ken; Krause, B.J.; Rahbar, K.; Chi, K.N.; Morris, M.J.; Sartor, O.; Tagawa, S.T.; Kendi, A.T.; Vogelzang, N.J.; Calais, J.; Nagarajah, James; Wei, X.X.; Koshkin, V.S.; Beauregard, J-M.; Chang, B.; DeSilvio, M.; Messmann, R.A.; de Bono, J.

Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. 627 – S628

DOI (Open Access)
Ferdinandus, J.; Fragoso Costa, Pedro; Kessler, Lukas; Weber, Manuel; Hirmas, N.; Kostbade, Karina; Bauer, Sebastian; Schuler, Martin; Ahrens, M.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.; Hamacher, R.

Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumors
Annual Congress of the European Association of Nuclear Medicine, October 20-23, 2021, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. S290

DOI (Open Access)
Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R; Tauber, Robert; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias

Interim PSMA PET/CT for response evaluation during LuPSMA treatment in mCRPC (INTERIM PET) : An explorative, multicenter study

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 15_Suppl, S. 5066 – 5066

DOI (Open Access)
Hadaschik, Boris; Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang

Nomograms to predict outcome after LuPSMA radionuclide therapy in men with metastatic castration-resistant prostate cancer : An international multicenter retrospective study

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 63 – S64
Fendler, Wolfgang; Golfieri, R.; Herrmann, Ken

PSMA PET and radiomics for the evaluation of liver metastases in castration-resistant prostate cancer patients : A multicenter retrospective study

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 234
Palmedo, H.; Ahmadzadehfar, H.; Eschmann, S.; Selkinski, I.; Straube, F.; Niesen, A.; Schönberger, J.; Barsegian, V.; Liepe, K.; Mottaghy, F.M.; Guan, R.; Pinkert, J.; Buetikofer, S.; Herrmann, Ken

Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. 641

DOI (Open Access)
Herrmann, Ken

Pain response and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) : Final results from a prospective, noninterventional study (PARABO)

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 313 – S314
Herrmann, Ken

Phase 3 Study of Lu-177-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (VISION)

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 63
Calais, Jeremie; Zhu, Shaojun; Hrimas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study Protocol
AACR Annual Meeting 2021, April 10-15, 2021 and May 17-21, 2021, Philadelphia, PA, USA,

In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 81, 2021, Nr. Suppl. 13, CT257

DOI
Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar Upadhyaya; Nickols, Nicholas George; Elashoff, David; Fendler, Wolfgang

Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study protocol NCT04457245
2021 Genitourinary Cancers Symposium, 11 - 13 Feb 2021, online,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 6, Supplement, S. TPS172

DOI (Open Access)
Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H.; Beer, Tomasz M.; Pérez-Contreras, Wendy J; Desilvio, Michelle; Kpamegan, Euloge E.; Gericke, Germo; Messmann, Richard Adam; Krause, Bernd J.; Sartor, A. Oliver

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 18_suppl, S. LBA4 – LBA4

DOI (Open Access)
Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin

Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the Esophagus

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 154 – S155
Mulcahy, M.F.; Salem, R.; Mahvash, A.; Pracht, M.; Montazeri, A.H.; Bandula, S.; Herrmann, Ken; Brown, E.; Zuckerman, D.; Wilson, G.; Kim, T-Y.; Weaver, A.; Ross, P.; Harris, W.P.; Johnson, M.S.; Sofocleous, C.T.; Padia, S.A.; Lewandowski, R.J.; Garin, E.; Sinclair, P.

Radioembolization with chemotherapy for colorectal liver metastases : A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
ESMO Congress 2021 ; 16 – 21 September 2021, online,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. S1295

DOI (Open Access)
Kupusovic, J.; Kessler, Lukas; Ferdinandus, J.; Hirmas, N.; Fendler, Wolfgang; Totzeck, Matthias; Herrmann, Ken; Wakili, Reza; Rischpler, Christoph; Rassaf, Tienush; Siebermair, Johannes

Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI-PET

In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 42, 2021, Nr. Supplement_1, ehab724.0255

DOI (Open Access)
Weber, M.; Koenen, J.; Deuschl, C.; Bechrakis, Nikolaos E.; Herrmann, Ken; Eckstein, Anja; Binse, Ina; Oeverhaus, M.

18F-FDG -PET/MRI in patients with Graves’ orbitopathy
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S251 – S252

DOI (Open Access)
Lazaridis, Lazaros; Kebir, Sied; Weber, Manuel; Schmidt, Teresa; Keyvani, Kathy; Pierscianek, Daniela; Stuschke, Martin; Antoch, Gearald; Forsting, Michael; Sure, Ulrich; Kleinschnitz, Christoph; Herrmann, Ken; Umutlu, Lale; Deuschl, Cornelius; Glas, Martin

18F-Fluorethyltyrosine positron emission tomography versus magnetic resonnace spectroscopy in preoperative detection of newly diagnosed gliomas by using machine learning

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 22, 2020, Nr. Supplement 2, S. ii149

DOI, Online Volltext (Open Access)
Calais, Jeremie; Armstrong, Wesley R.; Murthy, Vishnu; Heath, Courtney Lawhn; Behr, Spencer; Barbato, Francesco; Ceci, Francesco; Farolfi, Andrea; Schwarzenboeck, Sarah; Unterrainer, Marcus; Zacho, Helle; Cooperberg, Matthew R.; Nguyen, Hao Gia; Reiter, Robert Evan; Holden, Stuart; Herrmann, Ken; Fendler, Wolfgang; Eiber, Matthias; Czernin, Johannes; Hope, Thomas A.

Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection : A multicenter prospective phase III imaging study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S209

DOI (Open Access)
Kersting, David; Weber, M.; Sraieb, Miriam; Fragoso Costa, P.; Umutlu, Lale; Rischpler, Christoph; Fendler, Wolfgang; Conti, M.; Herrmann, Ken; Jentzen, Walter

Comparison of Lesion Detectability and Image Quality among Digital and Analog PET Systems for Recurrence in Thyroid Cancer Patients Using I-124
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S429

DOI (Open Access)
Kersting, David; Weber, Manuel; Berger, Alexander; Sraieb, Miriam; Fragoso Costa, Pedro; Umutlu, Lale; Rischpler, Christoph; Fendler, Wolfgang; Conti, Maurizio; Herrmann, Ken; Jentzen, Walter

Digital high sensitivity I-124 PET/CT improves the detectability of thyroid cancer metastases
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July, 11-14, 2020, Virtual,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 255

Online Volltext (Open Access)
Decker, Thomas; Seifert, R.; Tewes, Mitra; Heuschmid, M.; Welt, Anja; Herrmann, Ken

Early metabolic evaluation using F-18-FDG PET/CT might help to identify patients who benefit from treatment with cdk4/6 inhibitors
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,

In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 121 – 122

DOI (Open Access)
Baraliakos, X.; Tsiami, S.; Rischpler, Christoph; Bruckmann, N. M.; Fendler, Wolfgang; Kirchner, J.; Herrmann, Ken; Sawicki, L.; Braun, J.

Effects of anti-TNF-therapy on osteoblastic activity in ankylosing spondylitis : Results from a prospective study using PET-MRI of SIJ and SPINE
EULAR: Annual European Congress of Rheumatology, 2020, 03.-06.06.2020, Frankfurt,

In: Annals of the Rheumatic Diseases (ARD). London: BMJ Publishing Group, Jg. 79, 2020, Nr. Suppl. 1, S. 1125 – 1126

DOI (Open Access)
Gafita, A.; Fendler, Wolfgang P.; Wang, H.; Sandhu, S.; Weber, Manuel; Esfandiari, R.; Calais, J.; Rauscher, I.; Rathke, H.; Tauber, R.; Delpassand, E. S.; Weber, W.; Herrmann, Ken; Czernin, J.; Eiber, M.; Hofman, M. S.; LuPSMA

Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S491

DOI (Open Access)
Gafita, Andrei; Fendler, Wolfgang Peter; Wang, Hui; Sandhu, Shahneen Kaur; Weber, Manuel; Esfandiari, Rouzbeh; Czernin, Johannes; Rathke, Hendrik; Rauscher, Isabel; Tauber, Robert; Desspahand, Ebrahim; Weber, Wolfgang A.; Herrmann, Ken; Calais, Jeremie; Eiber, Matthias; Hofman, Michael S.

Efficacy and safety of Lu ¹⁷⁷-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : A multicenter retrospective study
2020 ASCO Annual Meeting, May 29-31, 2020, Chicago, Ill., USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 38, 2020, Nr. Suppl. 15, e17543

DOI (Open Access)
Gafita, Andrei; Fendler, Wolfgang; Hui, Wang; Weber, Manuel; Herrmann, Ken; Hofman, Michael; et al.

Efficacy and safety of Lu-177-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective study
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), July 11-14, 2020, Virtual,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 1284

Online Volltext (Open Access)
Weber, Manuel; Hofferber, R.; Herrmann, Ken; Fendler, Wolfgang P.; Conti, M.; Wetter, A.; Kersting, David; Rischpler, Christoph; Jentzen, Walter; Fragoso Costa, Pedro

Evaluation of 68Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients using a Digital PET/CT Scanner
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S27

DOI (Open Access)
Kaddu-Mulindwa, D.; Altmann, B.; Held, G.; Angel, S.; Stilgenbauer, S.; Thurner, L.; Bewarder, Moritz; Schwier, M.; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Pöschel, Viola; Hellwig, Dirk

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL > 60 trials
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,

In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 55 – 56

DOI (Open Access)
Ferdinandus, Justin; Herrmann, Ken

Impact of(68)Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, S. 43
Guberina, Marko; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Herrmann, Ken; Theegarten, Dirk; Aigner, Clemens; Plones, Till; Gauler, Thomas; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Darwiche, Kaid; Stuschke, Martin

Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S143

DOI (Open Access)
Hautzel, H.; Plönes, T.; Darwiche, Kaid; Fendler, Wolfgang; Rischpler, Christoph; Theegarten, Dirk; Aigner, Clemens; Herrmann, Ken

Lymphonodular anthracosis in patients undergoing FDG PET/CT for initial lung cancer diagnostics and/or staging is a mayor pitfall : a comparison to the histological gold standard
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S565 – S566

DOI (Open Access)
Farolfi, Andrea; Ilhan, Harun; Gafita, Andrei; Barbato, Francesco; Weber, Manuel; Ferdinandus, Justin; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang; et al.

Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection employing PSMA-PET
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July, 11-14, 2020, Virtual,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 1270

Online Volltext (Open Access)
Calais, J.; Armstrong, W. R.; Gartmann, J.; Thin, P.; Nguyen, K.; Lok, V.; Gosa, L.; Slavik, R.; Dalhbom, M.; Herrmann, Ken; Eiber, M.; Fendler, Wolfgang P.; Czernin, J.

Overall survival after177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrateresistant prostate cancer : Post-hoc analysis of a prospective phase II trial
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S488

DOI (Open Access)
Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel

PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020, Virtual,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 243

Online Volltext (Open Access)
Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang P.; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel

PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S353

DOI (Open Access)
Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Ferdinandus, Justin; Nader, Michael; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang

PSMA-PET identifies PCWG3 target populations with high concordance however superior reproducibility when compared to conventional imaging
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), July 11-14, 2020, Virtual,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 1260

Online Volltext
Michel, Lars; Hendgen-Cotta, Ulrike B.; Mincu, Raluca I.; Helfrich, Iris; Korste, S; Mrotzek, Simone; Rischpler, C; Herrmann, Ken; Ugurel, Selma; Zimmer, Lisa; Coman, C; Ahrends, R; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias

Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,

In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 41, 2020, Nr. Supplement_2, S. 3260

DOI (Open Access)
Gafita, Andrei; Calais, Jeremie; Hui, Wang; Weber, Manuel; Rathke, Hendrik; Esfandiari, Rouzbeh; Armstrong, Wesley; Kratochwil, Clemens; Tauber, Robert; Delpassand, Ebrahim; Haberkorn, Uwe; Weber, Wolfgang; Herrmann, Ken; Hofman, Michael; Czernin, Johannes; Fendler, Wolfgang; Eiber, Matthias

Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer : an international multicentre retrospective study
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), July 11-14, 2020, Virtual,

In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 593

Online Volltext (Open Access)
Fragoso Costa, P.; Sonnenschein, W.; Binse, Ina; Fendler, Wolfgang P.; Herrmann, Ken; Grootendorst, M. R.; Krafft, Ulrich; Radtke, J. P.; Hadaschik, Boris; Darr, Christopher

Preliminary Investigations on Radiation Exposure in [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S212

DOI (Open Access)
Gafita, A.; Calais, J.; Wang, H.; Weber, Manuel; Rathke, H.; Kratochwil, C.; Esfandiari, R.; Armstrong, W. R.; Sandhu, S.; Tauber, R.; Delpassand, E. S.; Haberkorn, U.; Weber, W. A.; Herrmann, Ken; Czernin, J.; Hofman, M. S.; Fendler, Wolfgang; Eiber, M.

Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S487

DOI (Open Access)
Gafita, Andrei; Calais, Jeremie; Wang, Hui; Weber, Manuel; Rathke, Hendrik; Kratochwil, Clemens; Esfandiari, Rouzbeh; Armstrong, Wesley R; Sandhu, Shahneen Kaur; Tauber, Robert; Delpassand, Ebrahim; Haberkorn, Uwe; Weber, Wolfgang A; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S; Fendler, Wolfgang Peter; Eiber, Matthias

Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer
2020 ASCO Annual Meeting, May 29-31, 2020, Chicago, Ill., USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 38, 2020, Nr. 15, Suppl., 5548

DOI (Open Access)
Christoph, Daniel; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang P.; Kessler, Lukas; Pomykala, Kelsey L.; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Ferdinandus, Justin

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
ESMO Virtual Congress 2020, 19.-21.09- und 16.-18.10.2020,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Suppl. 4, S. S1076 – S1077

DOI (Open Access)
Guberina, M.; Stuschke, Martin; Eberhardt, Wilfried; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Dirk, T.; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph

Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,

In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 105, 2019, Nr. 1, Supplement, S. S146 – S147

DOI (Open Access)
Calais, Jeremie; Fendler, Wolfgang P.; Eiber, Matthias; Lassmann, Michael; Dahlbom, Magnus; Esfandiari, Rouzbeh; Gartmann, Jeannine; Nguyen, Kathleen; Thin, Pan; Lok, Vincent; Herrmann, Ken; Czernin, Johannes; Delpassand, Ebrahim

RESIST-PC phase 2 trial : 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancer
2019 ASCO Annual Meeting, May 31 - June 4, 2019, Chicago, Ill., USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 37, 2019, Nr. 15, 5028

DOI (Open Access)
Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Ziepert, Marita; Menhart, Karin; Grosse, Jirka; Angel, Stephanie; Stilgenbauer, Stephan; Pfreundschuh, Michael; Herrmann, Ken; Duehrsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Hellwig, Dirk; Poeschel, Viola

Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma
Konferenz 61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,

In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1, S. 2892 – 2892

DOI (Open Access)
Schreder, M.; Barrio, S. G.; Drozdov, I.; Matar, Samir; Herrmann, Ken; Einsele, H.; Kidd, M.; Modlin, I.; Kortüm, K. M.

A whole blood gene expression signature accurately diagnoses multiple myeloma and differentiates patients in remission from those with active and progressive disease
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,

In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 231

DOI (Open Access)
Fendler, Wolfgang; Calais, Jeremie; Gartmann, Jeannine; Nickols, Nicholas George; Reiter, Robert Evan; Rettig, Matthew; Hope, Thomas A.; Slavik, Roger; Gupta, Pawan; Quon, Andrew; Allen-Auerbach, Martin; Herrmann, Ken; Czernin, Johannes; Eiber, Matthias

Accuracy of 68Ga-PSMA11 PET/CT on recurrent prostate cancer : Preliminary results from a phase 2/3 prospective trial
2018 ASCO Annual Meeting, June 1-5, 2018, Chicago, Ill., USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. 15, Suppl., 5001

DOI (Open Access)
Weber, M.M.; Kebir, S.; Lazaridis, L.; Deuschl, C.; Stoppek, A.; Schmidt, T.; Boehm, J.; Christoph, M.; Scheffler, B.; Keyvani, Kathy; Sure, Ulrich; Kleinschnitz, Christoph; Pierscanek, D.; Glas, M.; Herrmann, Ken

Ascertaining F18 positron-emission tomography skill in glioma classification pursuant to the revised WHO classification 2016

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 354 – S355

DOI
Binse, Ina; Pokladek, J.; Weber, M.; Theurer, S.; Jentzen, Walter; Nagarajah, James; Herrmann, Ken; Görges, Rainer

BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid Carcinoma

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 551

DOI
Oernek, A.; Jentzen, Walter; Umutlu, Lale; Unger, Nicole; Kirchner, J.; Ruhlmann, Marcus; Herrmann, Ken; Ruhlmann, Verena

Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumors
Annual Congress of the European Association of Nuclear Medicine, EANM‘18, October 13 – 17, 2018, Düsseldorf, Germany,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. S65

DOI
Ceci, F.; Polverari, G.; Gartmann, J.; Fendler, Wolfgang; Eiber, M.; Herrmann, Ken; Czernin, J.; Calais, J,

Comparison of 68Ga-PSMA-11 PET/CT and F-18-Fluciclovine PET/CT in recurrent Prostate Cancer
Annual Congress of the European Association of Nuclear Medicine, October 13 – 17, 2018 Düsseldorf, Germany,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. S150

DOI
Happel, C.; Bockisch, Andreas; Sabet, A.; Kranert, W.T.; Grünwald, F.; Herrmann, Ken

Correction of radiation induced stunning (CRIS) in pretherapeutic radioiodine-131 uptake test of patients suffering from goiter

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 420

DOI
Martin, O.; Kirchner, J.; Heusch, P.; Antoch, G.; Herrmann, Ken; Umutlu, Lale; Sawicki, L.

Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRI

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 176

DOI
Kip, A.; Heskamp, S.; Franssen, G. M.; Frielink, C.; Fracasso, G.; Herrmann, Ken; Gotthardt, M.; Rijpkema, M.; Lutje, S.

Development and Characterization of a PSMA-targeting Antibody for SPECT/CT, Fluorescence Imaging and Targeted Photodynamic Therapy of PSMA-expressing Tumors

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 39 – S40

DOI
Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin

Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. 15 Suppl., S. e15121

DOI (Open Access)
Schotten, Clemens; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, Amr; Müller, Stefan; Schulze, Maren; Neumann, Ursula; Raduenz, Sonia; Heider, Dominik; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan

Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCC

In: Hepatology. Hoboken: Wiley & Sons, Jg. 68, 2018, Nr. S1, S. 852A – 853A

DOI
Oernek, A.; Umutlu, Lale; Li, Y.; Kirchner, J.; Herrmann, Ken; Ruhlmann, Verena

Inflammation focus search with 18F-FDG-PET/MRI: comparative or additive value of PET and MRI

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 259 – S260

DOI
Martin, O.; Kirchner, J.; Buchbender, C.; Antoch, G.; Herrmann, Ken; Suntharalingam, S.; Forsting, Michael; Umutlu, Lale

Intraindividual comparison of subsequently performed PET/MRI to PET/CT for whole-body staging : Results of a unicenter trial in 1000 patients

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 210 – S211

DOI
Kebir, Sied; Lazaridis, Lazaros; Weber, Manuel; Deuschl, Cornelius; Stoppek, Ann-Kathrin; Schmidt, Teresa; Boehm, Judith; Mönninghoff, Christoph; Scheffler, Björn; Keyvani, Kathy; Pierscianek, Daniela; Sure, Ulrich; Kleinschnitz, Christoph; Herrmann, Ken; Glas, Martin

NIMG-32. COMPARISON OF L-METHYL-11C-METHIONINE POSITRON EMISSION TOMOGRAPHY WITH MAGNETIC RESONANCE SPECTROSCOPY IN DETECTING NEWLY DIAGNOSED GLIOMA
23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,

In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 20, 2018, Nr. suppl_6, S. vi182 – vi183

DOI (Open Access)
Kirchner, J.; Sawicki, L. M.; Schaarschmidt, B. M.; Umutlu, Lale; Herrmann, Ken; Buchbender, C.; Antoch, G.; Heusch, P.

Prospective comparison of F-18-FDG PET/MRI and F-18-FDG PET/CT for thoracic staging of non-small cell lung cancer

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. S502 Abstract EP-0517

DOI
Happel, C.; Kranert, W.T.; Gruenwald, F.; Herrmann, Ken

Radiation induced stunning in patients suffering from benign thyroid diseases due to pre-therapeutic radioiodine-131 uptake test

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 351 – S352

DOI

Beiträge in Sammelwerken und Tagungsbänden

Jaus, Alexander; Seibold, Constantin; Reiß, Simon; Heine, Lukas; Schily, Anton; Kim, Moon; Bahnsen, Fin Hendrik; Herrmann, Ken; Stiefelhagen, Rainer; Kleesiek, Jens

Anatomy-Guided Pathology Segmentation

In: Medical Image Computing and Computer Assisted Intervention – MICCAI 2024: 27th International Conference, Marrakesh, Morocco, October 6–10, 2024, Proceedings, Part VIII / MICCAI 2024, 27th International Conference, Marrakesh, Morocco, October 6–10, 2024 / Linguraru, Marius George; Dou, Qi; Feragen, Aasa (Hrsg.). Berlin: Springer Science and Business Media Deutschland GmbH, 2024, S. 3 – 13

DOI
Pomykala, Kelsey L.; Herrmann, Ken

Introduction : The Case for Radiopharmaceutical Therapy

In: Radiopharmaceutical Therapy / Bodei, Lisa; Lewis, Jason S.; Zeglis, Brian M. (Hrsg.). Berlin: Springer International Publishing, 2023, S. 3 – 11

DOI
Nagel, Isabel; Herrmann, Ken; Lahner, Harald; Rischpler, Christoph; Weber, Frank

Combined medical therapy, nuclear medicine therapy and other therapies in metastatic neuroendocrine tumor

In: Nuclear Medicine and Molecular Imaging: Volume 4: Nuclear Medicine Therapy / Signore, Alberto / Sathekge, Mike; Luster, Markus (Hrsg.). Amsterdam: Elsevier, 2022, S. 145 – 156

DOI
Husseini, Jad S.; Balza, Rene; Jarraya, Mohamed; Cañamaque, Lina Garcia; Barbato, Francesco; Herrmann, Ken; Picchio, Maria; Catalano, Onofrio Antonio

Musculoskeletal imaging

In: Clinical PET/MRI / Catalano, Onofrio Antonio (Hrsg.). London: Elsevier, 2022, S. 199 – 224

DOI
Lapa, Constantin; Herrmann, Ken; Troost, Esther G. C.

Specific PET Tracers for Solid Tumors and for Definition of the Biological Target Volume

In: Image-Guided High-Precision Radiotherapy / Troost, Esther G. C.. Cham: Springer, 2022, S. 31 – 53

DOI
Backer, Claus Maximilian; Bäumer, Christian; Bley, Aaron; Costa, Pedro Fragoso; Gerhardt, Marcel; Herrmann, Ken; Kauer, Samantha; Kroninger, Kevin; Nitsch, Christian; Siregar, Hilda Milani; Timmermann, Beate; Yazgan, Azad

Proton Beam Range Verification with Secondary Radiation from Titanium Implants

In: 2019 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2019 / IEEE Nuclear Science Symposium 2019 Manchester, 26 Oct.-2 Nov. 2019. Piscataway, NJ: Institute of Electrical and Electronics Engineers Inc., 2019

DOI
Lapa, Constantin; Kortüm, K. Martin; Herrmann, Ken

CXCR4-Directed Endoradiotherapy as New Treatment Option in Advanced Multiple Myeloma

In: Clinical Applications of Nuclear Medicine Targeted Therapy / Bombardieri, Emilio; Seregni, Ettore; Evangelista, Laura; Chiesa, Carlo; Chiti, Arturo. Cham: Springer International Publishing, 2018, S. 475 – 481

DOI
Umutlu, Lale; Herrmann, Ken

Current and emerging applications

In: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.). Cham: Springer, 2018, S. 1 – 8

DOI
Rezaee, Alireza; Herrmann, Ken; Raderer, Markus; Langsteger, Werner; Beheshti, Mohsen

Lung Cancer

In: PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging / Beheshti, Mohsen; Langsteger, Werner; Rezaee, Alireza (Hrsg.). Philadelphia: Elsevier, 2018, S. 23 – 42

DOI

Bücher/Sammelwerke/Tagungsbände

Veit-Haibach, Patrick; Herrmann, Ken

Artificial Intelligence/Machine Learning in Nuclear Medicine and Hybrid Imaging

Cham: Springer International Publishing, 2022

DOI
Umutlu, Lale; Herrmann, Ken (Hrsg.)

PET/MR Imaging : Current and Emerging Applications

Cham: Springer International Publishing, 2018

DOI

Poster / Posterbeiträge

Pabst, Kim M.; Bartel, Timo; Sandach, Patrick; Laschinsky, Christina; Weber, Manuel M.; Kessler, Lukas; Küper, Alina T.; Hadaschik, Boris A.; Kesch, Claudia; Hamacher, Rainer; Kasper, Stefan; Podleska, Lars E.; Siveke, Jens T.; Eckstein, Markus; von Tresckow, Bastian; Kuemmel, Sherko; Reinacher-Schick, Anke; Uhl, Waldemar; Herrmann, Ken; Fendler, Wolfgang P.

68Ga-FAPI-46 PET/CT for cancer imaging : Results of a single-center, prospective, interventional, single-arm clinical trial
2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 457

DOI
Kesch, Claudia; Meyer, Volker; Praus, Christine; Fragoso Costa, Pedro; Ingenwerth, Marc; Darr, Christopher; Radtke, Jan Philipp; Theysohn, Jens M; Schaarschmidt, Benedikt; Reis, Henning; Fendler, Wolfgang Peter; Grünwald, Viktor; Hadaschik, Boris A.; Herrmann, Ken

A phase I/II study of neoadjuvant, intra-arterial administration of (177Lu)lutetium vipivotide tetraxetan in subjects with high-risk, localised or locally advanced prostate cancer (LUPUS)
2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, TPS431

DOI
Juarez Casillas, Jesus Eduardo; Hope, Thomas A.; Calais, Jeremie; Fendler, Wolfgang Peter; Eiber, Matthias; Jiang, Fei; Moradi Tuchayi, Abuzar; Herrmann, Ken; Murthy, Vishnu; Willner, Luisa; Nguyen, Andrew; Karpinski, Madeleine J.; Theus, Lela; Hekimsoy, Türkay; Kretschmer, Alexander; McCarthy, Sharon; Miladinovic, Branko; Price, Megan; Bourla, Ariel B.; Zamalloa, Jose

Association of PSMA PET results at biochemical recurrence (BCR) with metastasis free survival (MFS) by conventional imaging (CI) in patients with locally advanced or high-risk localized prostate cancer initially treated with radical prostatectomy (RP) : A retrospective multicenter study
2025 ASCO Genitourinary Cancers Symposium, 13 - 15 February 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 355

DOI
Yazdanpanah, Omid; Calais, Jeremie; Chi, Kim N.; De Bono, Johann S.; Deymann, Sheila; El-Haddad, Ghassan; Herrmann, Ken; Fizazi, Karim; Ospina Gonzalez, Diego; Kendi, Ayse T.; Krause, Bernd J.; Morris, Michael J.; Nagarajah, James; Nordquist, Luke; Sartor, Alton Oliver; Rahbar, Kambiz; Tagawa, Scott T.; Vaishampayan, Nitin; Yue, Ye; Rezazadeh, Arash

Efficacy of 177Lu-PSMA-617 with or without ARPIs for the treatment of mCRPC : VISION secondary analysis
2025 ASCO Genitourinary Cancers Symposium, January 13-15, 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 121

DOI
Gudenkauf, Lisa Marie; Telli, Tugce; Delker, Astrid; Simon, Danielle F.; Jim, Heather S.L.; Oswald, Laura B.; Li, Xiaoyin; Hoogland, Aasha; Dicker, Adam P.; Tagawa, Scott T.; Cella, David; Hofman, Michael S.; Czernin, Johannes; Calais, Jeremie; Unterrainer, Lena; Fendler, Wolfgang Peter; Herrmann, Ken; El-Haddad, Ghassan; Gonzalez, Brian D.

Implementation and preliminary validity of the Functional Assessment of Cancer Therapy : Radionuclide Therapy (FACT-RNT) in patients receiving radionuclide therapy for prostate cancer
2025 ASCO Genitourinary Cancers Symposium, January 13-15, 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 118

DOI
Hadaschik, Boris A.; Von Amsberg, Gunhild; Herrmann, Ken; Merseburger, Axel Stuart; Goebell, Peter J.; Belleville, Erik; Fasching, Peter A.; Haeberle, Lothar; Roessler, Andrea; Grimm, Marc-Oliver

Prostate Cancer Real World Evidence Registry (PROCARE) : Recurrent and metastatic prostate cancer
2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, TPS274

DOI
Fendler, Wolfgang Peter; Karpinski, Madeleine J.; Hoberück, Sebastian; Rauscher, Isabel; Unterrainer, Lena; Rasul, Sazan; Bjartell, Anders; Lanfranchi, Francesco; Di Giorgio, Andrea; Pfob, Christian Helmut; Soeterik, Timo; Goffin, Karolien; Kind, Felix; Miksch, Jonathan; Calais, Jeremie; Hofman, Michael S.; Hope, Thomas A.; Herrmann, Ken; Hadaschik, Boris A.; Rahbar, Kambiz; PROMISE Registry Group

Prostate cancer risk groups by PSMA-PET PROMISE (PPP) : Results from an international multi-center registry study
2025 ASCO Genitourinary Cancers Symposium, January 13-15, 2025, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 266

DOI
Krafft, Ulrich; Grünwald, Viktor; Fendler, Wolfgang P.; Herrmann, Ken; Reis, Henning; Roghmann, Florian; Rahbar, Kambiz; Heidenreich, Axel; Giesel, Frederik; Niegisch, Guenter; Hadaschik, Boris A.

A randomized phase I/II study of neoadjuvant treatment with 177-Lutetium-PSMA-617 with or without ipilimumab in patients with very high-risk prostate cancer who are candidates for radical prostatectomy (NEPI trial)
2024 ASCO Genitourinary Cancers Symposium, January 25-27, 2024, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, TPS352

DOI
Ramonaheng, K.; Qebetu, M.; Ndlovu, H.; Kabunda, J.; Mokoala, K.; Smith, L.; Swanepoel, C.; Davis, C.; Mathiba, R.; Singh, K.; Mathabe, K.; Khanyile, R.; Mashudu, M.; Makvandi, M.; Kovacs, J.; Horton, J.; Herrmann, Ken; Sathekge, M.

Allometric scaling of preclinical dosimetry for the Nectin-4 miniprotein binders AKY-807 and AKY-1189 accurately predicts human absorbed dose to major organs
36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 23-25 October 2024, Barcelona, Spain,

In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 211, 2024, Nr. Supplement 1:36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, S. S116 – S117

DOI
Kersting, David; Kim, Moon-Sung; Püllen, Lukas; Seidl-Rathkopf, Kathi; Schinwald, Nicole; Mpofu, Philani; Altomare, Ivy; Sujenthiran, Arun; Royce, Trevor Joseph; Buhl, Christoph; Grünwald, Viktor; Herrmann, Ken; Kleesiek, Jens; Hadaschik, Boris A.

Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting
2024 ASCO Genitourinary Cancers Symposium, January 25 - 27, 2024, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 143

DOI
Unterrainer, Lena; Hope, Thomas A.; Fendler, Wolfgang P.; Ndlovu, Honest; Barbato, Francesco; Sathekge, Mike; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie

Low- and high-volume disease in mHSPC, from CHAARTED to PSMA-PET : An international multicenter retrospective study
2024 ASCO Genitourinary Cancers Symposium, January 25-27, 2024, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 44

DOI
Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang P.; Hadaschik, Boris A.; Rowe, Steven P.; Herrmann, Ken; Calais, Jeremie; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.; Farolfi, Andrea

Response evaluation criteria in PSMA PET/CT (RECIP 1.0) in metastatic castration-resistant prostate cancer
2024 ASCO Genitourinary Cancers Symposium, January 25–27, 2024, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 45

DOI
Nikitas, John; Lam, Ethan C.; Booker, Kiara M; Fendler, Wolfgang P.; Eiber, Matthias; Hadaschik, Boris A.; Herrmann, Ken; Hirmas, Nader; Lanzafame, Helena; Stuschke, Martin; Czernin, Johannes; Steinberg, Michael L.; Nickols, Nicholas George; Kishan, Amar Upadhyaya; Calais, Jeremie

Update from the PSMA-dRT trial : A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer
2024 ASCO Genitourinary Cancers Symposium, January 25–27, 2024, San Francisco, CA, USA,

In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Supplement 4, S. 291 – 291

DOI
Lanzafame, Helena; Hamacher, Rainer; Mavroeidi, Ilektra-Antonia; Pabst, Kim; Hirmas, Nader; Kessler, Lukas; Bartel, Timo; Leyser, Stephan; Barbato, Francesco; Schuler, Martin; Bauer, Sebastian; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.

68Ga-FAPI PET/CT novel diagnostic tool in sarcoma
Annual Congress of the European Association of Nuclear Medicine, 9-13 September, 2023, Vienna, Austria,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S414 – S415

DOI
Morris, M.J.; Armstrong, A.J.; Chi, K.N.N.; de Bono, J.S.; Herrmann, Ken; Krause, B.; Rahbar, K.; Sartor, O.; Tagawa, S.T.; Nagarajah, J.; Wei, X.X.; Nordquist, L.T.; Koshkin, V.S.; Saad, F.; Vickers, A.; Ghouse, R.; Wu, J.; Mirante, O.; Fizazi, K.

Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S979 – S980

DOI
Unterrainer, L.M.; Hope, T.; Fendler, Wolfgang; Ndlovu, H.; Barbato, F.; Sathekge, M.; Herrmann, Ken; Czernin, J.; Calais, J.

Low- and high-volume disease in mHSPC : From CHAARTED to PSMA PET
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S967

DOI
Wei, X.X.; Chi, K.N.N.; de Bono, J.S.; Fizazi, K.; Krause, B.; Herrmann, Ken; Rahbar, K.; Tagawa, S.T.; Morris, M.J.; Meisel, A.; Holder, G.; Mirante, O.; Wu, J.; Sartor, O.

Prognostic value of neutrophil-to-lymphocyte ratio and lymphopenia in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with [177Lu]Lu-PSMA-617 : VISION post hoc analysis
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,

In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S995 – S996

DOI (Open Access)
Zehnder, A.; Castillo, J.; Bouterfa, H.; Reis, H.; Kaufmann, J.; Keller, U.; Gotthardt, M.; Weber, W.; Ferreri, A.; Kraeber-Bodéré, F.; Madsen, J.; Herrmann, Ken

A planned, prospective, international, multi-center, open-label, single-arm phase II study investigating the predictive value of [68Ga]GaPentixaFor PET imaging in primary and isolated secondary CNS lymphoma patients
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S415

DOI (Open Access)
Sraieb, Miriam; Coelho, M.; Himmen, Stefan; Pabst, K. M.; Kazek, S.; Rischpler, Christoph; Fendler, Wolfgang P.; Herrmann, Ken; Costa, P.; Jentzen, Walter

Comparison of the Safety and Tolerability of Paraaminohippurate (PAH) and Amino Acid (AA) Co-Infusion in Patients with Neuroendocrine Tumours Receiving Peptide Receptor Radionuclide Therapy (PRRT) : A Case Series of Eight Patients
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S579

DOI (Open Access)
Hautzel, H.; Bartel, T.; Darwiche, Kaid; Aigner, Clemens; Taube, Christian; Herrmann, Ken

Determination of the Efficiency of Filter Pads in expiratory Filters with 99mTc-labelled Graphite Eerosol
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,

In: Pneumologie. Stuttgart: Thieme, Jg. 76, 2022, Nr. Supplement 1, S. S68

DOI
Hautzel, H.; Bartel, T.; Darwiche, Kaid; Aigner, Clemens; Taube, Christian; Herrmann, Ken

Expiratory filter sets substantially reduce exhaled small bioaerosol particles and potential COVID-19 virus load
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S318

DOI (Open Access)
Pogorzelski, M.; Fendler, Wolfgang; Berliner, C.; Hussain, T.; Lang, Stephan; Ting, Saskia; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Gauler, Thomas; Stuschke, Martin; Laue, K.; Herrmann, Ken; Grünwald, Viktor; Schuler, Martin; Kasper-Virchow, S.

Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,

In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 230 – 231

DOI (Open Access)
Kersting, David; Jentzen, Walter; Jeromin, D.; Mavroeidi, I.; Conti, M.; Büther, F.; Herrmann, Ken; Rischpler, Christoph; Hamacher, R.; Fendler, Wolfgang P.; Seifert, R.; Fragoso Costa, P.

Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S636

DOI (Open Access)
Leyh, Catherine; Heucke, Niklas; Schotten, Clemens; Büchter, Matthias; Bechmann, Lars; Wichert, Marc; Dechene, Alexander; Herrmann, Ken; Katsounas, Antonios; Özcürümez, Mustafa; Heider, Dominik; Sydor, Svenja; Ludwig, Johannes M.; Theysohn, Jens; Damm, Robert; Powerski, Maciej; Pech, Maciej; Canbay, Ali; Weigt, Jochen; Keitel-Anselmino, Verena; Lange, Christian; Best, Jan; Manka, Paul

LiMAx faciliates patient selection prior radioembolization for patients with hepatocellular carcinoma in liver cirrhosis
The International Liver Congress 2022 ; 22-26 June 2022, London, UK,

In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 77, 2022, Nr. Supplement 1: Abstracts of The International Liver CongressTM 2022, S. S378 – S379

DOI (Open Access)
Zaremba, Anne; Ferdinandus, J.; Zimmer, Lisa; Umutlu, Lale; Seifert, R.; Barbato, F.; Ugurel, Selma; Chorti, E.; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth

Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, Hamburg, Germany and Virtual,

In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 19, 2021, Nr. Suppl. 4, S. 75 – 76

DOI (Open Access)
Fragoso Costa, Pedro; Jentzen, Walter; Süßelbeck, Florian; Fendler, Wolfgang P.; Rischpler, Christoph; Herrmann, Ken; Conti, M.; Kersting, David; Weber, Manuel

Emission time optimisation for [68Ga]Ga-PSMA-11 with a SiPM PET/CT based on phantom measurements
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S256

DOI (Open Access)
Fragoso Costa, Pedro; Bramer, A.; Weber, Manuel; Kersting, David; Conti, M.; Fendler, Wolfgang P.; Rischpler, Christoph; Herrmann, Ken; Jentzen, Walter

Emission time reduction for 2-[18F]FDG examinations in lymphoma patients with a PET/CT with SiPM - a feasibility phantom study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,

In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S257 – S258

DOI (Open Access)

ZIM

Zentrum für Informations- und Mediendienste

Personensuche

Personensuche

Prof. Dr. med. Ken Herrmann

Funktionen

Direktor, Klinik für Nuklearmedizin

Aktuelle Veranstaltungen

WiSe 2025

Vergangene Veranstaltungen (max. 10)

SoSe 2025

Artikel in Zeitschriften

Aufsätze

Vorworte / Nachworte

Interviews

Abstracts

Beiträge in Sammelwerken und Tagungsbänden

Bücher/Sammelwerke/Tagungsbände

Poster / Posterbeiträge